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Abstract
At every moment, our brain is bombarded with sensory information. How we filter and
process sensory information is critical for daily functioning and cognition. Examples of sensory
filtering include habituation (a progressive decrease in responding) and prepulse inhibition (PPI,
gating of responding). Our aim is to understand the differential role acetylcholine (ACh) plays in
these processes.
To study this we used both reflexive (acoustic startle response: ASR) and non-reflexive
(locomotor) behaviours. PPI is hypothesized to occur via inhibitory cholinergic projections from
the Pedunculopontine Tegmental Nucleus (PPT) to the startle pathway. The role of ACh in
habituation of reflexive and non-reflexive behaviours is controversial. We found that, contrary
to the predictions of the field, ACh modulated, not mediated, PPI. There was no impairment of
PPI in cholinergic deficient mice. When we inhibited PPT cholinergic neurons using DREADDs
we did not detect an impairment of PPI. Likewise, we were unable to induce PPI by optogenetic
activation of these neurons.
Instead we found that cholinergic function is critical for long-term habituation
(decrement occurring across days) as cholinergic deficient mice showed an impairment which
was rescued by galantamine. Furthermore, inhibition of PPT cholinergic cells decreased startle
magnitude, whereas optogenetic activation of cholinergic PPT neurons increased startle. This
demonstrates that these neurons are critical for regulating startle reactivity. Despite
modulating reflexive behaviours, PPT cholinergic inhibition did not impact habituation of
locomotion, re-affirming differential regulation of habituation of reflexive and non-reflexive
behaviours.
i

To uncover which cholinergic receptor type mediates effects on PPI and habituation we
used an α7-nicotinic acetylcholine receptor (nAChR) knock-out mouse. These mice displayed a
mild impairment of PPI, and no enhancement of startle magnitude or PPI via nicotine. This
suggests ACh modulates PPI through this receptor, and confirms that cholinergic function
enhances startle. Of interest, optogenetic enhancement of startle was blocked by nAChR
antagonism.
In conclusion, we demonstrate that ACh modulates PPI through α7-nAChRs and that
ACh is critical for regulating startle reactivity, indicating a potential role in long-term
habituation or sensitization of startle. In contrast to the common view, cholinergic PPT function
does not inhibit startle, ruling out a mechanistic role in PPI.

Keywords: Sensory Filtering, Sensorimotor Gating, Acoustic Startle Response, Habituation,
Prepulse Inhibition, Acetylcholine, Pedunculopontine Tegmental Nucleus, Nicotinic Receptors,
α7 Nicotinic Receptors, Locomotion, Sensitization, DREADDs, Optogenetics
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1. Chapter 1: General Introduction

1.1 Modulations of the Acoustic Startle Response as a Tool to Study Information Processing
Within the Brain
We live in a complex sensory world. The ability to filter sensory information is critical for
accurate sensory information processing. In most instances, the filtering of sensory information
is pre-attentive and can occur on different levels within sensory pathways. The ability to reduce
the brain’s awareness and behavioural responding to unnecessary sensory information is critical
for proper daily functioning. Several psychiatric syndromes, including Schizophrenia and Autism
Spectrum Disorders, are associated with disrupted sensory filtering. Sensory filtering can be
analyzed in many different ways. However, in rodents and humans a commonly used measure is
the acoustic startle response (ASR).
The ASR, as will be discussed in more detail in the following section, is a plastic response.
It is subject to both enhancement, e.g. sensitization or prepulse facilitation, or attenuation, e.g.
habituation and prepulse inhibition (PPI). Briefly, habituation is defined as the gradual decrease
in startle magnitude to a startling stimulus after repeated exposure. This is an example of sensory
filtering, which is thought to reduce the cognitive load of redundant sensory information so that
the brain has more available resources to exert elsewhere. Prepulse Inhibition also reflects a
decrease in startle; however it is due to the presence of a pre-pulse prior to the startling stimulus.
PPI can be thought of as a gate-keeper, preventing irrelevant information from conscious
awareness and thus precluding useless attentional and energy expenditure; it is often referred
to as sensorimotor gating. Many studies in both animals and humans use habituation and PPI of
the ASR as measures of sensory filtering and/or sensorimotor gating.
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1.1.1 How We Process Sensory Information is Critical for Higher Order Cognitive Function
Sensory filtering and sensorimotor gating are pre-attentive processes. This type of basic
cognition can provide the building blocks for higher-order cognitive function. By reducing the
cognitive load of unnecessary sensory information, the brain has more available resources to
exert elsewhere. On the other hand, PPI and habituation may be a proxy measure for the speed
or efficiency of information processing within the brain. Evidence for this idea stems from studies
that have found that sensory filtering and sensorimotor gating mechanisms correlate with higher
cognitive function. For example, PPI efficacy has been correlated with spatial working memory in
rodents (Singer et al., 2013; Oliveras et al., 2015). Additionally, rats selectively bred for low PPI
showed increased perseverative errors across spatial and operant conditioning tasks
(Freudenberg et al., 2007).
Many psychiatric illnesses display sensory filtering and PPI deficits (see section 1.1.2 for
more detail), and within these disorders the severity of PPI or habituation deficits can correlate
with cognitive functions across a variety of tasks. For example, in Schizophrenic patients, PPI
deficits correlate with performance on the Global Assessment of Functioning Scale (Swerdlow et
al., 2006) and severity of symptoms as assessed by the 18-item Brief Psychiatric Rating Scale score
(Hazlett et al., 2007).
As sensory filtering and sensorimotor gating seem to be indicative of higher cognitive
function, understanding the mechanisms underlying these processes may provide principles that
could apply to the understanding of higher cognitive function and their disruptions as well.

3

1.1.2 Habituation and PPI Deficits are Present in a Number of Psychiatric Illnesses
A major behavioural hallmark of Schizophrenia is a deficit in sensorimotor gating as
assessed by a disruption in PPI (Braff and Geyer, 1990; Parwani et al., 2000; Braff et al., 2001;
Wynn et al., 2007; Takahashi et al., 2008). This deficit in inhibitory gating has been proposed to
be linked to the hyper-vigilance displayed by these patients, suggesting that they over-process
information within their environment (Freedman et al., 1994). PPI deficits are also present in a
number of other psychiatric illnesses including Obsessive Compulsive Disorder (OCD), Tourette’s
Syndrome, Anxiety Disorders, and Huntington’s Disorder (as reviewed by Braff et al., 2001; Geyer,
2006).
Impairments of PPI are thought reflect fundamental aspects of inhibitory processing that
are differentially impacted in a variety of illnesses. For example, deficits of PPI in OCD and
Schizophrenia may reflect a deficit in the gating of sensory and cognitive information whereas
Tourette’s and Huntington’s reflect a reduced ability to gate motor responses. Whether this
reflects co-morbidity or diagnostic overlap of impaired global inhibitory processes is unclear
(Geyer, 2006).
Impairments of habituation of the startle response has been shown in animal models of
Fragile X Syndrome (Nielsen et al., 2002), and Autism Spectrum Disorders (Ornitz et al., 1993)
(however see Perry et al., 2007). Schizophrenic patients display impairments of both habituation
and PPI of the startle response (Braff et al., 1992; Ludewig et al., 2002; Ludewig et al., 2003);
whereas people suffering from OCD have normal habituation but impaired PPI (Hoenig et al.,
2005). Impairments of habituation versus PPI may reflect subtle differences in cognitive deficits,
but what these might be has not been extensively examined. Regardless, understanding the
4

mechanisms underlying both habituation and PPI may help improve treatment of these disorders
and provide new drug targets.

1.1.3 The Acoustic Startle Response is an Excellent Tool to Investigate Information Processing
As mentioned, we use the ASR as a tool to study both habituation and PPI. The startle
response is highly conserved across evolution. It occurs across species from invertebrates to
humans. It is a multi-modal response and can be induced by visual, tactile, vestibular, and or
auditory stimuli (Davis, 1984; Koch, 1999). Any sudden acoustic stimulus louder than 80 dB can
elicit the ASR (Koch, 1999). This reflex commences with closure of the eyelids, followed by muscle
contractions in the face, neck and skeletal muscles (Koch and Schnitzler, 1997; Koch, 1999). This
is also accompanied by acceleration in heart rate and an arrest of ongoing behaviour (Gogan,
1970).
The ASR is highly adaptive, and it is an instinctive behaviour. Pilz and Schnitzler (1996)
suggested that startling to an intense stimulus allows an organism to orient to potentially
threatening stimuli and assess behavioural output accordingly. As startling halts ongoing
behaviour, induces stiffening of neck musculature, limb flexion, and eyelid closure, it prepares
the organism for a fight or flight response and protects vital organs in case of attack or injury.
The ASR is an innate behaviour and requires no learning. It is functional as soon as the auditory
system has been developed, which in rodents is as early as postnatal day 12 (Sheets et al., 1988;
Kungel et al., 1996). The simplicity of the ASR pathway is fitting with the very short motor
response latency (5-10 ms) observed following the onset of acoustic stimulation.
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The primary startle pathway is well described. The sound is transduced into neuronal
signals by hair cells of the inner ear which are innervated by spiral ganglion cells that project to
the cochlear root (in rodents) and cochlear nucleus. The cochlear root neuron sends direct
glutamatergic sensory afferents to the caudal pontine reticular nucleus (PnC), where they
synapse on giant neurons. The giant neurons in turn directly synapse on facial, cranial and
motoneurons in the spinal cord which when activated elicit a motor response (Davis et al., 1982a;
Davis et al., 1982b; Koch et al., 1992; Lingenhohl and Friauf, 1992; Koch and Schnitzler, 1997). For
schematic representation of this pathway please refer to figure 1.1.
This circuitry highlights the PnC as the sensorimotor interface of the ASR (Lingenhohl and
Friauf, 1994). This area consolidates sensory information and transforms it into an adaptive
behavioural output. The PnC does not only receive sensory projections, however. It also receives
afferents from higher brain areas which can serve to modulate the startle response, making the
ASR a plastic response (for review see Koch, 1999). As discussed previously, the ASR is subject to
both enhancement and attenuation.

Figure 1.1 The Primary Startle Pathway
When a sound is detected by the ear it activates the auditory pathway. If the sound is
sufficiently loud, this will cause excitation of the giant neurons in the PnC, which directly
6

innervate motor neurons of the spinal cord, eliciting a startle response. Adapted from (SimonsWeidenmaier et al., 2006).
1.2 An Introduction to Sensory Filtering: Habituation
Habituation is a modulation of information processing and is a form of non-associative
learning. It refers to the progressive decrease of a behavioural response following repeated
exposure to the behaviour-inducing stimuli. Virtually any behaviour can be subject to
habituation. This review will focus on habituation of reflexes, like the ASR, and habituation of
motivated behaviors, like locomotion.
Habituation of the ASR is denoted by the decrease in startle amplitude after repeated
presentation of a loud, intense sound. In some organisms, such as C. Elegans it is a decrease in
startle probability and not magnitude. In mammals, this decrement is most commonly negatively
exponential and eventually, with continued exposure, reaches an asymptotic level of stable
response magnitude (Rankin et al., 2009). If the stimulus is re-introduced after a prolonged
period of absence, the organism will respond highly again, but this response will not be quite as
great when it was presented for the first time (Thompson and Spencer, 1966).
This process of habituation is considered an adaptive form of learning. It is separated from
simple muscle or receptor fatigue by displaying 10 core characteristics (for review see Rankin et
al., 2009). Most critically, these include that habituation is stimulus specific, subject to
spontaneous recovery, and lasts longer when it is induced by lower frequency stimulation (Best
et al., 2005; Rankin, 2009). Habituation is adaptive as the unconditioned stimulus, the loud noise,
contains no biologically relevant information. By lessening responding, the organism prevents
useless expenditure of energy and attention (Koch, 1999).
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1.2.1 There are Two Types of Habituation: Short and Long-Term
There are two forms of habituation, short-term and long-term. Short-term habituation
refers to the decrease in startle magnitude that occurs when a loud sound is presented
repeatedly within a short time span. Typically in a lab setting, short-term habituation occurs
across trials within a single testing session. However, long-term habituation refers to the
attenuation of startle that occurs across multiple testing sessions, or days.
A debate exists about whether short-term and long-term habituation are mediated by the
same processes. Traditionally, it was thought that short-term habituation is non-associative,
whereas long-term habituation was an associative learning process that involves retrieval
mechanisms (Davis, 1970; Wagner, 1981; Sanderson and Bannerman, 2011). However, recent
studies have suggested that long-term habituation is also non-associative (Pilz et al., 2014).
Despite both being non-associative, the neuronal underpinnings of these processes are
very different. The mechanism underlying short-term habituation occurs directly within the
startle pathway. It is largely hypothesized to be due to presynaptic depression, mediated by BK
channels, between the secondary auditory afferent neurons and the giant neurons of the PnC
(Weber et al., 2002; Simons-Weidenmaier et al., 2006; Typlt et al., 2013).
Much less is known about the mediation of long-term habituation of startle. Studies have
implicated multiple brain structures. De-cerebrated rats show intact short-term but severely
disrupted long-term habituation, providing evidence for involvement of the cortex (Leaton et al.,
1985). While this was re-affirmed by Groves et al. (1974), they also noted that lesions to the
posterior aspect of the mesencephalic reticular formation also resulted in an absence of longterm habituation. However, this was accompanied by a large reduction in startle magnitude as
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well, making interpretation of the results difficult. Other studies demonstrated that the
cerebellar vermis was critical (Timmann et al., 1998), as lesions to this area cause disruptions in
long-term habituation (Leaton and Supple, 1986). Clearly, a greater understanding of the
mechanisms and structures underlying long-term habituation is needed.

1.2.2 Habituation and Sensitization: The Dual Process Theory
The most prominent theory of habituation was proposed by Groves and Thompson (1970)
termed the dual process theory. Although this theory is applicable to the habituation of all
behaviours, for ease it will be discussed using habituation of the ASR as an example. Groves and
Thompson suggested that following repeated exposure to a stimulus, behavioural outcome is
dependent on two opposing processes: habituation and sensitization.

Behaviourally,

sensitization is the opposite of habituation, an enhancement of response magnitude (Koch,
1999).
Groves and Thompson hypothesized that habituation occurs within the stimulusresponse pathway (which in this case would be the primary startle pathway), and that
sensitization occurs in a separate “state” pathway (see also Poon and Schmid, 2012). Repeated
exposure to a startling stimulus simultaneously activates both sensitization and habituation
pathways. The input of these pathways is integrated at some point of the startle pathway, a likely
candidate would be the PnC (Lingenhohl and Friauf, 1994), and the behavioural output equals
the summative activity of these opposing processes.
The balance between sensitization and habituation is not only detectable on the resulting
startle amplitude. The onset latency of the startle response itself is thought to reflect a state of
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sensitization. In general, startle amplitude is negatively correlated with startle latency. However,
in studies with testing parameters promoting habituation, startle latency decreases with startle
amplitude. This is thought to be a reflection of a parallel increase in sensitization that impacts
latency rather than the startle amplitude (Pilz and Schnitzler, 1996).
The neuronal underpinnings of the pathway of startle sensitization have not been well
established. Furthermore, within the literature it is hard to distinguish if any manipulations that
result in an increased startle reactivity in general can be classified as a mechanism of
sensitization. Fear-potentiation of startle, where an aversive-conditioned stimulus is presented
before a startling sound, has been well studied, but it is unclear if these mechanisms reflect the
same type of plasticity required for general (non-associative) sensitization of the startle response.
Regardless, sensitization of the startle response can be induced with electrical stimulation of the
amygdala, an effect that was most reliably induced when stimulation sites targeted the ventral
amygdalofugal pathway, which projects to lower brainstem nuclei (Rosen and Davis, 1988).
Although the amygdala has direct projections to the startle-mediating PnC, it appears
that startle sensitization is relayed through intermediary nuclei. Potential relay sites include the
periaqueductal grey area, substania nigra, deep mesencephalic nucleus, laterodorsal tegmental
(LDT) or pedunculopontine tegmental nucleus (PPT; Hitchcock and Davis, 1986; Yeomans and
Pollard, 1993; Fendt et al., 1994; Krase et al., 1994; Frankland et al., 1995; Frankland and
Yeomans, 1995). Interestingly, electrical stimulation at certain potential relay centers (e.g. the
PPT) can induce startle-like responses (Yeomans and Pollard, 1993).
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The neuropeptide Substance P has also been strongly linked to unconditioned
sensitization of startle (Krase et al., 1994). Interestingly, Kungel et al. (1994) found that Substance
P innervation of the PnC mainly came from the PPT and LDT, and not the amygdala. They also
observed that Substance P’s ability to increase excitability of PnC neurons was increased with the
co-administration of a cholinergic agonist. A subset of cholinergic midbrain neurons, including
those in the PPT, are known to co-express Substance P markers (Standaert et al., 1986).
Additionally, a rat line with hypocholinergia (Flinders Resistant Line) showed a decreased startle
response magnitude, as well as sensitization of startle to tones (Markou et al., 1994). Taken
together, this may suggest that cholinergic PPT function could be involved in sensitization of the
startle response. However, a more widely accepted view of cholinergic-midbrain function has
been that these neurons inhibit, or decrease, startle and that this is a mechanism for prepulse
inhibition, as discussed in section 1.3.4 and 1.4.3.

1.2.3 Comparing Habituation of Reflexive vs. Non-Reflexive Behaviours
Previously, we discussed habituation in terms of the ASR, but habituation is not limited to
just reflexive behaviours: it is applicable to all behaviours. Incremental attenuation of nonreflexive behaviours, in the literature referred to as emitted or motivated behaviours, are also
important processes to understand. Research on habituation of non-reflexive behaviours can
focus on everything from habituation of food foraging, aggression, to exploratory behaviour.
Here, we focus on the latter, which is reflected in the habituation of locomotion in a new
environment.
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Habituation of locomotor behaviour generally displays the same features as habituation
of reflexive behaviours. Both behaviours show short-term (intra-session) and long-term (intersession) habituation. Overall, the principles discussed in section 1.2.1 can also extend to emitted
behaviours. The most important shared feature is that habituation of non-reflexive behaviours is
also not due to muscle or receptor fatigue (Rankin et al., 2009). Additionally, Muller and
colleagues (1994) also defined decreases of locomotion within a testing session to reflect
adaptation and decreases across sessions to reflect both adaptation and a memory for the
environment. Groves and Thompson’s dual process theory of habituation is also applicable to
locomotor behaviour as Welker (1957) found that the motivational state of an animal can greatly
alter habituation of locomotion. Therefore, both reflexive and non-reflexive habituation is
subject to the same behavioural principles; however the underlying physiological mechanisms
are thought to be very different.
This idea is best illustrated in a study by Williams, Hamilton and Carlton (1975). They
examined both habituation of the ASR and locomotion. They observed that the two processes
were ontogenetically dissociable. Habituation of locomotion differs according to age. Habituation
of locomotion was not present in rodents younger than 13 days, but was present in older rodents,
whereas habituation of the startle response was present as early as 13 days of age. This suggested
that the two processes are actually mediated by distinct physiological mechanisms.

1.2.4 Habituation of the ASR and Acetylcholine
One of the first general theories of habituation was proposed by Carlton (1968). This
theory stated that acetylcholine (ACh) was the neurotransmitter which mediated all inhibitory
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processes, including habituation. Later studies, however, have greatly refuted this idea. There
has been little evidence to suggest that ACh has a role in short term habituation of the ASR. In
fact, most research has concluded that ACh is not involved in habituation of reflexes (Hughes,
1984). Across a variety of species, and developmental stages, anticholinergics have had no effect
of the short-term habituation of the startle response (Williams et al., 1975; Brown, 1976).
Interestingly, none of these studies investigated long-term habituation. This is surprising
as ACh innervates the entire brain, and is well poised to regulate a global process like long-term
habituation. In part this could be because chronic manipulation of the cholinergic system was not
available at the time these studies were performed, and it is likely that studying long-term
habituation would require chronic rather than transient alterations. The cerebellar vermis, one
of the structures linked to long-term habituation does receive cholinergic input from the lateral
reticular nuclei (Barmack et al., 1992a; Barmack et al., 1992b). Furthermore, the mesencephalic
reticular formation that has also been linked to long-term habituation, houses two cholinergic
cell groups, the LDT and PPT. Despite this, no current study has looked at long-term habituation
of the startle response and the role of ACh. This will be one of the goals of this thesis.

1.2.5 Habituation of Locomotor Behaviour and Acetylcholine
As previously discussed, there is little evidence to suggest that ACh is involved in
habituation of the ASR, but there is much more evidence to suggest that ACh is very important
for habituation of locomotor behaviour. The differential role that ACh plays in the habituation of
locomotor behaviour compared to the ASR once again reiterates that the primary physiological

13

mechanisms of underlying these processes are distinct, as evidenced by different ontogenetic
and cholinergic regulation.
There are many studies that have sought to understand the role of cholinergic function in
habituation of locomotion. General septal cholinergic lesions by 192 IgG-saporin produced
deficits in short-term habituation, but it also produced a decrease in overall locomotor behaviour
compared to controls (Lamprea et al., 2003). Other studies have used in vivo microdialysis to
monitor the profile of ACh release during open field tasks. In the hippocampus, it was observed
that when rats are exposed to novel environments, extracellular ACh levels increased and that
this is correlated with increased locomotor and exploratory behaviour (Ikegami, 1994; Thiel et
al., 1998; Giovannini et al., 2001). This could suggest that ACh is important for encoding
memories about new environments, or that it is somehow inducing increased motor activity.
Theil and colleagues (1998) provide evidence against the later argument. They re-exposed
animals to the same environment the following day and found that ACh levels increased again,
but that locomotor behaviour decreased compared to the first exposure. In summary, evidence
suggests that ACh has a role in the process of both short- and long-term habituation of
locomotion whether through memory formation or arousal. Regardless, the cellular
mechanism(s) and the potential cholinergic receptor subtypes involved remain elusive.
1.2.5 Habituation of Locomotor Behaviour and Cholinergic Receptors
ACh binds to two distinct receptor types: nicotinic and muscarinic receptors. Muscarinic
receptors are metabotropic; there are 5 types of muscarinic receptors (M1-M5) all of which are
G-protein coupled receptors. Activation of M1, M3, and M5 leads to decreased K+ conductance
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thereby increasing neuronal excitability, whereas M2 and M4 activation leads to increased K+ and
decreased Ca+ conductance causing inhibition.
Green and Summerfield (1977) provided the first evidence of muscarinic receptor
involvement in habituation of locomotor behaviour. They administered the muscarinic
antagonist scopolamine and found that both short-term and long-term habituation were
disrupted (Ukai et al., 1994; Brodkin, 1999).
More recently Schildein and colleagues (2002) investigated the role of nicotinic receptors
in open field habituation. They found that local infusions of nicotine into the nucleus accumbens,
right after exposure to an open field task, improved long-term habituation. Fittingly, they also
observed that a general nicotinic antagonist, mecamylamine, disrupted this. If nicotine was given
5 hours after exposure to the open field, then again, they found disruptions in long-term
habituation. This suggested that nicotinic receptors play an important, time dependant role in
early consolidation phases of long-term habituation. While this provides an interesting basis for
the role of the nucleus accumbens nicotinic receptors in habituation learning, questions remain
about what specific nicotinic receptors are involved, and if there is a role for these receptors
outside of the nucleus accumbens in short-term habituation of locomotor or other behaviours,
as well as in the encoding processes of long-term habituation. Thus one of the goals of this thesis
will be to understand what role the α7-nAChR specifically is playing in short and long-term
habituation of locomotor behaviour and of the ASR.
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1.3 An Introduction to Sensorimotor Gating: Prepulse Inhibition
Prepulse inhibition (PPI) was first described by Sechenov in 1863 (Sechenov, 1863). Like
habituation, it is a pre-attentive mechanism which can reduce the cognitive burden of sensory
information. However, unlike habituation, PPI of the startle response is not a learned behaviour
(Koch, 1999); it occurs on the first trial. It can improve across days of repeated testing, known as
PPI learning (Plappert et al., 2006, Typlt et al., 2013), or be enhanced (or disrupted) through
associative conditioning of the prepulse (Li et al., 2009). Another critical distinction between PPI
and habituation is that PPI reflects a direct gating of a motor response, in this case the startle
response.
PPI occurs when the presentation of a weak pre-stimulus reduces the behavioural
response to a strong startling stimulus, the pulse (Peak, 1939; Hoffman and Fleshler, 1963). The
strength of this inhibition can vary and is partly dependent on the latency between the pulse and
prepulse, termed the interstimulus interval or ISI (Jones and Shannon, 2000a; Bosch and Schmid,
2008). PPI occurs at ISIs ranging between 10-1000 ms. A prepulse can be of the same sensory
modality as the startle pulse or PPI can be cross-modal. Current theories suggest that the
processing of the prepulse inhibits processing of the pulse, resulting in decreased startle (for
schematic representation see to figure 1.2).
The adaptive value of gating neural circuits is proposed to be the prevention of distractive
interference during concurrent neural activation, thereby acting as a protective processing
mechanism. Essentially, this prevents sensory information from flooding our brain and usurping
finite attentional capacities (Braff et al., 1992; Koch and Schnitzler, 1997; Wynn et al., 2004).
Another prominent theory regarding the adaptive function of PPI is that the prepulse facilitates
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orienting responses such as approach eye-saccades by activating neurons in the Superior
Colliculus while simultaneously inhibiting startle-mediating neurons in the brainstem. This is
thought to coordinate approach behaviours. By visually orienting to a stimulus and inhibiting eye
closure (that accompanies the startle response), PPI can be thought of as a very early form of
response selection (Yeomans, 2012).

Figure 1.2 Prepulse Inhibition
When a loud, intense acoustic stimulus is presented it induces a robust startle response. If a less
intense stimulus is presented, in this case termed the prepulse, it will not induce a startle
response. If a prepulse precedes a pulse by 10-1000 ms, this will greatly reduce the magnitude of
the startle reflex compared to when the pulse is presented alone. This attenuation of the startle
magnitude is referred to as prepulse inhibition (adapted from Koch, 1999)
1.3.1 Prepulse Inhibition vs. Prepulse Facilitation
The presence of a prepulse prior to a startling pulse does not always inhibit the ASR.
Prepulse Facilitation (PPF) describes the situation when the presence of a prepulse increases
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startle magnitude, compared to when the startling sound is presented alone. Whether PPF or PPI
is induced seems to be best predicted by ISI and prepulse type. Very short (>10-15 ms) or very
long (<1000 ms) ISIs tend to be the most effective at inducing PPF. While both discrete and
continuous prepulses (duration lasting throughout the entire ISI) can induce PPF, continuous
prepulses tend to be the most effective –especially at longer ISIs (Graham, 1975; Hsieh et al.,
2006).
One feature of both PPF and PPI is that they are disrupted in Schizophrenia (Wynn et al.,
2004); however they are thought to be separate, independent processes. They display different
time courses, different sensitivity to prepulse saliency, and are modulated differentially by
background sound and Gamma-aminobutyric acid (GABA) agonism (Graham, 1975; Ison et al.,
1997). They also have opposing effects on the response latency of startle: PPI tends to increase
response latency, whereas PPF decreases it (Ison et al., 1973).
The mechanisms and function of PPF have remained elusive. PPF is not due to temporal
summation of the prepulse and the startling pulse (Ison et al., 1997). One theory suggests that in
PPF the prepulse generally increases arousal, resulting in an increase in startle (Graham, 1975;
Reijmers and Peeters, 1994), however there is evidence as well to suggest this may not be the
case (Ison et al., 1997). For example, several studies suggest that PPF reflects an orienting or
attentional mechanism by which a prepulse stimulus leads to an enhanced startle response
(Hazlett et al., 1998; Wynn et al., 2004). Confusingly, PPI has also been suggested to reflect and
orienting response (Yeomans, 2012). How two independent and opposing processes may reflect
the same orienting response is unclear. One possibility is that they may reflect different aspects,
or timing, of the orienting response.
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Akin to the dual process theory for habituation, at ISIs close to the border of PPI and PPF,
the behavioural output is thought to be balanced between opposing PPF and PPI processes
(Reijmers and Peeters, 1994; Ison et al., 1997). Despite the fact that the mechanisms and
functions of PPF are largely unknown, because PPF represents a phenomenon that is the
behavioural opposite of PPI, it is critical to be aware of the effects this process may have on
studies of PPI.

1.3.2 The Neural Circuitry of Prepulse Inhibition
The neuroanatomical circuitry of PPI clearly illustrates its function as a neural gating
mechanism. PPI occurs due to the manner in which PPI-mediating structures impinge upon the
primary startle pathway. When the pre-pulse is first detected by the ear it excites the Cochlear
Root neurons (apart from the ascending hearing pathway, which is not discussed here). It is at
this point where the signal is divergently processed through the primary startle pathway as well
as by a parallel PPI pathway (see figure 1.3). Within the PPI pathway the signal is transmitted to
the inferior and the superior colliculi. Neurons of these nuclei induce activation of the PPT
(Kandler and Herbert, 1991). It is supposed that the superior colliculus (SC) integrates and
transmits information from all sensory modalities, whereas the inferior colliculus (IC) transmits
strictly auditory information to the PPT (Semba and Fibiger, 1992; Fendt et al., 2001). Once
activated the PPT is thought to release ACh within the PnC (Koch et al., 1993; Swerdlow and
Geyer, 1993). This is the site of imposition that is hypothesized to be critical for PPI of startle. The
PPT cholinergic input inhibits startle mediating giant neurons of the PnC (Fendt and Koch, 1999;
Bosch and Schmid, 2006), which translates into less activation of the spinal motoneurons
resulting in a decreased startle response. This is the major hypothesized mechanism underlying
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PPI. New evidence has suggested that there is an additional fast PPI circuit that involves
cholinergic projections from the ventral nucleus of the trapezoid body onto cochlear root
neurons (Gomez-Nieto et al., 2008; Gomez-Nieto et al., 2014).
It is important to note that the prepulse and pulse are processed in the exact same
manner. Due to the ISI, it is thought that the presumed cholinergic inhibition of giant neurons is
still in effect when the startle pulse is being processed. Due to this residual inhibition, the PnC is
unable to activate the spinal motoneurons as strongly as if the pulse was presented alone. The
efficacy of this inhibition is dependent on the duration of the ISI (Jones and Shannon, 2000a;
Bosch and Schmid, 2008). Different paths within the PPI circuitry may reflect differential circuits,
neurotransmitter systems, and receptors being activated during PPI and playing different roles
at different ISIs (Yeomans et al., 2010).
The previously described circuitry is located within the brainstem, however many higher
brain structures have also been linked to PPI. These include the hippocampus, amygdala, medial
prefrontal cortex, ventral striatum, ventral pallidum, substantia nigra, the ventral tegmental area
and the nucleus accumbens, (for review see Koch, 1999). These areas act to modulate PPI via
direct, or indirect, projections to the PPT. Figure 1.2.4 illustrates how the PPT is able to act as an
integration point for top-down control of PPI. One example for this top-down modulation is the
enhancement of PPI in rats and humans by increased attention to the prepulse (Li et al., 2009)
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Figure 1.3 The Neural Circuitry of Prepulse Inhibition
This figure displays a simplified neuroanatomical summary of known PPI circuitry. The primary
startle circuit is shown in red. The darker grey highlights the structures important for the
mediation of PPI, and the lighter grey displays structures that modulate PPI. This diagram
illustrates the PPT as the interface for PPI modulation by these higher brain regions. Shown in
blue is a fast circuit of PPI suggested by Gomez-Nieto et al. (2014). Both the pulse and prepulse
are processed through these pathways in the same manner, but due to the latency between each
stimulus, residual (presumed) acetylcholine from the PPT is still inhibiting the PnC during
processing of the pulse. This causes a decreased startle response.
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1.3.3 Neurotransmitters Involved in Prepulse Inhibition
It was the findings of Koch, Kungel and Herbert (1993) alongside Swerdlow and Geyer
(1993), that lead to the principle cholinergic hypothesis of PPI. Both these studies induced
general lesions of the PPT, and observed a substantial deficit in PPI. While these seminal studies
provided an essential foundation for the field, the methodology was too limited to determine
PPT cholinergic input as the singular mediator of PPI. Firstly, the PPT is a heterogeneous structure
in terms of neurotransmitter release (Wang and Morales, 2009). Secondly, recent papers have
demonstrated that other neurotransmitters play an important role in PPI. Differential modulation
of PPI according to the ISI is a prime example of this. Yeomans and colleagues (2010) suggested
that ACh transmission mediates PPI at medium to long ISIs (100-1000 ms), but that at shorter ISIs
(1-10 ms) GABA is involved. GABAA antagonism disrupted PPI at short ISIs, whereas GABAB
antagonism disrupted PPI at longer ISIs, suggesting that GABA transmission may be an additional
mediator of PPI.
While the field has largely hypothesized that GABA and ACh mediate PPI, other
neurotransmitters can modulate PPI at different levels of the neuron circuitry as well. Serotonin
modulation has been shown in the hippocampus (Adams and van den Buuse, 2011) and raphe
nuclei (Fletcher et al., 2001); whereas dopamine transmission has been heavily implicated in the
medial prefrontal cortex (Ellenbroek et al., 1996; Zhang et al., 2000) and striatum (Zhang et al.,
2000). Removal of a single neurotransmitter system does not completely ablate PPI. When
examining the PPI literature it becomes apparent that even this pre-attentive behaviour is
sensitive to changes in the transmission of different neurotransmitters across many different
areas of the brain.
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1.3.4. Prepulse Inhibition and Acetylcholine
Although PPI is a complex process that is modulated by many neurotransmitter systems,
literature within this field has particularly focussed on PPI regulation by ACh. The strongest
evidence that ACh is a primary mediator of PPI stems from pharmacology studies. For example,
Fendt and Koch (1999) found that cholinergic antagonism within the startle-mediating PnC
disrupted PPI, and that general cholinergic agonism enhanced PPI. A choline-free diet also causes
drastic reductions in PPI which can be restored by re-introducing a general cholinergic agonist,
arecoline, back into the rodent’s diet (Wu et al., 1993). Manipulations of the cholinergic system
have been well documented to alter PPI, but the cholinergic receptors responsible (discussed
below), and the source of cholinergic modulation (discussed in section 1.4.3) remains to be
determined.
1.3.4.1 Muscarinic Receptors and Prepulse Inhibition
Systemic muscarinic antagonism using scopolamine disrupted PPI at ISIs of 100 and 300
ms; ISIs of 30 ms or less were unaffected (Jones and Shannon, 2000a). At the cellular level, Bosch
and Schmid (2006) found that muscarinic antagonism prevented cholinergic inhibition of the PnC
giant neurons in vitro. Furthermore, they found that muscarinic M2 and M4 subtype-preferring
antagonists mediated this effect. This suggests that the inhibitory, presumably presynaptic M2
and M4 receptors are responsible for the muscarinic component of PPI. However, Bosch and
Schmid (2006) did note that the most effective inhibition occurs when general cholinergic
agonism is used, suggesting a complementary role of nicotinic receptors.
A lot of emphasis has been placed on understanding how ACh may influence PPI at the
level of the PnC. This cholinergic input is assumed to arise from the PPT, and will be discussed
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more thoroughly in section 1.4.3. Recently, a novel, ‘fast PPI circuit’ has been proposed (see
figure 1.3), whereby a cholinergic projection from the ventral nucleus of the trapezoid body sends
inhibitory cholinergic projections to the cochlear root nucleus (Gomez-Nieto et al., 2014). What
receptor types may underlie this inhibition is currently unknown.
There also have been a few studies that have looked at cholinergic modulation of PPI by
higher brain structures. Microinfusion of cholinergic agonists into the CA1 and dentate gyrus of
the hippocampus disrupted PPI as well as generally reduced startle reactivity. This could be
rescued by muscarinic antagonism, suggesting that muscarinic receptors in the hippocampus play
a role in modulating PPI (Caine et al., 1992).
1.3.4.2 Nicotinic Receptors and Prepulse Inhibition
Nicotinic acetylcholine receptors (nAChR) are pentameric ligand-gated ion channels. They
are can be found within the peripheral and central nervous system. Once activated by
endogenous ACh, or an agonist, the channel opens to allow passive flow of positively charged
ions through the cell membrane. According to electrochemical gradients this causes an influx of
Na+ and Ca+, and an efflux of K+ and overall excitation of the membrane. These channels are
composed of a variety of potential subunits. In vertebrates there are 17 known nAChR subunits
(α1-10, β1-β4, γ, δ, and ε) and channel composition differs according to the location of the
nAChR. General nicotinic agonism, via nicotine, is well known to enhance PPI in human and
rodent models (Acri, 1994; Acri et al., 1995; Kumari et al., 1997; Guan et al., 1999).
The most common nAChR expressed in the brain are the α7 and the α4β2 subtypes (Ripoll
et al., 2004) and both have been suggested to play a role in PPI. It seems that only α4β2 nAChR
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are expressed in PnC giant neurons however, as local, but not systemic α4β2 agonism could
improve PPI. In contrast, systemic, but not local, α7 nAChR agonism improved PPI; this suggests
that α4β2 nAChRs directly alter startle, whereas there is a modulatory role for α7 nAChR outside
the primary startle pathway (Pinnock et al., 2015).
1.3.4.3 A Closer Look at Prepulse Inhibition and the α7 Nicotinic Receptor
This section will take an in depth view of the role the α7 nAChR plays in sensorimotor
gating. The α7 nAChR is a homomeric channel, with 5 identical α7 subunits composing the core
of the channel (Paterson and Nordberg, 2000). The α7-nAChR rapidly becomes up-regulated and
desensitized (Couturier et al., 1990; Fenster et al., 1997) in the persistent presence of ACh (or
agonist), and has a lower affinity for ACh than other nAChRs (Hajos and Rogers, 2010). Distinctly,
the α7 receptor is more permeable to Ca+ than other nAChRs, particularly α4β2-nAChRs (Seguela
et al., 1993). The α7-nAChRs transiently amplifies Ca+ signalling by “Ca+-induced Ca+-release” via
calcium stores in the endoplasmic reticulum and activation of voltage gated calcium channels
(Dajas-Bailador et al., 2002). This signalling pathway is activated by α7-nAChRs at post- and presynaptic sites and has been linked to long-term plasticity processes such as modulation of
neurotransmitter release, regulation of postsynaptic excitability, and long-term potentiation, (for
review see Dajas-Bailador and Wonnacott, 2004). This cellular mechanism clearly illustrates how
the α7-nAChR is poised to play an important role in cognition.
There are several different lines of evidence to suggest that that the α7-nAChR is involved
in PPI. For example, one of the main behavioural hallmarks of schizophrenia is a deficit in
sensorimotor gating. Subsets of schizophrenic patients have abnormalities in the CHRNΑ7 gene,
which encodes the α7-nAChR. These abnormalities, particularly the dinucleotide polymorphism
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in the intron 2 region, have been correlated with deficits in inhibitory gating mechanisms
(Freedman et al., 1997; Leonard et al., 2002).
Furthermore, the brains of schizophrenic patients typically have abnormally low levels of
α7-nAChRs in the medial prefrontal cortex and hippocampus (Freedman et al., 1995; Guan et al.,
1999), both of which are implicated in the neural circuitry of top-down modulation of PPI (see
figure 1.3). A DBA/2 mouse model of schizophrenia also correlated a decrease in α7-nAChRs in
the hippocampus with the strength of gating deficits (Stevens et al., 1996). Selective agonism of
the α7-nAChR restored this mouse model’s PPI deficit (Simosky et al., 2001) and can restore many
other types of PPI deficits as well (O'Neill et al., 2003; Dunlop et al., 2009; Wallace et al., 2011).
Despite this strong line of pharmacological evidence that the α7-nAChR is an important
modulator of PPI, recent studies have shown that α7-nAChR KO mice have normal PPI of the
acoustic startle response (Paylor et al., 1998; Young et al., 2011). However, other studies have
shown auditory gating deficits in heterozygous α7(-/+) KO mice, as assessed by in vivo evoked
potential recordings in the hippocampus (Adams et al., 2008). In summary, the current literature
suggests that the α7-nAChR is a modulator, rather than a mediator, of PPI, which will be further
studied as one aim of this thesis.

1.4 The Pedunculopontine Tegmental Nucleus (PPT)
The PPT, alongside with the parabigeminal (PBG) and LDT nuclei compose the cholinergic
cell groups of the midbrain. The LDT and PPT are very similar in structure and connectivity,
however, this review will focus on the PPT.
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The PPT is a heterogeneous structure in terms of neurotransmitter release. In addition to
ACh, GABA (Lavoie and Parent, 1994b), and glutamate (Clements and Grant, 1990)
immunoreactivity has been observed in the PPT. There has been debate if these
neurotransmitters are co-released or not. This may be in part due to species differences, but in
the rodent it appears these neurotransmitters are released independently (Wang and Morales,
2009); however, see (Clements et al., 1991; Lavoie and Parent, 1994b).
A special note regarding the cholinergic neurons of the PPT is that they also release nitric
oxide as the all choline acetyltransferase (ChAT) positive neurons co-stain for the nitric oxide
marker, β-nicotinamide adenine dinucleotide phosphate (NADPH)-diaphorase (Vincent et al.,
1986; Lavoie and Parent, 1994b). Around 30% of these cholinergic neurons also express
substance

P

markers,

corticotropin-releasing

factor

and

gastrin-releasing

peptide

immunoreactivity (Standaert et al., 1986; Vincent et al., 1986).

1.4.1 Connectivity of the PPT
There are two distinct cholinergic regions within the PPT: the pars dissipatus, which
encapsulates the rostral PPT and has sparse ACh neurons; and the pars compactus, which is
densely packed with cholinergic neurons and denotes the caudal aspect of the PPT (MartinezGonzalez et al., 2011). The anterior vs. posterior PPT receive different input and project to
different regions of the brain.
The rostral PPT receives inhibitory GABAergic input from the substania nigra and global
pallidus (Granata and Kitai, 1991; Florio et al., 2007). It is also highly innervated by the
subthalamic nucleus and ventral tegmental area, and deep cerebellar nuclei (Semba and Fibiger,
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1992). The PPT receives the majority of its cortical input from the primary auditory and medial
prefrontal cortex (Semba and Fibiger, 1992; Schofield and Motts, 2009). The nucleus basalis, LDT
and contralateral PPT seem to innervate the entirety of the PPT. The caudal PPT receives the
majority of the incoming sensory input from the ipsilateral SC and IC, as well as ventral cochlear
nucleus, principle sensory trigeminal nucleus, and the superior olivary complex (Semba and
Fibiger, 1992).
The projections of the cholinergic PPT are diffusely spread through the brain. They can
also be dissociated topographically. The anterior PPT innervates the dorsolateral striatum,
substania nigra (pars compacta), global pallidus, and nucleus basalis (Semba and Fibiger, 1992;
Lavoie and Parent, 1994a; Dautan et al., 2014), whereas the caudal PPT preferentially innervates
the dorsal striatum and nucleus accumbens, IC, SC, ventral tegmental area, nucleus pontis oralis,
reticular pontine formation, PnC, and thalamus (Semba et al., 1990; Koch et al., 1993; Lavoie and
Parent, 1994a; Garcia-Rill et al., 2001; Dautan et al., 2014). Interestingly, the same cholinergic
neurons innervate both the PnC and thalamus (Semba et al., 1990).

1.4.2 Function of the PPT
The PPT has been implicated in a number of different behavioural and cognitive function.
As rostral vs. caudal regions display a distinct pattern of afferent and efferent connectivity, it is
no surprise that there is a topographical hypothesis in the functioning of the PPT (see MartinezGonzalez et al., 2011; Gut and Winn, 2016 for more detail). However, this review will focus on
the general hypothesized function of the PPT as a whole.
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Cholinergic projections from the PPT to the thalamus encompass an arm of the ascending
reticular activating system which mediates wakefulness and sleep transitions (Walter, 2014).
Cholinergic PPT neurons are activated during rapid eye movement (REM) sleep (Hobson et al.,
1975) and optogenetic activation of these neurons is sufficient to induce REM sleep (Van Dort et
al., 2015). It is thought these cholinergic neurons drive state-transitions by producing transient
responses to sensory events (Petzold et al., 2015). While induction of REM sleep might be
mediated by projections to the nucleus pontis oralis (Nguyen et al., 2013), the cholinergic PPT is
well poised to influence arousal and cortical processing through its connections.
It is suggested that the PPT has a greater influence on cognitive control than previously
thought. Historically the PPT was highly implicated in motor control, specifically locomotion.
However, after extensive review of animal studies following PPT lesions (that generally show no
gross motor impairments), Gut and Winn (2016) suggest that the PPT can be more appropriately
thought as a part of a lower-level action selection process. Due to its rapid detection of sensory
information, and output to striatal and thalamic inputs, Gut and Winn predict the PPT prevents
impulsive and inappropriate responding. Accordingly, a recent study found that while rats with
selective cholinergic lesions of the PPT showed little impairment in a 5-choice serial reaction time
task, the only notable difference in their behaviour was a tendency towards more impulsive
responding (Cyr et al., 2015).
Expanding this idea further, the PPT may also play a role in associating the outcome of
actions with outcomes or environment. The PPT is well known to be implicated in reward-based
learning as lesions to this area disrupt morphine-induced (Olmstead and Franklin, 1993) and
nicotine-induced conditioned place preference (Laviolette et al., 2002). Modulation of PPT
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activity can differentially influence the activity of the ventral tegmental area (Pan and Hyland,
2005; Xiao et al., 2016), particularly when associated with a sensory cue (Pan and Hyland, 2005).
This may suggest that the PPT can execute basic action selection and associate this with reward.
Fittingly, recent studies have shown that neuronal activity in mouse PPT reflects both action and
outcome in a decision-making task (Thompson and Felsen, 2013) indicating that the PPT’s role in
action-selection could adapt with experience.

1.4.3 The Cholinergic Midbrain and its Role in Sensorimotor Gating
The idea that the PPT may mediate early action selection fits excellently with its
hypothesized role in PPI. As stated, PPI has also been suggested to be an early form of action
selection, mainly though promoting orienting responses (eye saccades) while inhibiting startle
and eye-closure (Yeomans, 2012). The execution of these functions is predicted to be mediated
via the PPT. It sends cholinergic projections to the SC which can influence eye saccades
(Kobayashi et al., 2002), and as discussed, it is known to innervate and inhibit the startle
mediating brainstem (Koch et al., 1993; Bosch and Schmid, 2008).
The longstanding hypothesis that the mechanism underlying PPI stems from cholinergic
inhibition of startle-mediating neurons via the PPT has been supported by a large body of
evidence. As previously discussed this primarily comes from a seminal study by Koch, Kungel and
Herbert (1993), where they lesioned the PPT and saw a disruption in PPI but no difference in
baseline startle magnitude. They inferred this was mediated by diminished cholinergic input from
the PPT, as they observed 35% decrease in ChAT immunoreactivity in the PPT. Similar findings
were reported by Swerdlow and Geyer (1993) using electrolytic lesions, however they also
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reported an increase in startle magnitude (when no prepulse was present). Fittingly,
microinfusions of cholinergic agonists into the PnC enhanced PPI, and muscarinic antagonism
disrupted it (Fendt and Koch, 1999). The idea that this cholinergic modulation stemmed from the
PPT was further supported by in vitro stimulation of PPT projections and sensory afferents to the
PnC which caused a delayed inhibition of synaptic transmission (Bosch and Schmid, 2008).
Together, the evidence strongly supports that the cholinergic cells of PPT mediate PPI.
However, a recent study by MacLaren and colleagues (2014) had the unique advantage
to selectively lesion the cholinergic cells of the PPT using a urotensin II diptheria toxin fusion
protein. Following this, they found no disruption in PPI, but profoundly reduced baseline startle
magnitudes. When they completed a general lesion of the PPT, they could re-affirm past studies
showing disruptions in PPI. Additionally, a mouse with a conditional knock-out of cholinergic
transmission in the midbrain (LDT, PPT and PGB) displayed improved PPI compared to wildtype
mice, with no change in baseline startle magnitude (Machold, 2013). These studies represent
some of the first evidence to suggest that it is not the cholinergic cells of the PPT that are critical
for PPI. However, it is impossible to rule out compensatory mechanisms that accompany lesion
techniques or knock-out models (for review see Barbaric et al., 2007; Otchy et al., 2015).
Although in vitro patch clamp studies in the rodent have shown that cholinergic agonism
can inhibit synaptic signals in startle-mediating giant neurons of the PnC fitting with cholinergic
midbrain mediation of PPI (Bosch and Schmid, 2006, 2008); in vitro recordings of unidentified
PnC neurons in the cat following electrical stimulation of the PPT caused excitatory prolonged
responses (a train of action potentials lasting greater than 12 ms following stimulation). This
could be blocked by administration of scopolamine, a muscarinic antagonist, and induced using
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carbachol, a general ACh agonist (Homma et al., 2002). Interestingly, this prolonged
responsiveness seems similar to that observed during in vivo recordings of PnC neurons following
application of Substance P. Furthermore, as previously discussed, activity in PnC neurons in
response to to acoustic stimulation was also enhanced by cholinergic agonism in rats (Kungel et
al., 1994). This suggests that ACh may have an excitatory influence on startle mediating neurons.
How this influences the output of the PnC (and ultimately behaviour) remains unanswered. In
light of this recent evidence, it is clear that the midbrain cholinergic hypothesis of PPI may need
to be re-evaluated, specifically using techniques that can manipulate neuronal activity with
improved cell-type and temporal specificity.

1.5 Rationale and Hypothesis
In this thesis, I aimed to understand the differential role ACh may play in sensorimotor
gating and the sensory filtering of reflexive vs. non-reflexive behaviours. Based on the literature
review above, my overall hypothesis is that ACh is critical for sensorimotor gating of the ASR, and
habituation of locomotor behaviour. It seems to play no role in the short-term habituation of the
ASR, however, ACh’s role within long-term habituation of the ASR has been largely unexplored.
Understanding the role of ACh in sensory filtering and sensorimotor gating is important for
several reasons. Firstly, these processes are disrupted in a number of psychiatric illnesses and
better treatment options may result from understanding the underlying pharmacological
mechanisms related to these processes. Secondly, sensory filtering and sensorimotor gating are
thought to act as proxy measures for an individual’s efficiency of information processing and/or
methods for reducing cognitive burden. Uncovering the subtle differences in modulation of these
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processes will help us not only to better understand the processes themselves, but how they
relate to higher-cognitive function.
My aim was to re-define the role of cholinergic modulation of sensory filtering and
sensorimotor gating. Next, we aimed to refine this by investigating what cholinergic receptor is
critical for modulation of these processes, as well as what nucleus was providing the necessary
cholinergic input.
Chapter 2 defines the role of ACh on PPI and habituation of the ASR using transgenic mice
with a reduced cholinergic tone. Hypothesis: I hypothesize that ACh is the primary mediator of
prepulse inhibition, but plays no role in habituation of the acoustic startle reflex. Mice with
deficient cholinergic tone mice will show a disruption on PPI, but intact habituation.
Chapter 3 uncovers the receptors mediating cholinergic modulation of sensorimotor
gating mechanisms. Specifically, I investigated the α7-nAChR’s role, using an α7-nAChR knockout mouse model. Hypothesis A: I hypothesized that the α7-nAChR is involved in PPI of startle,
and predict these mice will have a deficit in PPI. Additionally, I hypothesized that this receptor is
necessary for nicotine-induced enhancement of PPI, but not involved in the short-term or longterm habituation of startle. Hypothesis B: If deficits in pre-attentive cognitive mechanisms like
sensorimotor gating were observed, I predicted these deficits would lead to disruptions in higher
cognitive function, such as working memory in spatial tasks (e.g. the Barnes Maze).
In Chapter 4 I aimed to evaluate the role of cholinergic PPT neurons in sensorimotor
gating using designer receptors exclusively activated by designer drugs (DREADDs) and
optogenetics. Using these complementary techniques I both transiently inhibited (DREADDs) and
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activated (optogenetics) cholinergic cells specifically in the PPT to elucidate the role of this
nucleus. Hypothesis: Based on findings from Chapter 2, I hypothesized that pulsatile cholinergic
release from the PPT is responsible for the cholinergic modulation of PPI. I predicted that by using
DREADDs to selectively inhibit these cells, I would observe a reduction in PPI. Using the opposite
approach, I predicted that optogenetic stimulation of cholinergic PPT neurons would induce PPI
(in place of an auditory prepulse) prior to a startling stimulus.
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2. Chapter 2

VAChT KD Mice Show Normal Prepulse Inhibition but Disrupted Long-term
Habituation

Sections 2.1-2.5 were published previously, see Schmid S, Azzopardi E, De Jaeger X, Prado MA,
Prado VF (2011) VAChT knock-down mice show normal prepulse inhibition but disrupted longterm habituation. Genes Brain Behav 10:457-464.
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2.1 Introduction
The neurotransmitter acetylcholine (ACh) plays an important role in both the central and
peripheral nervous system. Disruptions in the central cholinergic system has been associated
with different human disorders, including Alzheimer’s disease (Felder et al., 2001; Mesulam,
2004), and Schizophrenia (Felder et al., 2001; Barak, 2009). One hallmark in Schizophrenia is
impaired prepulse inhibition (PPI) of the acoustic startle response. Prepulse inhibition is a
measure of sensorimotor gating, referring to the inhibition of the startle response to a sudden
intense auditory stimulus (pulse) because of prior presentation of a sub-threshold stimulus
(prepulse). This reflects the ability to suppress sensory information from processing and
conscious awareness. It has been used as an assay and endophenotype of sensorimotor gating
deficits exhibited by patients with Schizophrenia.
Prepulse inhibition can pharmacologically be disrupted by systemic injections of
cholinergic muscarinic antagonists (as reviewed by Jones and Shannon, 2000a; Barak, 2009),
whereas systemic nicotine has been shown to enhance PPI in Schizophrenic patients and healthy
humans (Kumari et al., 2001, 2002; Postma et al., 2006; Kumari et al., 2008), as well as in different
animal models (Acri et al., 1994; Curzon et al., 1994). Prepulse inhibition of the startle response
has been proposed to be at least partly mediated by inhibitory cholinergic projections from the
laterodorsal tegmental (LDT) and pedunculopontine tegmental nucleus (PPT) to the startlemediating neurons in the pons (Koch, 1993; Bosch and Schmid, 2006, 2008). Besides its
descending inhibition to the caudal pontine reticular nucleus (PnC), the PPT projects to higher
brain structures, including the Thalamus, Substantia Nigra and Ventral Tegmental Area (Steriade
et al., 1990; Yeomans, 1995; Blaha et al., 1996; Fendt et al., 2001). It is suggested that these
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cholinergic PPT projections may be responsible for cortical activation and eliciting approach
behaviours, while inhibiting avoidance behaviours like startle through the descending projections
(Fendt et al., 2001).
Habituation is another form of sensory filtering that is disrupted in Schizophrenia and
delayed in patients suffering from Autism Spectrum Disorders. Short-term habituation (STH)
describes the decline of a behavioural response (e.g. startle) to repeated presentation of the
same stimulus within a testing session, whereas long-term habituation (LTH) describes the
decline of the first (or the average) response over consecutive testing sessions. Habituation is a
basic form of non-associative learning. Although STH of startle occurs within the primary startle
pathway (Davis et al., 1982a; Schmid et al., 2010), LTH is disrupted by lesions outside of this
pathway, for example in the cerebellar vermis (Leaton and Supple, 1986, 1991). Yet, there is little
indication for a role of ACh in habituation of startle (Hughes, 1984).
Habituation and PPI deficits have been associated with cognitive symptoms in neural
disorders. The cholinergic system plays a major role in cognitive function and drugs facilitating
cholinergic transmission have been developed as cognitive enhancers. Efficient synaptic release
of ACh depends on its transport into synaptic vesicles by vesicular ACh transporter (VAChT; Prado
et al., 2006; de Castro et al., 2009). Homozygous VAChT knock-down mice (VAChT KDHOM) with a
65% reduced immunoreactivity for VAChT in the brain show decreased ability to refill synaptic
vesicles (Prado et al., 2006; de Castro et al., 2009). Homozygous VAChT KD mice have a reduced
capability to sustain ACh release and the injection of the cholinesterase inhibitor galantamine
has previously shown to reverse motor and memory deficits in mutant mice (Prado et al., 2006;
de Castro et al., 2009). Homozygous VAChT KD mice are therefore an excellent model to study
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the consequences of disruptions in central cholinergic function. We studied the effect of VAChT
KD on basic cognitive processes such as STH and LTH as well as PPI of startle.

2.2 Methods
2.2.1 Subjects
For this experiment we used a mutant mouse line which had the vesicular acetylcholine
transporter protein knocked-down (VAChT KDHOM). Generation and genotyping of the mice has
been described before (Prado et al., 2006; de Castro et al., 2009). The mice were generated by
targeting the 5’ untranslated region of the VAChT gene for homologous recombination by
inserting a TK-Neo resistance cassette 1.5 kb downstream from the VAChT stop codon. The
placement of this cassette interrupts VAChT expression in cholinergic neurons of the central
nervous system, but leaves somatomotor cholinergic neurons relatively intact. These mice had a
mixed 129/terSV x C57BL/6J background. Mice were back-crossed for at least three generations
(N3). Ten different breeding pairs of heterozygous mice were bred to generate wild-type (WT)
and homozygous KD littermates. Only male WT and KD animals were used in this study. They
were housed in groups of 3-4 in a temperature controlled room a with 12 hour light–dark cycle.
Food and water were available ad libitium. All testing occurred during the light phase while the
animals were between 2-5 months of age. Animals were cared for according to the ethical
guidelines of the University of Western Ontario Animal Use Subcommittee and Canadian Council
on Animal Care (CCAC).
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2.2.2 Drugs
In an attempt to rescue cholinergic function, galantamine (1 mg/kg, intraperitoneal (IP)),
an acetylcholine-esterase inhibitor, was administered to both WT and KD animals. Galantamine
was dissolved in sterile saline (0.9% NaCl) to a dilution of 1 mg/ml. Both genotypes were also
given saline as a control. Injections were given either before testing (WT n=14: n=7 saline, n=7
galantamine. KD n=37, n=18 saline, n=19 galantamine) or after (KD saline n=9, galantamine n=10)
in order to elucidate the effects of ACh during encoding and retrieval or consolidation processes.

2.2.3 Startle Testing
Mice were randomly assigned to a sound-proofed startle box (Med Associates, St Albans,
VT, USA) in which they consistently underwent all behavioural testing. For an overall schematic
representation of the behavioural protocol see figure 2.1.
Mice were acclimated to the startle box for 5 minutes/day for 3 days with background
noise (65 dB SPL white noise). On the final day of acclimation animals also underwent an
input/output (I/O) test. For this test animals are placed in their respective holders and placed in
the startle box. Testing began with an acclimation phase (5 min, 65 dB white noise) which was
followed by the presentation of white noise bursts (20 ms duration) starting at 65 dB SPL and
increasing to 120 dB SPL (increasing by 5 dB SPL with each trial for a total of 12 trials; 15 seconds
between trials).
The I/O test allowed us to ensure our animals have normal hearing ability as well as
assessing the animal’s individual startle reflex magnitude. Rodents fall within a spectrum
between high and low startle reactivity much like humans (Hutchison et al., 1997; Schwegler et
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al., 1997). The I/O function assessed where the mice fall in this spectrum and according to this
we determined a gain setting. This gain amplified the signal from the movement sensitive
platform to the digitizer, allowing for a more a more accurate reading. If the signal was too low,
the transducer (which converted the amount of movement-induced displacement into an
electrical signal) may not have been sensitive enough to detect changes, specifically decreases,
in startle magnitude. We increased the output so that each animal responded within the optimal
range, making the data more stable between animals and improved measurement accuracy.
Using this method we did not have to separate data into low and high startling reactivity as
previous studies have done (see Hutchison et al., 1997) which can make analysis complicated.
We prescribed high startling mice a gain of 1, medium startling 2-3, and low startling 4 (refer to
figure 1.2). This gain was kept constant for each animal over every day of testing. We factored
out the gain (by dividing the amplitude of the startle by the gain factor) when analyzing baseline
startle amplitudes, to reduce confounding of results.
Once I/O testing was completed, the animals began the experimental protocol. Animals
were tested once daily for 5 days. The protocol consisted of a 5 minute acclimation phase (65 dB
SPL white noise) and two blocks of trials (see figure 2.1). Block one was used to assess habituation
and block two was used to assess PPI.
The first block consisted of 30 pulse-alone trials. A startle pulse was a 105 dB SPL (20 ms
duration) burst of white noise. The intertrial interval (ITI) was 15 sec. This pulse was chosen based
on data from the I/O test as it was the first to induce the maximal startle amplitude (see figure
2.2). Using a higher startle pulse could risk hearing damage. Following the pulse the resulting
startle magnitude was recorded digitally using Med Associate software. The magnitude reflected
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the amount of displacement, induced by the startle, of the movement sensitive platform placed
at the bottom of the startle box.
The second block of trials was a mix of 60 prepulse and 10 pulse-alone trials. The pulsealone trials, which were exactly the same as described in block one, measured baseline startle
magnitude. The prepulse trials consisted of a 85 dB SPL (4 ms duration) prepulse with an
interstimulus interval (ISI) of either 6, 12, 50, 100, 200 or 250 ms. This created 6 types of prepulse
trials, and 10 trials of each type. All trials were presented in a pseudo-randomized manner to
ensure an accurate baseline startle measurement. Startle magnitudes, recorded digitally in the
same manner as described previously, were compared between pulse-alone trials and prepulse
trials.
When galantamine (1 mg/kg, intraperitoneal) was administered either pre or post testing
(see figure 2.1), mice only completed block one of testing as only habituation was necessary.
Presenting a stimulus too many times can cause sensitization to that stimulus, which would
confound our results (Plappert et al., 1999). Therefore for this part of the study, all long-term
habituation results were derived during a separate testing session where just the acclimation
phase and block one were presented. If an animal was re-used for injection testing, sessions
were separated by a minimum of 2 weeks.
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Figure 2.1 A Graphic Representation of Sensory Filtering and Sensorimotor Gating Testing
This represents one day of testing. This testing is repeated for every day, for 5 days. Block I
assesses habituation, and block II assesses PPI. All trials in block II appear in a pseudo-randomized
order. Only the habituation rescue experiments contained injections, which occurred either
directly before or directly after testing (Intertrial interval: ITI, interstimulus interval: ISI).

2.2.3.1 Data Analysis for Startle Testing
To analyze PPI and habituation data, unpaired or paired Student’s t tests or two-way
repeated measures analysis of variance (ANOVAs) were used. To assess if VAChT KDHOM animals
displayed differences in STH, all responses from block one were normalized by dividing them by
the average of the first three responses. We analyzed this using a two way ANOVA (trial number
x genotype). This was done for everyday of testing and then averaged across days. For LTH the
first three trials of block one were averaged for each day of testing. These averages were
combined across animals and then plotted (across days) for visualization. We also normalized all
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data points to the average of the first 3 trials on day 1, and plotted values across days. To
statistically analyse long-term habituation (LTH) we used a two-way ANOVA (day x genotype). For
rescue experiments, for each genotype, we analyzed LTH using a two-way ANOVA (day x drug
type).
In our studies, PPI was expressed as percent of baseline startle. This means that the
responses from the prepulse trials of block two were divided by the average of the pulse alone
trials of block two (baseline startle). This was then multiplied by 100 to give a percent
([startle/baseline startle] x 100). We determined percent of startle for each trial type, for each
day. We then performed a two-way ANOVA (genotype x day) to determine if PPI improved across
days of testing. We then averaged PPI values across days and performed a two way ANOVA (trial
type x genotype).
We assessed baseline startle, to ensure startle ability between genotypes was equal, by
using the pulse-alone trials of block two. This was the optimal measurement as startle responses
within block one are not stable due to habituation. Criteria for significance for all statistical tests
was p<0.05.

2.3 Results
2.3.1 Both Genotypes Have the Same Startle Reactivity
Fourteen WT and 12 VAChT KDHOM mice were tested for their startle response amplitude
with increasing startle stimulus intensities from 65 to 120 dB SPL white noise in 5 dB SPL steps.
All startle boxes were calibrated to box 1 in order to allow for a direct comparison of startle
amplitudes. As shown in figure 2.2a,b, the absolute startle response amplitude differed
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substantially between individual mice with high, intermediate and low startling mice in both
genotypes. A two-way repeated measures ANOVA (genotype x sound intensity) showed no effect
of the genotype on startle response amplitudes (F(1,311)= 0.08, p=0.78), however there was a
significant effect of the sound intensity (F(11,301)= 17.21, p<0.0001), but no interaction of the two
factors (F(1,311)= 0.9, p=0.33). Although high startling mice overshot the scale, low startling mice
barely raised the signal above the noise level, making it difficult to quantify startle attenuation
by PPI or habituation, which illustrates the necessity of gains for appropriate startle magnitude
detection. The average startle amplitude of the final three startle trials from this test was also
used to further compare absolute startle responses amplitudes between genotypes. A two-tailed
independent Student’s t-test indicated no difference in baseline startle magnitude amplitudes
between genotypes (t24=0.7, p>0.05).

54

Figure 2.2 Individual Input/Output Functions of VAChT KDHOM Mice Compared to Wild-type
After three acclimation sessions, animals were exposed to 65 dB SPL background noise and
increasing startle stimulus intensities from 65 to 120 dB SPL. No difference in startle response
amplitudes between genotypes was observed. Both WT (a) and KD mice (b) reached maximum
startle amplitude at around 105 dB SPL; however, there was considerable variability in the
maximum startle responses between individuals within both the groups. Although some mice
overshot our range of measurement, others barely raised the signal above noise level. In
subsequent experiments, gain factors for the measured motor response were adjusted according
to the following scheme: mice that overshot were measured with a gain of 1.0, intermediate mice
were measured with the default gain of 2 and low startling mice were measured with a gain of 4.
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2.3.2 Prepulse Inhibition of the Acoustic Startle Response is Normal in VAChT KDHOM Mice
Prepulse inhibition of startle was tested across ISIs. As shown in figure 2.3, VAChT KDHOM
mice and their WT littermates did not differ in their ability to suppress startle stimuli that were
preceded by a prepulse as we could detect no influence of genotype (F(1,58)= 0.82, p=0.78).
Prepulse inhibition differed across ISIs (F(5,58)=11.5, p<0.001), but this was unaffected by genotype
as there was no interaction between genotype and ISI (F(5,58)=0.8, p=0.84).
Both groups inhibited their startle by around 70% at ISIs between 5 and 50 ms, with a
maximum PPI of 75% at 50 ms ISI. Prepulse inhibition slightly decreased in both the groups at ISIs
of 100 ms (66% for WT and 67% for KD) and 250 ms (50% WT and 54% KD). Overall, this suggests
that PPI is unaffected by the knockdown of VAChT.
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Figure 2.3 Prepulse Inhibition is Unaltered by VAChT Knock Down
Startle response amplitudes to acoustic startle stimulus alone trials were compared with startle
amplitudes when startle stimuli were preceded by an acoustic prepulse. This prepulse occurred
at different interstimulus time intervals (ISI), as indicated. The average startle amplitude of each
animal to startle stimulus alone trials was set to 100% and all other responses are expressed as
percentage of it. Both genotypes, the VAChT KDHOM mice (KD) as well as their WT littermates,
showed up to a 75% reduction of startle by the prepulse with no difference between groups
(n=16/genotype).

57

2.3.3 Short-Term Habituation is Unaffected by VAChT KD, but Long-Term is Impaired
All animals were habituated to startle stimuli during block I prior to testing PPI. As shown
in figure 2.4a, both groups of animals habituated to 70–75% of their initial startle amplitude
(measured as the average of the first two responses) within each testing session. An ANOVA
showed a significant main effect of trial number (F(29,270)= 2.98, p<0.001), with no interaction of
genotype and trial number (F(20,270)= 0.75, p=0.82), which confirmed no effect of genotype on
STH.
We tested for LTH by analyzing the average of the first three startle responses over the 5
days of testing. As shown in figure 2.4b initial startle responses declined over the course of 5 days
to around half of the amplitudes on day 1 in WT mice. In contrast, VAChT KDHOM mice did not
show any LTH across sessions. The ANOVA showed a significant interaction between the factors
genotype and day (F(4,145)= 2.52, p=0.045).This effect is summarized in figure 2.4c. This figure
displays the course of both STH and LTH over five consecutive days of testing in both genotypes.
Both genotypes still showed STH, but only the WT mice showed LTH as the mutant mice startled
to the same extent at the beginning of each test session.
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Figure 2.4 Short-Term Habituation is Normal in VAChT KDHOM Mice, but Long-Term is Impaired
(a) Short-term habituation in VAChT KDHOM mice was similar to that of their WT littermates. The
startle response amplitude of each mouse was normalized to the average of its first three startle
responses. (b) The long-term habituation of VAChT KDHOM and WT mice. The averages of the first
three startle responses of each day were calculated for each mouse and then averaged within
genotypes. Startle response magnitude declined over days in WT animals, but not in VAChT KD
mice. (c) The course of STH and LTH over 5 days. For more clarity, six consecutive startle
responses of an animal were always averaged (blocks of six, for a total of five blocks). The data
of each animal was then normalized to the value of the first block (=100%). The graph shows that
both genotypes show STH at every day, but whereas the overall startle amplitudes decline in WT
animals over the 5 days, startle amplitudes remain at the same level in VAChT KDHOM mice,
indicating a lack of LTH (n=16/genotype).
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2.3.4 Rescuing the Long-Term Habituation Deficit
Next, we tested if we could rescue LTH by increasing cholinergic tone using galantamine
injections (1 mg/kg IP) prior to experiments. For this experiment, half of the WT and VAChT KDHOM
mice were injected with saline and half with galantamine before the gain setting I/O test (WT
n=14, VAChT KDHOM n=37). A two-way ANOVA (genotype x drug) was performed on the average
of the final three startle responses of the gain setting test (equal gains for all groups). It did not
detect any difference between genotypes (F(1,13)= 0.03, p=0.86) or drug (F(1,13)= 3.93, p=0.06) or
interaction between these factors (F(1,13)= 2.74, p=0.11). In order to further exclude the possibility
that galantamine injections caused a general increase of startle responses, 16 WT and 16
VAChTKDHOM mice were injected with saline after 2 days acclimation to the boxes and startle was
tested. On the next day, they received a galantamine injection prior to testing startle amplitude
(figure 5a). A paired t-test showed no difference in baseline startle amplitudes between saline
and galantamine injections in WT (t15=1.2, p=0.12) or VAChTKDHOM mice (t15=0.9, p=0.19).
For the rescue experiment, we injected animals with galanthamine or saline prior to
testing for 5 days. In WT animals, a repeated measure ANOVA (injection x trial OR day) showed
that there was no effect of injection group on STH. We found no interaction between drug and
trial (F(29,390)= 1.08, p=0.35, figure 2.5b), and no effect of repeated galantamine injection over 5
days on LTH (F(4,66)= 1.54, p=0.2, figure 2.5c). We noted that both injection groups display less
STH and LTH than in the previous experiment without injections. This is probably due to the
aversive nature of the injection procedure itself (compare figure 5b,c with figure 4a–c).
In VAChT KDHOM mice, a repeated measure ANOVA (injection x trial OR day) showed there
was also no effect of injection on STH (F(29,270)= 0.70, p=0.87, figure 2.5b). However, pre-testing
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galantamine-injected VAChTKDHOM mice displayed a decline of their average startle responses
between days, whereas saline-injected animals did not show any LTH, confirming the lack of LTH
in VAChTKDHOM mice in a second cohort of mice (figure 2.5d). The ANOVA confirmed this as there
was a trend towards a significant interaction between drug and day (F (4,22)= 1.33, p=0.054).
Unpaired Student’s t-tests confirmed no difference between injection groups at days 1 (t35=0.9,
p=0.39), 2 (t35=1.75, p=0.08) and 4 (t35=1.68, p=0.08), but a significant difference between
injection groups at days 3 (t35=2.6, p=0.01) and 5 (t35=2.4, p=0.02).
In order to test whether the acetylcholine-esterase inhibitor had to be present during
learning/retrieval, or if it was sufficient when present during the consolidation phase following
learning, we repeated the rescue experiment with the VAChT KDHOM mice, but administered
galantamine (or saline) immediately after the behavioural testing. As expected, STH in this group
of animals was not affected by the type of injections and animals showed STH comparable to
non-injected animals (figure 2.6a, compare figure 2.4a). As revealed by a repeated measures
ANOVA (day x drug) galantamine failed to rescue LTH when injected immediately after the
behavioural testing session (F(1,159)= 0.43, p=0.79), as shown in figure 2.6b,c.
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Figure 2.5 Rescue of LTH by Pre-Test Injections of Galantamine
(a) Control experiments were performed which tested the effect of galantamine (gal) vs. saline
(sal) on baseline startle responses. Sixteen WT and 16 VAChT KDHOM mice were exposed to
acclimation and block I (habituation) in two subsequent days, with sal injection on day 1 and gal
injection on day 2. The first three startle responses of each animal after saline were compared
with the first three responses after galantamine on the subsequent day. There was no effect of
drug type on baseline startle amplitude in either genotype. (b) The STH to 30 startle stimuli in
WT (n=23) and VAChT KDHOM mice (n=27) injected with gal or sal. For each mouse, the startle
response amplitude of each trial was normalized to the average of its first three startle responses.
Short-term habituation was overlaid by initial sensitization in both genotypes (compare with
figure 4a), probably due to the aversive nature of injections. No difference between genotypes
or injection group was detected. (c) The LTH of WT mice following 5 days of sal or gal treatment
prior to behavioural testing. The average of the first three startle amplitudes of each day were
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calculated for each mouse and then averaged within treatment. No differences between injection
groups could be detected at any of the 5 days (n=7/group). Finally, (d) displays the LTH of VAChT
KDHOM mice following 5 days of sal or gal injections prior to behavioural testing. Homozygous
VAChT KD mice that were injected with gal (n=19) show a decline of their startle responses mainly
after day 1. Animals injected with sal (n=18) did not show LTH, confirming the previous results.
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Figure 2.6 Post-Test Injections of Galantamine Did Not Rescue LTH
Animals were injected with 1 mg/kg of galantamine (gal) immediately after behavioural testing.
(a) The STH to 30 startle stimuli in VAChT KDHOM mice injected by gal and in control VAChT KDHOM
mice injected by saline (sal). For each mouse, the startle responses for all 5 days were normalized
to the average of its first two startle responses. Both injection groups show intact STH. (b) The
LTH of sal- and gal-injected mutant mice. The averages of the first three startle responses of each
day were calculated for each mouse and averaged within treatment. Both groups of animals show
the same level of startle amplitudes over the 5 days. (c) The course of STH and LTH over 5 days.
For more clarity, six consecutive startle responses of an animal were averaged (blocks of six, for
a total of 5 blocks). The data of each animal was then normalized to the value of the first block
(=100%). Both groups of animals show STH, but no LTH, over 5 days (KDHOM mice sal n=9, KDHOM
mice gal n=10).
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2.4 Discussion
Homozygous VAChT knock-down mice had a 65% reduced expression of the VAChT
protein resulting in reduced cholinergic neurotransmission. It has been shown previously that
these mice have a decreased ability to maintain physical activity. This impairment was most
evident during tasks where prolonged muscle contraction was required, such as in the rotarod or
wire hang tests. Heterozygous VAChT KDHOM mice with a 40% reduction of VAChT
immunoreactivity display slower motor learning than their WT controls and impaired object and
social recognition, however their motor function, olfaction and spatial memory are mainly
unperturbed (Prado et al., 2006; de Castro et al., 2009). In this study, we found that VAChT KDHOM
mice have normal PPI and STH of startle, but disrupted LTH. Surprisingly, our data indicates that
VAChT KDHOM mice do not exhibit lower startle responses than their WT littermates, as assessed
by comparison of the I/O function (figure 2.2). Small differences between genotypes, however,
would be very difficult to detect, given the huge variability of startle responses between animals
of the same genotype. It still seems safe to state that the previously reported motor deficits of
the VAChT KDHOM mice did not have a major impact on our results. A short startle response every
15-20 seconds may not be sufficient to deplete cholinergic synaptic vesicles. Indeed, the
previously reported motor deficits were specific for prolonged motor activity, whereas initial
synaptic release and release probability have been shown to be normal in these mice (Prado et
al., 2006).

2.4.1 Prepulse inhibition
The inhibitory effect of a prepulse on the startle reflex is largely assumed to occur via
cholinergic PPT projections to the PnC, but descending limbic cortico–striato–pallido–pontine
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circuitry is also known to regulate pontine inhibitory tone. This regulation determines the degree
to which the prepulse can inhibit the subsequent startle response. The cholinergic system closely
interacts with dopaminergic systems in the striatum; therefore, it is not clear to what extent
cholinergic drugs affect the PPI circuitry directly as opposed to PPI modulation through
alterations in the signaling of other neurotransmitter systems, including dopamine. The
expression of normal PPI in VAChT KDHOM mice was surprising given the large body of evidence
for an important role of cholinergic modulation of PPI and the reported effects of systemic
cholinergic drugs.
We tested PPI at different ISIs between prepulse and startle stimuli, since it has been
hypothesized that different neurotransmitter systems mediate PPI at different time scales (Jones
and Shannon, 2000a, b; Fendt et al., 2001; Jones et al., 2005; Yeomans et al., 2010). We chose
the prepulse intensity that yielded maximum PPI without causing a startle reaction itself (85 dB
SPL). We varied the ISI from the commonly used 100 ms to 30 and 50 ms, which are the ISIs
yielding maximum PPI in mice, plus a very short and a long ISI, in order to ensure that we did not
miss any cholinergic contribution. There was no PPI deficiency at any ISI. However, as with the
lack of an effect on baseline startle reactivity, we cannot exclude the possibility that although
cholinergic transmission was reduced in the mutant mice, it still may have been sufficient for PPI
signaling in response to a short prepulse every 15-20 seconds. Furthermore, other
neurotransmitter systems contributing to PPI, such as GABA (Kodsi and Swerdlow, 1995; Fendt,
1999; Yeomans et al., 2010), could be upregulated and compensate for the lack of cholinergic
transmission in these mice. The unperturbed PPI in the mutant mice therefore cannot lead to the
assumption that ACh plays no role in mediating and modulating PPI.
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2.4.2 Habituation
Short-term habituation of startle is assumed to occur within the glutamatergic primary
startle pathway. More specifically, the glutamatergic synaptic terminals of sensory afferent fibers
projecting on the startle-mediating giant neurons in the PnC are assumed to undergo synaptic
depression during STH (Weber et al., 2002; Simons-Weidenmaier et al., 2006; Schmid et al.,
2010). The role of cholinergic modulation in habituation has been investigated in the past and it
is assumed that STH to external stimuli is not directly modulated by cholinergic
neurotransmission (Hughes, 1984), which is in accordance with our results. The disruption of STH
in both treatment groups in the rescue experiment with pre-test injections is likely because of
the aversive procedure of IP injections immediately prior to behavioural testing. Aversive stimuli
can cause sensitization and fear-potentiation of startle that could override the habituation
process (Groves and Thompson, 1970). The fact that STH was normal in both groups in the posttest injection rescue experiment supports this conclusion.
Galantamine injections did not enhance baseline startle responses. Although it prolongs
the effect of ACh, it might not affect the initial startle response amplitude, but rather the
duration. Most importantly, pre-test galantamine injections seem to restore LTH in VAChT KDHOM
mice, although the ANOVA failed to show a clear significance with p values just slightly above
0.05. A paired t-test confirmed a significant difference in startle amplitudes between
galantamine- and saline-injected VAChT KDHOM mice for days 3 and 5. The rescue experiment was
difficult to perform, as the injection procedure itself leads to sensitization, which opposed
habituation in the following startle test (compare STH and LTH in figures 4 and 5), and decreasing
the differences between WT and VAChTKDHOM mice in terms of habituation. Disruptions in LTH
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could be rescued only by pre-test injections of galantamine, when galantamine was present
during acquisition and expression of LTH. Unfortunately, unlike in many other learning
paradigms, acquisition and expression of learning are difficult to separate in LTH experiments.
Galantamine did not restore LTH when present during the consolidation phase only (post-test
injections).
Little is known about mechanisms underlying LTH of startle. Long-term habituation can
be disrupted by lesions of the cerebellar vermis (Leaton and Supple, 1986, 1991). Thus it is an
extrinsic modulation of startle that employs cellular substrates different from the ones that
mediate startle and STH. There is evidence for a cholinergic innervation of the cerebellum
(Jaarsma et al., 1997), but its connection to the vermis or to LTH is unclear. Although the
cerebellar vermis is important for LTH, the cholinergic PPT projections to the PnC might be a
downstream effector mediating the inhibition of startle during LTH. An increase of the cholinergic
tone in this projection could mediate LTH. Interestingly, the first injection of galantamine seemed
to induce maximum LTH, as opposed to the gradual startle decline during normal LTH. This would
be expected if galantamine strongly enhanced cholinergic activity as opposed to a gradual
increase in cholinergic tone during LTH. A tonic cholinergic function would also be more
vulnerable to reduced cholinergic neurotransmission in VAChT KDHOM mice, as opposed to a
transient cholinergic activation during PPI.
Interestingly, the lack of LTH to startle stimuli in VAChTKDHOM mice is paralleled by a lack
of habituation to a juvenile intruder in these mice (Prado et al., 2006). Moreover, mutant mice
showed a deficit in object recognition, which could also be explained by a lack of habituation to
the recently explored object. It will be crucial to gain more information about the respective
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underlying circuitry and mechanisms in order to elucidate in what way these disruptions are
connected to each other. Future studies should seek to include comparisons of reflexive
behaviour, like startle, versus non reflexive behaviours like locomotion and exploratory
behaviour.
In conclusion, although PPI and STH were not impaired, the unexpected disruption of LTH
in VAChT KDHOM mice gives us valuable insights into both cognitive functions of cholinergic
neurotransmission and mechanisms underlying LTH of startle. Future experiments may want to
address whether the LTH deficit is specifically mediated by the cholinergic dysfunction in the
midbrain (i.e. PPT) or by higher brain areas modulated by the basal forebrain cholinergic cell
groups, using brain region selective regional knockouts for VAChT.
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2.6 Link between Chapter 2 and Chapter 3

To re-define the role of ACh in sensory filtering and sensorimotor gating of the ASR, we
used a transgenic mouse model with a 65% reduction in VAChT (which loads ACh into secretory
vesicles). In these mice secretory vesicles are not re-filled efficiently and therefore the
sustained release of ACh is reduced. Using these mice, we were able to discover the important
and novel role of ACh in the mediation of long-term habituation which previous studies were
unable to determine, mainly due to the methodological considerations. The transgenic mice
had normal PPI, which was surprising given the litany of pharmacological studies linking ACh to
PPI. Therefore, we suggested that transient release may be relatively intact in this transgenic
mouse model, and that this type of cholinergic transmission is critical for PPI; whereas
prolonged release mediates LTH.
Our next step was to uncover what cholinergic receptor is involved in the mediation of
LTH and PPI. As our observed LTH deficit was rescued by galanthamine, a cholinergic agonist
and positive allosteric modulator of nicotinic receptors, we specifically chose to investigate the
role of the α7-nAChR. This receptor has also been linked to gating deficits in schizophrenic
populations, is abundant within several areas of the sensory filtering and sensorimotor gating
pathways, and has been strongly implicated in learning and memory.
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3. Chapter 3

Sensorimotor Gating and Spatial Learning in α7-Nicotinic Receptor Knockout
Mice

Sections 3.1-3.5 were published previously, see: Azzopardi, E., Typlt, M., Jenkins, B. & Schmid, S.
(2013). Sensorimotor gating and spatial learning in α7-nicotinic receptor knockout mice. Genes,
Brain and Behavior, 12: 414–423.
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3.1 Introduction
Sensorimotor gating refers to the ability of the brain to implicitly filter unnecessary
sensory information, preserving its limited neuronal capacity for the processing of salient
information. Prepulse inhibition (PPI) and habituation of the acoustic startle response represent
two different behavioural measures of sensory filtering (Braff et al., 1978). Prepulse inhibition
(PPI) occurs when the presentation of a sensory stimulus (prepulse) reduces the behavioural
response to a strong startling stimulus (pulse). Theoretical expositions suggest that the
processing of the prepulse actively inhibits the processing of the pulse, resulting in decreased
responsiveness (for review see Koch et al., 1999). The startle response can also be used to assess
habituation of a reflexive behaviour. Habituation is defined as the progressive decrease in
response amplitude following repeated exposure to the stimulus. There are two forms of
habituation: short-term and long-term, which refer to the attenuation of responding within a
testing session or across multiple testing sessions, respectively.
Nicotine is well known to enhance PPI (Acri, 1994; Acri et al., 1994; Faraday et al., 1999;
Ingram et al., 2005), but the responsible nicotinic receptor subtype is unknown. Pharmacological
studies have suggested a role of α7-nicotinic acetylcholine receptors (nAChRs). Positive
modulation of α7-nAChRs improves auditory gating in the DBA/2 mouse model of Schizophrenia
(Simosky et al., 2001), and rescues apomorphine and MK801-induced PPI deficits in rats (Dunlop
et al., 2009; Wallace et al., 2011). Surprisingly, previous studies using α7-nAChR knockout (KO)
mice have shown that these mice have normal PPI (Paylor et al., 1998; Young et al., 2011). This
discrepancy with drug studies may be due in part to methodological considerations, as another
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study observed a deficit in auditory P50 gating in heterozygous α7-nAChR KO mice (Adams et al.,
2008).
In terms of habituation, a study by Williams et al. (1975) has shown that habituation of
reflexive behaviours, like startle, is mediated by separate mechanisms to those of habituation of
motivated behaviours, such as exploratory behaviour and spontaneous locomotion.
Pharmacological studies have suggested that acetylcholine (ACh) is very important for short- and
long- term habituation of locomotion (Ikegami, 1994; Thiel et al., 1998; Giovannini et al., 2001).
In particular, it has been shown that nicotinic receptors in the Nucleus Accumbens play an
important role in early consolidation phases of long-term habituation of locomotion (Schildein et
al., 2002). In contrast, reflexive behaviours historically have been suggested to be independent
of ACh (Brown, 1976; Hughes, 1984). Indeed, there is no evidence to suggest that nicotinic
receptors are involved in short-term habituation of startle (Brown, 1976; Hughes, 1984; Paylor
et al., 1998). However, a recent study by Schmid et al. (2011) linked ACh to long-term habituation
of startle, as mice with a general knock-down of the Vesicular Acetylcholine Transporter show
clear long-term habituation deficits.
In this study, we therefore sought to evaluate the sensory filtering capacities of α7-nAChR
KO mice using PPI, short- and long-term habituation of both startle and locomotion. We also
treated animals with nicotine prior to testing in order to determine whether the enhancement
of PPI is dependent on α7-nAChRs. Finally, we performed a spatial learning task in order to test
whether sensorimotor gating deficits correlate with impairments in higher cognitive function.
Recently, Singer et al. (2013) have demonstrated that in CB57BL/6 mice, PPI correlated with
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working memory performance in the Morris water maze. We sought to reaffirm and expand on
this correlation using the Barnes maze, which also emphasizes spatial learning and memory.

3.2 Methods
The order of testing was as follows: startle testing, locomotor box, Barnes maze and
elevated plus maze for all animals.

3.2.1 Subjects
We used a commercially available mutant mouse line (B6.129S7Chrna7, stock no. 003232;
Jackson Laboratories, Bar Harbour, ME, USA) that has a null mutation in the Chrna7tm1Bay gene,
which encodes the α7-nAChR protein. The KO was produced by a deletion of the last three exons
(8–10) of the Chrna7 gene. The strain originated on a mixed129/SvEv and C57BL/6 background
and has been backcrossed to the C57BL/6J line for at least eight (N8) generations. Control mice
were age-matched wild-type (WT) C57BL/6J counterparts. Animals were cared for according to
the ethical guidelines of the University of Western Ontario Animal Use Subcommittee and
Canadian Council on Animal Care (CCAC). Mice were group housed, with a 12-h light–dark cycle
with ad libitum food and water. Testing occurred at age 6–14 weeks during the light phase. For
most tests, 18 male KO and WT mice (C57BL/6J from Jackson Laboratories) were used. Long-term
habituation of startle and locomotor testing were tested with a separate batch of mice of both
sexes (WT: n=21, 16 males/5 females; KO: n=14, 9 males/5 females).

3.2.2 Testing of the Acoustic Startle Response
All startle testing was completed using Med Associates sound-proofed startle boxes and
associated software (Startle Reflex Version 5.95, St Albans, VT, USA). Figure 3.1 shows a
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schematic representation of behavioural protocol. Animals were acclimated to the startle box for
5 min/day for 3 days with background noise (65 dB SPL, white noise). All testing sessions began
with an acclimation phase (5 min, 65 dB SPL, white noise). On the final day of acclimation, animals
also underwent an input/output (I/O) test to determine an appropriate gain setting for each
individual animal (figure 3.2). An I/O function began with stimulation at 65 dB SPL (20-ms
duration) and increased in 5 dB SPL steps to 120 dB SPL (for details see Schmid et al., 2011;
Valsamis and Schmid, 2011). Once the gain was set it was kept constant throughout the
remainder of the experiment.
For the next 5 days, the animals were tested once daily with the following behavioural
protocol. Mice of each genotype (n=18/group, male) underwent PPI and short-term habituation
testing. The protocol consisted of two blocks of trials (figure 3.1). Block I assessed habituation by
presenting 33 trials of the startle pulse (20 ms white noise at 105 dB SPL and 15 s inter-trial
interval, ITI). Block II assessed PPI. There were five different trial conditions (10/condition) for a
total of 50 trials. All trials were presented in a pseudo-randomized order. The trial conditions
were as follows: startle pulse alone trials (to determine baseline) and combinations of commonly
accepted prepulses (75 or 85 dB SPL; 4 ms) at two different interstimulus intervals (ISIs; 30 or 100
ms). Separate animals were used for long-term habituation experiments (WT: n=21, 16 males/5
females; KO: n=14, 9 males/5 females). To examine long-term habituation, we employed the
same acclimation schedule, but removed block II to prevent over presentation of startle stimuli,
which can induce sensitization (Plappert et al., 1999).
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Figure 3.1 Testing of the Acoustic Startle Response
As shown in the graph, animals underwent 3 days of acclimation to startle boxes and background
noise and an I/O function was measured on the third day. Next, they completed five subsequent
testing days, where they were exposed to a 5-min acclimation period, a first block with 33 startle
stimuli alone for measuring short-term habituation, and a second block with 50 trials, 10 trials
each of startle stimuli alone, and any combination of 75 or 85 dB SPL prepulses, administered 30
or 100 ms before the startle pulse. Asterisks indicate the first three startle responses and squares
indicate the last three responses in block I that were used to calculate the amount of short-term
habituation in each animal. The dots indicate the first three startle responses on day 5 that were
used along with the first three responses on day 1 (asterisks) to calculate the amount of longterm habituation. Please note that block II was omitted for testing long-term habituation as
displayed in figure 3.5b,d, and a shortened program was used for testing the effects of nicotine
injections (see section 3.2.2.1).
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3.2.2.1 Nicotine Administration and Acoustic Startle Testing
To test the effect of nicotine on PPI, we used a shorter protocol to account for the drug’s
short half-life in mice blood plasma. Block I was reduced to 3 trials and block II to 30 trials (three
different trial conditions, 10 trials per condition): startle pulse alone and 75 or 85 dB SPL prepulse
(both with 30 ms ISI). Both WT (n=20, male) and KO (n=18, male) mice were given a single
subcutaneous injection of either nicotine (1 mg/kg free base nicotine, nicotine hydrogen tartrate
salt, Sigma Chemical Co., St. Louis, MO, USA, dissolved in phosphate-buffered saline, 0.9% NaCl)
or saline immediately before behavioural testing. Each mouse was administered both treatments
on separate days. We allotted a 2-day recovery period between treatments and the order of
nicotine/saline administration was randomized and counterbalanced across genotypes.
3.2.2.2 Data and Statistical Analysis of Sensory Filtering and Sensorimotor Gating of the ASR
Startle magnitude was calculated as the maximal displacement of the movementsensitive platform induced by the startle reflex following the startle pulse (arbitrary units). To
detect differences in baseline startle between genotypes, we examined the I/O function, where
all animals had the same gain factor, as well as initial startle values (average of the first three
trials) on day 1 of testing for the group tested on long-term habituation. We used a two-way
repeated measure analysis of variance (ANOVA) (genotype × sound level) for the I/O function and
an unpaired Student’s t-test for the latter group.
To analyse short-term habituation of startle, we calculated short-term habituation ratios
(average of trials 28–30/average of first 3 trials; see figure 3.1, stimuli marked with squares and
asterisks, respectively), and compared them using an unpaired Student’s t test. To analyse longterm habituation, we normalized all data points to the average of the first three trials on day 1
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for each individual mouse. We then used a three-way repeated measures ANOVA (day ×
genotype × sex) and post hoc unpaired Student’s t -tests. We also calculated a long-term
habituation ratio (average of first five trials on day 5/average of first five trials on day 1;
corresponding to stimuli marked with asterisks and dots in figure 3.1), and compared ratios
between genotypes using an unpaired Student’s t-test.
The PPI was expressed as percent of prepulse inhibition (%PPI=[1−{startle magnitude with
prepulse/baseline startle without prepulse}×100). We determined the average %PPI for each
prepulse type and performed two-way ANOVA (trial type × genotype). We also calculated
averages for each trial type per day and performed a two-way repeated measures ANOVA
(genotype × day) in order to determine if PPI changed across days. When nicotine was
administered, we performed a three-way repeated measures ANOVA (drug × genotype ×
prepulse) to determine changes in %PPI with drug treatment. Additionally, we subtracted PPI
with nicotine administration from PPI with saline (%PPI nicotine−%PPI saline) for each animal,
and used a one sample t-test to determine if the difference significantly differed from zero. To
determine the effect of nicotine on baseline, we again subtracted baseline startle with saline
treatment from baseline with nicotine and compared between genotypes with an unpaired t test.

3.2.3 Locomotor Testing
We used locomotor behaviour to assess habituation of non-reflexive behaviours. To
examine short-term habituation of locomotor behaviour mice (WT: n=6 males, KO: n=12 males)
were placed in a locomotor box (Versamax, Columbia, OH, USA) to freely explore for 2h. Distance,
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rearing, rest time and time spent in each quadrant of the box were measured. Data values were
totalled and parsed into 5-min blocks, and a two-way repeated measures ANOVA (blocks of time
× genotype) was performed to assess short-term habituation of locomotion.
Long-term habituation of locomotor behaviour was tested in separate mice (WT: n=15,
10 males/5 females; KO: n=13, 8 males/5 females), once daily for 15 min for 5 consecutive days.
The values of the first 5-min block were analysed using a three-way repeated measures ANOVA
(day × genotype × sex). Short-term habituation data were analysed in raw values, but for longterm habituation data was also normalized (activity/activity of first 5 min on day 1). This was for
graphical representation and to reduce individual variability in locomotor behaviour as suggested
by Thiel et al. (1998).

3.2.4 The Barnes Maze
The Barnes maze is designed to test spatial learning and memory in rodents. The protocol
used for this test has been previously described by Sunyer et al. (2007). Mice (n=10/genotype,
male) completed four trials per day on days 1–4 to ensure acquisition of the task. Trials were
considered completed when a mouse entered the target hole, or when 3 min had passed. The
inter-trial interval between testing was on average 20 min. On days 5 and 12 of testing, the
animals completed probe trials to assess short- and long-term spatial memory, with the target
hole covered to prevent entrance. Mice were given a single 90-second trial to freely explore the
apparatus on probe days.
For all days, holes investigated by mice were tracked by ANY-Maze software (Version 4.82,
Stoelting, Wood Dale, IL, USA). Investigation was defined as when a mouse hovered over a hole
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with their nose (i.e. nose poke). The distance, latency to approach and enter target, as well as
errors was tracked. In addition, on probe trial days, we measured the location of errors (based
on distance to target). We defined two types of errors: a primary error was defined as any time
the mouse investigated a hole that was not the target, and a secondary error was defined as the
first instance a mouse investigated a non-target hole after investigating the target hole. Total
errors were the sum of primary and secondary errors.
3.2.4.1 Data and Statistical Analysis of the Barnes Maze
Performance on days 1–4 showed how well the animals were able to learn the task. The
values for each of the measures (distance, latency, or errors) examined were averaged over all
four trials/day, in order to give us average performance for each day. Each measure was analysed
using a two-way repeated measures ANOVA (day × genotype). For performance on day 1 only, a
separate analysis was completed where latency to approach target was analysed by trial using a
two-way repeated measures ANOVA (genotype × trial). This aimed to assess working memory
performance, based on improvement across trials. Analysis of only day 1 was appropriate for this
measure, to remove memory of the task as a potential confound. Performance on days 5 and 12
showed how well animals were able to recall the task in their short- or long-term spatial memory,
respectively. To analyse this, separate two-way repeated measures ANOVAs were performed
(hole × genotype).

3.2.5 Elevated Plus Maze
Both WT (n=14, male) and KO (n=14, male) mice were placed in the centre of the elevated
plus maze. The apparatus contained four arms: two covered and two uncovered. Animals had 5
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min to freely explore the maze. The number of entries, latency to enter and time spent in closed
and open arms were digitally recorded by ANYMaze software (Version 4.82, Stoelting). Unpaired
Student’s t-tests were then used to determine differences between genotypes.

3.3 Results
3.3.1 α7-nACHR KO Mice Have Normal Startle Reactivity
Critical to our study was the ability of α7-nAChR KO mice to startle normally. We found
that startle I/O functions did not differ between genotypes (F (11,,403)=3.0, p=0.1; n=18/genotype:
figure 3.2). Furthermore, baseline startle in block I (average of first three trials on day 1) and in
block II (pulse-alone trials) did not differ between the genotypes (t34=1.5, p=0.14; t34=0.52, p=0.6,
respectively).
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Figure 3.2 α7-nAChR KO Mice Have Normal Startle Reactivity
Representative I/O functions of startle response amplitudes for different startle stimulus
intensities. Both genotypes display natural variability of startle magnitudes with very high and
very low startling animals within each group. Based on startle amplitude (low, intermediate or
high), a gain was prescribed as indicated in the figure (see also Methods). This allowed for
accurate signal detection and prevented floor effects in low startling mice. The I/O function of (a)
WT and (b) KO did not differ statistically. The solid black line indicates the average across all
animals of the group (n=18/genotype, all male. Not all mice shown here for clarity).
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3.3.2 Prepulse Inhibition is Mildly Impaired in α7-nAChR KO Mice
Eighteen male WT and KO animals underwent PPI testing. We observed a mild, but
consistent impairment of PPI in α7-nAChR KO mice. In WT mice, when a 75 dB SPL prepulse
preceded the startle pulse, startle was reduced by about 52.1% and 52.2% at the ISIs of 30 and
100 ms, respectively; whereas in KOs startle was only reduced by 38.5% and 37.2%, respectively.
Therefore, PPI was significantly reduced in KO mice compared to WT (F(1,34)=6.87, p=0.02, figure
3.3a) with a 75 dB SPL prepulse regardless of ISI. In all groups, PPI was stable across days of testing
as there was no main effect of day at either ISI (30 ms ISI F(4,175)=0.27, p=0.9; 100 ms F(4,175)=1.0,
p=0.4) or interaction between day and genotype (30 ms F(4,700)=0.87, p=0.59; 100 ms F(4,700)=0.27,
p=0.9).
When a higher prepulse level of 85 dB SPL was used we did not observe any PPI
differences between genotypes. In WT animals, startle was suppressed by 49% and 62.3% at 30
and 100 ms ISIs, respectively, and in KO mice by 44% and 53.8%, respectively. While there is still
a trend of impaired PPI in KO, this failed to reach statistical significance (F(1,34)=1.5, p=0.32, figure
3.3b). There was also no main effect of day (30 ms F(4,175)=2.2, p=0.08; 100 ms F(4,175)=0.48, p=0.8)
or day by genotype interaction (30 ms F(4,700)=1.9, p=0.11; 100 ms F(4,700)=0.38, p>0.82).
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Figure 3.3 α7-nAChR KO Mice Have a Mild Impairment of PPI
(a) α7-nAChR KO mice were unable to suppress startle as effectively as WT across ISIs using a 75
dB SPL prepulse. (b) When an 85 dB SPL prepulse was used, α7-nAChR KO mice displayed the
same ability as WT type to suppress startle across ISIs (n =18/genotype, male).

3.3.3 The α7-nAChR is Critical for Nicotine-Induced Enhancement of PPI
Many previous studies have shown that acute, systemic nicotine improved PPI; we
wanted to investigate the role of the α7-nAChR in this enhancement. We injected WT (n =20,
male) and α7-nAChR KO mice (n =18, male) with saline and nicotine (1 mg/kg, figure 3.4) before
PPI testing with both prepulse intensities and an ISI of 30 ms. We performed a three-way ANOVA
(drug × genotype × prepulse) and confirmed an impairment of PPI in KO mice at both prepulse
intensities (F(1,36)=5.5, p=0.025). The ANOVA did not detect a main effect of nicotine treatment
(F(1,36)=0.6, p=0.43) or interaction between genotype, drug, and prepulse (F(1,36)=1.1, p=0.3).
However, we did see that the drug tended to act differently according to the prepulse level, but
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the drug by prepulse interaction just failed to reach significance (F(1,36)=4.05, p=0.052). Generally,
at the 75 dB SPL prepulse, we saw no effect of nicotine; PPI of WT mice was 45.2% with saline
and 47% with nicotine administration. A similar trend was observed in the KO mice. When KO
mice were administered saline, PPI was 34.6%, and when given nicotine it was 35.3% (figure
3.4a). At the higher prepulse of 85 dB SPL however, nicotine seemed to improve PPI in WT mice.
When WT mice were administered saline, PPI was 43.6%, and when given nicotine it increased
to 55.6%, whereas in the KO mice PPI was similar in both conditions: PPI with saline was 27.6%
and with nicotine it was 30%. When we looked at the individually normalized changes in PPI, we
found a significant improvement of PPI in WT (t17=2.43, p=0.03), but not in KO animals (t17=0.34,
p=0.73, figure 3.4b). Two WT mice were eliminated from this analysis as outliers (±3 standard
deviations from mean).
Nicotine also enhanced baseline startle amplitudes compared with saline treatment in
WT animals (t17=2.4, p=0.03), but not in KO mice (t17=0.43, p=0.67). Once again, however, this
effect was strongest when the data was analysed for individual changes in each mouse between
saline and nicotine conditions. The WT mice showed an increased baseline startle when given
nicotine, whereas KO mice showed no changes (mean change around 0, figure 4.4c). Changes in
baseline startle were significantly different between genotypes (t 34=2.05, p=0.048).
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Figure 3.4 Nicotine-Induced Enhancement of PPI and Startle Magnitude is Absent in α7nAChR KO Mice
(a) We reconfirmed that KO mice have impaired PPI compared with WT in both drug conditions
and prepulses. Nicotine tends to enhance PPI at the 85 dB SPL prepulse in WT mice. We do not
see enhancement at lower prepulse levels as PPI is generally weaker and more variable with a 75
dB SPL prepulse. (b) There was a significant effect of nicotine at 85 dB SPL prepulse on changes
of PPI in WT, but not in KO mice. The asterisk denotes that the change in PPI (PPI nicotine−PPI
saline) between drug conditions is significantly different from zero in WT but not KO mice. (c) The
change in baseline (BL) startle amplitude between treatment conditions (nicotine baseline−saline
baseline) is displayed for both genotypes. Nicotine enhanced baseline startle in WT animals, but
not in α7-nAChR KO mice (n =18/genotype, male).
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3.3.4 The Habituation of Reflexive and Non-Reflexive Behaviours is Unaltered in α7-nAChR KO
Mice
We examined short- and long-term habituation of the startle response in male WT and
α7-nAChR KO mice over 5 days of testing. Wild-type mice (n=18, male) show a progressive
decrease in startle amplitude within a testing session, on average they reduced responding by
about 27% by the end of block I (short-term habituation ratio=0.73). In KO mice (n=18, male)
responses also decreased by about 23% (short-term habituation ratio=0.77).
The short-term habituation ratios between genotypes did not differ (t34=1.7, p=0.1, figure
3.5a,b). We used a separate batch of animals to examine long-term habituation of startle with a
shortened behavioural program in order to avoid overexposure. In WT mice (n=21, 16 males/5
females) average startle response decreased to 92%, and in KO mice (n=14, 9 males/5 females)
to 91% within 5 days. These long-term habituation ratios did not significantly differ (F(1,31)=1.6,
p=0.22), neither was there any interaction between sex and genotype (F(1,31)=0.6, p=0.46). When
startle was normalized to day 1 of testing, the ANOVA revealed that startle significantly changed
across days (F(4,31)=21, p<0.001). There was no effect of sex (F(1,31)=0.16, p=0.67) or genotype
(F(1,31)=0.01, p=0.79), or sex by genotype by day interaction (F(4,28)=0.4, p=0.57; figure 3.5b).
Habituation of reflexive behaviours like the startle response is mediated by mechanisms
distinct from habituation of non-reflexive, or motivated, behaviours like locomotion (that reflects
exploratory behaviour). Therefore, we also examined short-term habituation of locomotion in
WT (n=9, male) and α7-nAChR KO (n =12, male) mice. There was a significant decrease of distance
travelled within the 2 h test session (F(23,529)=9.9, p<0.001) with no effect of genotype (F(1,23)=0.3,
p=0.87) or interaction between genotype and time (F(23,529)=1.26, p=0.2, figure 3.5c). Rearing
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activity also significantly decreased within a test session (F(23,506)=4.6, p<0.001), with no
significant time by genotype interaction (F(23,506)=1.0, p=0.49). For rearing analysis, one KO animal
was eliminated as it never reared. Rest time tended to increase across time, but this failed to
reach significance (F(23,529)=1.3, p=0.14), with no interaction between time and genotype
(F(23,529)=1.2, p=0.22).
While the above data suggests that α7-nAChR KO mice have normal short-term
habituation of locomotor behaviour, we did observe one difference between genotypes: KO mice
spent significantly less time in the centre of the open field throughout testing compared with WT
(t23=1.82, p=0.04). They also tend to travel less in the centre, although this failed to reach
significance (t23=1.67, p=0.11).
To examine long-term habituation of locomotor behaviour, we used separate mice (WT:
n=16, 9 males/5 females; KO: n=13, 8 males/5 females) and tested them in the locomotor box
across 5days. We found that there was no difference in activity between genotypes (F (1,25)=2.7,
p=0.11) or sex (F(1,25)=0.5, p=0.51). With normalized data (to day 1 of each animal) we found that
the distance travelled significantly decreased across days (F(4,100)=5.3, p=0.017), with no main
effect of genotype (F(1,25)=3.25, p>0.05), sex (F(1,25)=0.8, p=0.37) or interaction of day, sex , and
genotype (F(4,100)=0.7, p=0.41). This shows that both genotypes had normal long-term habituation
of locomotor behaviour, see figure 3.5d.
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Figure 3.5 Habituation of Startle and Locomotion is Unaltered in α7-nAChR KO Mice
(a) Short-term habituation ratios for the startle response did not differ between genotypes. (b)
Short- and long-term habituation of startle at days 1 and 5. In both genotypes startle amplitudes
progressively decrease within a testing session and across testing sessions to a comparable
degree. (c) Both genotypes show significant short-term habituation of locomotor behaviour, with
activity greatly attenuated by the end of testing. (d) Both WT and KO mice decreased locomotor
activity across days, displaying normal long-term habituation of locomotion (WT n=21, 16
males/5 females; KO n=14, 9 males/5 females). Overall, this suggests that the α7-nAChR was not
critical for these behaviours.
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3.3.5 α7-nAChR KO Mice Have No Impairments of Spatial Learning and Memory
To date, discrepancies exist whether α7-nAChR KO mice have normal or impaired spatial
learning and memory, and spatial memory performance has been linked to PPI performance
(Singer et al., 2013). Therefore, we tested male WT and α7-nAChR KO mice in the Barnes maze
(n=10/genotype, male) in order to reassess spatial learning.
When we analysed the latency to approach target, we observed a main effect of day,
which suggested that learning occurred across days (F(5,114)=18.9, p<0.001). We found no main
effect of genotype (F(1,114)=0.1, p=0.78) or interaction between day and genotype (F(5,570)=0.4,
p=0.86), which indicates that both genotypes performed similarly (figure 3.6a). Furthermore, we
observed normal activity levels as both genotypes travelled the same distance across days
(F(5,114)=2.6, p=0.14). While there was no difference in the number of primary errors made by
genotypes (F(5,114)=4.4, p=0.07), KO mice tended to make significantly less total and secondary
errors (F(5,114)=5.1, p=0.036; F(5,114)=17.6, p=0.015, respectively). Consequently, they also took
significantly less time to enter the target (as opposed to approach it) than WT mice (F (3,76)=10.2,
p=0.005), despite both genotypes improvement across days of testing (F(3,76)=5.1, p=0.003).
Additionally, as Singer et al. (2013) found the strongest correlation between PPI and spatial
working memory; we also examined improvements on day 1 across trials. Both genotypes
considerably improved across trials (F(3,54)=6.53, p=0.001) with no difference between genotypes
(F(1,18)=0.09, p=0.78, figure 3.6b).
We found a significant preference for the target hole on days 5 (F(19,380)=39, p<0.001) and
12 (F(19,380)=23.3, p<0.001) with no main effect of genotype (F(1,18)=0.01, p=0.93; F(1,18)=1.1,
p=0.32, days 5 and 12, respectively, figure 3.6c,d). Furthermore, latency to approach the target
93

did not differ between genotypes on days 5 or 12 as there was no effect of day (F(1,18)=0.18,
p=0.68),genotype (F(1,18)=0.12, p=0.73) or interaction between day and genotype (F(1,18)=0.14,
p=0.71), which shows that α7-nAChR KO mice have normal retention of spatial tasks.

Figure 3.6 α7-nAChR KO Mice Have Normal Spatial Learning and Memory
(a) α7-nAChR mice show normal acquisition of a spatial task, as both genotypes significantly
improved performance on training days 1–4. Unchanged performance on days 5 and 12 suggests
that both genotypes accurately remembered the task. (b) The analysis of spatial working memory
during the first training sessions within day 1. Both genotypes show similar times to approach
the target on day 1. (c) Number of nose pokes on the different holes on the maze. Both WT and
α7-nAChR KO mice show a preference for the target holes on day 5 and (d) day 12, suggesting
that α7-nAChR KO mice have normal short- and long-term spatial memory (n=10/genotype,
male).
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3.3.6 Elevated Plus Maze Testing in α7-nAChR KO Mice
The fact that α7-nAChR KO mice spent less time in the centre of the locomotor box and
seem to have an increased drive to enter the target drop box in the Barnes maze may be
indicative of an increased level of anxiety in these mice. Therefore, we decided to directly assess
anxiety using the elevated plus maze (n=14/genotype, all male). We found that total distance
travelled (WT=17.0 ± 0.8 m, KO=16.5 ± 1 .0 m; t26=0.3, p=0.76), latency to enter the open arm
(WT=4.5 ± 1.9 s, KO=4.9 ± 2.6 s; t24=0.3, p=0.87) and number of entries into closed (WT=28.0 ±
1.3, KO=27.4 ± 2.1; t26=0.25, p=0.80) or open arms (WT=16.1 ± 1.2, KO=15.4 ± 1.1; t26=0.5, p=0.63)
did not differ between genotypes. However, we did find that KO animals spent more time in
closed vs. open arms compared with WT (WT=152 ± 14.9 s, KO=199.1 ± 8.0 s; t24=2.8, p=0.001),
which suggests that they are more anxious than their WT littermates.

3.4 Discussion
The aim of this study was to understand the role of α7nAChR in sensory filtering and
sensorimotor gating mechanisms and how they relate to higher cognition.

3.4.1 Prepulse Inhibition
We observed that α7-nAChR KO mice had a mild, but consistent and significant
impairment of PPI. The KO mice consistently show reduced PPI at the 75 dB SPL prepulse,
regardless of ISI. At the higher prepulse level of 85 dB SPL, PPI differences failed to reach
significance in one of two groups. Generally, PPI is more robust at higher prepulse levels, and so
we suggest that this impairment is mild and therefore most apparent when PPI is not at its
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maximum. As pharmacological data suggest that α7-nAChR plays a very important role in PPI, our
observation of a mild deficit may in part be due to compensation by other nicotinic receptors in
our KO model. Supportive of this idea, Adams et al. (2008) observed P50 auditory gating deficits
only in heterozygous KO mice.
Our observed PPI deficit does not match with the results of previous α7-nAChR KO mice
studies. Both Paylor et al. (1998) and Young et al. (2011) observed normal PPI in KO mice. Both
studies also used a α7-nAChR subunit null mutation, generated in a mixed 129/SvEv C57BL/6J
line that were backcrossed onto the C57BL/6J strain for at least six generations. As our line
(purchased from Jackson Laboratories) matches this background, genetic differences are unlikely
to account for our observed results. The explanation for the discrepancy might lie in the
differences between experimental protocols. Prepulse levels and ISIs were the same in all studies;
however, both Paylor et al. (1998) and Young et al. (2011) used male and female mice, and found
a main effect of sex on PPI and baseline startle. This might have increased the variability of their
data and thereby occluded a mild PPI deficit. Reduced variability by only using male mice makes
our experiment more apt to detect this deficit in PPI.
Additionally, in past studies, animals may not have been sufficiently habituated to the
startle stimulus prior to PPI testing. Without sufficient prior exposure to startle stimuli alone,
short-term habituation interferes with PPI measurements, especially with the first trials, thereby
further increasing the variability. Finally, Young et al. (2011) did not normalize PPI measurements
for each mouse, which greatly increases the inherent variability between mice (see figure 3.2). In
fact, they show a higher average baseline startle magnitude in KO mice compared with WT, but
the same startle response magnitude when a prepulse is present, which may have reflected a
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disruption of PPI in KO mice had normalized PPI been calculated for each animal. Additionally,
studies have shown that differences in baseline startle also influence PPI, particularly when data
is not normalized (Csomor et al., 2008).

3.4.2 Nicotine-Induced Enhancement of PPI
Apart from the fact that α7-nAChRs play a minor role in PPI, we also observed that they
are critical for nicotine-induced enhancement of startle amplitude and PPI. Although the overall
ANOVA failed to yield a significant effect of nicotine, we did observe a slight, but significant
enhancement of PPI with nicotine when %PPI was normalized to reflect changes from the saline
condition (%PPI nicotine−%PPI saline), which is in accordance with the previous studies (Gould et
al., 2005). The ANOVA likely failed to reach significance because of the high number of factors
involved in the analysis and because of a ceiling effect, as WT mice were already performing well
with saline administration. By reducing variability, via normalizing to the saline condition, this
effect was strengthened and able to achieve significance.
Where this nicotine effect is mediated is not fully understood yet. Nicotine may simply
amplify the contribution of the α7-nAChR to PPI, thereby causing PPI enhancement. Startlemediating neurons of the Caudal Pontine Reticular Nucleus (PnC) receive cholinergic input from
the midbrain that is assumed to mediate PPI (Fendt and Koch, 1999; Bosch and Schmid, 2006,
2008). Potentially, α7-nAChRs in the PnC could directly modulate baseline startle effects and
possibly even PPI. Alternatively, many PPI-modulating brain areas are known to express α7nAChRs, including the Prefrontal Cortex, Hippocampus, Ventral Tegmental Area and Nucleus
Accumbens (Gotti et al., 1997; Paterson and Nordberg, 2000). Future studies should seek to
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understand where this effect is occurring through localized injections of α7-nAChR agonists and
antagonists.
Studies estimate that smoking rates in Schizophrenic populations are two to four times
greater when compared with the normal population (Hughes et al., 1986; Leonard et al., 2000).
In both healthy and Schizophrenic patients, PPI improved after smoking (Kumari et al., 1997;
Kumari et al., 2001), which may indicate that Schizophrenics are smoking as a form of selfmedication (Kumari and Postma, 2005). Our study indicates that the α7-nAChRs are at least
partially mediating aspects of the initial beneficial effects of nicotine. It is important to note,
however, that we only provide evidence that α7-nAChRs are critical for acute effects of nicotine.
Chronic nicotine is known to alter nicotinic responses and receptor levels; therefore, the situation
may be different in smokers.

3.4.3 Habituation of Reflexive and Non-Reflexive Behaviours
In accordance with previous literature, we did not find that the α7-nAChR was involved in
short- or long-term habituation of the startle response. A recent study by Schmid et al. (2011)
showed that the neurotransmitter acetylcholine was involved in long-term habituation of startle,
but we did not find any influence of the α7-nAChR on long-term habituation, which suggests that
the effect is mediated by other cholinergic receptors.
Furthermore, we did not find any evidence that the α7-nAChR is involved in short- or longterm habituation of locomotor behaviour. Previous studies suggested that nAChRs were
important for the consolidation of long-term habituation of locomotion (Schildein et al., 2002).
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Again, our study indicates that a different nicotinic receptor subtype might be responsible for the
previously reported effects.
Overall, we found that the α7-nAChRs are not necessary for habituation of reflexive or
non-reflexive behaviours, although, as with all constitutive KO mice, compensation by the
knockout model cannot be ruled out.

3.4.4 Spatial Learning and Higher Cognition
We tested whether deficits in sensory filtering and sensorimotor gating correlate with
deficits in higher cognitive processes, especially in spatial working memory tasks, as previously
shown (Erwin et al., 1998; Singer et al., 2013). Studies of spatial learning and memory in the α7nAChR KO mouse have been inconclusive in the past (Paylor et al., 1998; Curzon et al., 2006;
Fernandes et al., 2006). In accordance with the findings of Paylor et al. (1998), we found normal
spatial learning and memory in α7-nAChR KO mice. This was rather surprising as the α7-nAChR is
known to be highly expressed in the Hippocampus (Freedman et al., 1995; Guan et al., 1999).
Again, there may be compensation by other nicotinic receptors in our KO model as Curzon et al.
(2006) found that a deficit in spatial learning existed in an inducible KO model. However, a recent
study by Winterer et al. (2013) also failed to show improvements in P50 sensory gating in
schizophrenic patients using an α7-nAChR positive allosteric modulator, which implied that the
role of α7-nAChR in higher cognition is still unclear.
We found mildly impaired PPI in α7-nAChR KO mice but normal spatial learning and
memory, and so did not observe the hypothesized correlation between sensorimotor gating
deficits and higher cognitive function. The difference between our and Singer et al.’s (2013)
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findings could be due to task differences as their protocol emphasized spatial working memory.
We assessed improvement of performance on day 1 to examine working memory, but found no
differences between genotypes. Conversely, recent data suggests that impaired attention is
central in the cognitive deficits observed in α7-nAChR KO mice (Young et al., 2007); therefore,
the observed PPI deficit might correlate better with disruptions in attentional-based tasks.

3.4.5 Anxiety
Interestingly, we found that KO mice were significantly faster to enter the target during
Barnes maze testing, despite no genotype differences in latency to approach target. Accordingly,
we also observed that KOs were significantly less likely to make secondary errors. During
locomotor testing KO mice spent less time in the centre of the locomotor box. Accumulating this
evidence, we suggest that an increased level of anxiety in α7-nAChR KO mice may explain these
findings. Increased anxiety would make the mice more motivated to enter the target in the
Barnes maze instead of exploring other holes, as well as stay closer to the walls in the locomotor
box. In the elevated plus maze test, however, most parameters were similar between genotypes,
except the time spent in closed vs. open arms. This finding suggests that α7-nAChR KO mice may
be slightly more anxious. It should be noted that we also ran light/dark box testing on a separate
batch of animals (data not shown), but increased anxiety could not be reconfirmed.
Other studies have noted no changes in anxiety compared to wildtype mice (Paylor et al.,
1998; Fernandes et al., 2006); however, one study observed that α7-nAChR mice had longer
freezing times during conditioning tasks, which correlates with heightened anxiety (Davis and
Gould, 2007). Additionally, a recent study by Pandya and Yakel (2013) found that in rats, high
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doses of an α7-nAChR agonist (10mg/kg, PNU-282987) had anxiogenic effects during open field
testing that could be rescued by serotonin (5-HT1a) antagonism. Clearly, the role of α7-nAChR in
anxiety needs further elucidation.

3.4.6 Conclusions
In summary, we have shown that α7-nAChRs play a (small) role in PPI, and are critical to
nicotine-induced enhancement of both PPI and startle magnitude. We did not find any evidence
to suggest that this receptor is involved in habituation of reflexive or non-reflexive behaviours.
We also found that α7-nAChR KO mice had normal spatial learning and memory, consistent with
most previous studies, and that they may have had slightly heightened anxiety. Future studies
will seek to understand the mechanisms underlying the α7-nAChR effects on startle and PPI.
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3.6 Link between Chapter 3 and 4
Our last study suggested that the α7-nAChR has a minor role in the mediation of PPI, but
no role in the LTH of the ASR. Our first study (Chapter 2) also uncovered no major deficits in PPI
in mice with deficient cholinergic tone. Together, our evidence seems to suggest that perhaps
ACh is not a major contributor to PPI, in contrast to what has been traditionally assumed.
However, as both our models used congenital and chronic manipulations of cholinergic activity,
it is hard to rule out what role compensatory mechanisms may have played.
Historically the PPT has been hypothesized to provide the cholinergic input necessary
for PPI. The PPT is a heterogeneous structure, composed of glutamatergic, GABAergic and
cholinergic neurons. Deficits in PPI have been reliably induced after non cell-type specific
lesions of the PPT, but this deficit was attributed to the loss of cholinergic cells. As our previous
chapters have only seen a mild link between PPI and ACh, we wanted to re-evaluate the role of
the cholinergic neurons in the PPT in PPI. To do so, we used optogenetics and DREADDs, which
both specifically targeted only cholinergic neurons of the PPT. Furthermore, we were able to
transiently manipulate the activity of cholinergic PPT neurons, reducing the impact of
compensation.

105

4. Chapter 4

Cholinergic Midbrain Neurons Modulate Startle Magnitude, but Not Prepulse
Inhibition
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4.1 Introduction
We are constantly bombarded with incoming sensory information from our five senses
that our brain needs to process. How we process sensory information is critical for our daily
functioning. Appropriate reduction of sensory information reaching conscious awareness and
removal of behavioural responding to unnecessary sensory information is therefore highly
adaptive. An inability to filter inundating sensory information can overwhelm our cognitive
capabilities. Deficits in sensory filtering and sensorimotor gating occurs in many mental illnesses,
including schizophrenia, obsessive compulsive disorder, and autism spectrum disorders (Braff
and Geyer, 1990; Ornitz et al., 1993; Wynn et al., 2004; Hoenig et al., 2005). Examples of sensory
filtering processes include habituation and prepulse inhibition (PPI), both can be studied in
humans and pre-clinical animal models using the acoustic startle response (ASR).
Habituation is defined as the progressive decrease in startle magnitude after repeated
exposure to the startle-inducing sound. This reduces the cognitive and motor burden of repetitive
sensory information (Koch, 1999). Habituation can occur within a day (short-term habituation)
or across days (long-term habituation). Sensitization is the opposite of habituation; it reflects the
increase in behavioural responding after repeated exposure and is mediated through an
independent mechanism (Groves and Thompson, 1970). In any case, it is important to keep in
mind that an individual’s behavioural output is always the sum of these influences; therefore,
they cannot be studied independently.
PPI occurs when the presentation of a sensory stimulus (prepulse) prior to a startleinducing sound reduces the magnitude of the startle response compared to when that same
startling sound is presented alone. This is termed sensorimotor gating and it is thought to protect
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ongoing neuronal processing from distractive interference by the secondary stimulus (Koch,
1999). Alternatively, the prepulse is predicted to coordinate approach behaviours by facilitating
orienting responses such as eye-saccades through activation of neurons in the superior colliculus
while simultaneously inhibiting startle-mediating neurons in the brainstem. In this way, PPI can
thought of as a very early form of response selection (Yeomans, 2012).
The timing between the prepulse and startle pulse, termed the interstimulus interval (ISI)
can greatly impact the amount PPI (Yeomans et al., 2010). The behavioural opposite of PPI is
paired pulse facilitation (PPF), where the presentation of a pulse prior to a startling sound
enhances startle magnitude. PPI generally occurs at ISIs of 20-1000 ms, whereas PPF occurs at
short (>10 ms) or very long ISIs of more than 1 second (Ison et al., 1973; Graham, 1975; Ison et
al., 1997). There is evidence to suggest that PPF opposes PPI by an independent mechanism to
determine behavioural output in a manner similar to habituation and sensitization (Ison et al.,
1973). However this may only be the case at ISIs that border the induction of PPI or PPF (around
10 ms).
PPI and habituation both lead to an attentuation of sensory signals, but they are thought
to be mediated by very different brain mechanisms. Also, habituation of reflexive compared to
non-reflexive behaviours has been observed to be differentially regulated (Williams et al., 1975;
Hughes, 1984). Prepulse inhibition of the ASR has been very reliably shown to be impacted by
manipulations of ACh (Fendt and Koch, 1999; Hohnadel et al., 2007; Yeomans et al., 2010;
Pinnock et al., 2015); whereas cholinergic manipulations have been shown to differentially
regulate habituation of reflexive (ASR) versus non-reflexive (locomotor) behaviours (Hughes,
1984; Thiel et al., 1998; Schildein et al., 2002). While there appears to be no role of ACh in the
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short-term habituation of the ASR (Hughes, 1984), recent evidence suggested it may be
important for long-term habituation of the ASR (Schmid et al., 2011). Regarding non-reflexive
habituation, ACh has been linked to both long- (Thiel et al., 1998) and short-term habituation
(Lamprea et al., 2003). Understanding the source of this cholinergic modulation as well as the
receptors involved may help uncover more about this differential regulation on habituation.
It has been a long-standing hypothesis within the field that the pedunculopontine
tegmental nucleus (PPT) provides cholinergic inhibition onto startle-mediating neurons of the
brainstem, more specifically the giant neurons of the caudal pontine reticular formation (PnC)
(Koch et al., 1993; Swerdlow and Geyer, 1993; Fendt and Koch, 1999; Bosch and Schmid, 2006,
2008). This cholinergic inhibition is the hypothesized mechanism underlying PPI; there has been
no suggestion that it has any role in the habituation of the ASR or locomotion, but this has been
largely untested.
Recent evidence has challenged the cholinergic midbrain hypothesis of PPI. For example,
a conditional knock-out of cholinergic function in the midbrain (including the PPT, laterodorsal
tegmental (LDT) and parabigeminal nucleus (PGB)) caused mice to have improved PPI (Machold,
2013). Additionally, a study by MacLaren et al. (2014) was the first to selectively lesion the
cholinergic cells of the PPT and examine sensorimotor gating. Specific lesions of cholinergic PPT
neurons profoundly reduced startle magnitude, but left PPI intact. Similar to previous studies
which originally provided the foundation for this hypothesis (Koch et al., 1993; Swerdlow and
Geyer, 1993), they found that non-specific lesions to the PPT still reliably induced PPI deficits.
Their observed reduction in startle magnitude was counter-intuitive to the hypothesized
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inhibitory role of cholinergic neurons and their mediation of PPI, however earlier studies also
suggested that these neurons may modulate startle magnitude.
Stimulation of the ventral amygdalofugal pathway and ventral midbrain at sites that
included (but were not limited to) the PPT have been shown to enhance, or even induce, startlelike responses (Yeomans and Pollard, 1993). Furthermore, electrical stimulation of PPT neurons
caused prolonged excitation of PnC neurons in the cat (Garcia-Rill et al., 2001; Homma et al.,
2002), and substance P-induced excitation of giant neurons was augmented by cholinergic
agonism (Kungel et al., 1994). This is particularly interesting as substance P has been strongly
linked to sensitization of startle (Krase et al., 1994), and is known to be co-expressed by a subset
of cholinergic neurons in the PPT which directly innervated the PnC (Kungel et al., 1994).
Together, these studies suggest that the cholinergic midbrain hypothesis of PPI and
cholinergic inhibition of startle in general, may need to be re-examined. With the advent of new
technologies, namely chemogenetic and optogenetic approaches, we aimed to revisit the impact
of PPT cholinergic projections to the startle pathway with improved cell-type and temporal
resolution that was previously unachievable. We specifically wanted to test the impact of
cholinergic PPT activity on PPI and habituation of both the ASR and locomotion.

4.2 Methods
This chapter is composed of 3 parts with overlapping but distinct methodology. Firstly,
we verified the phenotype of our transgenic rat line (discussed below) to ensure it was an
appropriate model for sensory filtering and sensorimotor gating testing. We then used this line
to inhibit (section 4.2.3) or activate (section 4.2.4) cholinergic PPT neurons during behavioural
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tasks. For each experimental approach we completed ASR testing, as well as a positive
behavioural control task, conditioned place preference. In cholinergic inhibition studies, we also
examined the habituation of locomotor behaviour. Finally, we completed immunohistochemistry
and/or electrophysiology as proof of functional neuronal inhibition or activation.

4.2.1 Subjects
For this study we used a hemizygous transgenic rat line (Long Evans-Tg(Chat-Cre)5.1Deis,
RRRC#00658. Rat Resource & Research Center, Columbia, MO, USA). This rat line has a bacterial
artificial chromosome (BAC, RP23-246B12) randomly inserted into its genome. This BAC contains
the mouse ChAT gene with a Cre insertion before the ATG of the ChAT promoter. This strain is
estimated to carry six copies of the transgene (Witten et al., 2011) and was maintained by
breeding a carrier male with a wild-type (WT) Long Evans female. This model allowed us to
achieve cell-type specificity by using viral vectors dependent on Cre recombinase for expression
in order to create either an optogenetic or chemogenetic model of the cholinergic system
depending on the Cre-dependent viral vector employed.
Animals were genotyped at age 4-6 weeks via tissue punches taken from the ear and
performing polymerase chain reaction (PCR). Procedure and primers are described by Witten et
al., (2011). Briefly, we used the Extract-N-Amp Tissue PCR Kit (Sigma Aldrich, Oakville, Ont, CAN)
for Cre detection with the primers Cre-F: AAGAACCTGATGGACATGTTCAGGGATCG and Cre-R:
CCACCGTCAGTACGTGAGATATCTTTAACC.
Animals were cared for according to the ethical guidelines of the University of Western
Ontario Animal Use Subcommittee and Canadian Council on Animal Care (CCAC). For the first 8111

10 weeks of age, animals were group housed. Following surgery, animals were individually
housed. Rats were given ad libitum food and water, and maintained on a 12 h light-dark cycle. All
testing occurred during the light phase.

4.2.2 Validation of Transgenic Model
Our first aim was to ensure our transgenic rat model was appropriate for sensory filtering
and sensorimotor gating testing. For this validation both sexes were used and compared with WT
littermates as controls (WT n=16, 8 male, 8 female; Cre-ChAT n=16, 7 male, 9 female).
4.2.2.1 Testing of the Acoustic Startle Response
Testing of the ASR was completed in an enclosed sound attenuated startle box from MED
Associates (MED-ASR-PRO1, St Albans, VT, USA). Transgenic and WT animals were placed into
small transparent tubes (25 cm x 12 cm) mounted on a movement sensitive platform. A
piezoelectric transducer mounted below the platform converted the vertical displacement of the
platform induced by a startle response into a voltage signal. Startle amplitude was determined
using the amplitude of the largest positive and negative peaks of the signal measured in a 300
ms window after the presentation of the acoustic stimulus. Determination of the amplitude was
done by MED Associates’ software (Startle Reflex version 6.0, MED Associates, Inc. St Albans, VT,
USA)
For a schematic representation of ASR testing, see figure 4.1. Testing began with
acclimatization to the startle box for 5 minutes every day, for 3 days. During this acclimation, and
throughout each test session, there was a 65 dB SPL white-noise background sound. Every testing
session began with a 5 min acclimation period. On day 3 rats were tested on an input/output
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(I/O) function which assessed startle reactivity. This test began with the presentation of a 65 dB
SPL white noise (20 ms) and increased to 120 dB SPL, in 5 dB SPL steps at an intertrial interval
(ITI) of 20 s. Startle reactivity determined the setting of the gain of the movement sensitive
platform (for detail see Valsamis and Schmid, 2011). This gain amplified the signal from the
platform in order to ensure animals startled within a detectable range. Once an animal’s gain was
determined, it was kept constant throughout the remaining days of testing. The I/O was
completed at a gain of 1 for all animals. Following the I/O, experimental testing began.
Experimental testing consisted of two blocks of trials. Block I was used to assess shortterm habituation and block two was used to assess PPI. The STH block consisted of 30 startlealone trials (20 ms white noise, 105 dB SPL, 30 s ITI). The PPI block consisted of 7 different trial
types (10 trials/condition, total=70 trials, pseudorandomized order). The trial conditions were as
follows: startle pulse-alone trials (for comparison of startle amplitude with prepulse) and
combinations of two different prepulses (75 or 85 dB SPL white noise; 4 ms) at three different
interstimulus intervals (ISIs; 15, 30 or 100 ms). The ITI for this block varied between 15-25 ms.
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Figure 4.1 Schematic Representation of Startle Testing
Animals were acclimated to the startle chambers three times (indicated by the grey box in the
diagram). Animals then completed an input/output function to assess startle reactivity (blue
box). During this, animals were presented with increasingly louder auditory stimuli (indicated by
the black bars) and the resulting startle magnitude was recorded. Following this, ASR testing
began (purple box). Animals began testing with a 5 min re-acclimation to the box. The first block
of testing assessed habituation. Identical startle-pulses were presented repeatedly and startle
magnitude was recorded. Short-term habituation ratios were calculated by using the average of
the final five trials (denoted by dots) divided by the first two startle responses in Block I (denoted
by asterisks). Block II assessed PPI which contained a mix of trial types as we used 2 prepulse
intensities (75 or 86 dB SPL) and a variety of interstimulus intervals (ISI; 15, 30 or 100 ms).
Pseudorandomly placed within this block were 10 startle-alone trials, which were used for
quantification of PPI.
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4.2.2.2 Statistical Analysis for Habituation and PPI
To analyse the majority of data, we used an analysis of variance (ANOVA). For all statistical
analysis included in this chapter, whenever this test was performed, Levene’s Test of Equality of
Error Variance or Mauchley’s Test of Sphericity (repeated measures ANOVA only) was examined.
If Levene’s Test was violated, an equivalent non-parametric ANOVA was run. In the case of a
repeated measures ANOVA, if sphericity was violated, corrections were applied based on the
epsilon value (if ε<0.75 the Greenhouse-Geisser correction was applied, or if ε>0.75 the HuynhFeldt correction was used). If post-hoc tests were necessary, we used student t-tests with
Bonferroni corrections. For all analyses included in this chapter, outliers were removed. Outliers
were defined as any data point that was outside the range of ±3 standard deviations from the
mean (calculated using all animals). Finally, criterion for significance was α=0.05.
With regards to ASR testing, in order to detect differences in startle reactivity and startle
magnitude between genotypes, we examined the I/O function (where all animals had the same
gain factor). We used a three-way repeated measure ANOVA (genotype × sex × sound level) for
the I/O function. To analyse short-term habituation of startle, we calculated STH ratios by dividing
the average of trials 25-30 by the average of trials 1-2 for each animal; see figure 4.1, (stimuli
marked with squares and asterisks respectively) and compared them using a two-way ANOVA
(genotype × sex).
Prepulse Inhibition was expressed as percent of prepulse inhibition: %PPI= (1− [startle
magnitude with prepulse/baseline startle without prepulse] × 100). This indicated the amount
that startle was inhibited, as a percentage of the baseline response. We determined the average
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%PPI for each prepulse type and performed four-way ANOVA (prepulse dB SPL × ISI × genotype
× sex).
4.2.2.3 Testing of Locomotor Behaviour
We tested the locomotor behaviour of transgenic and WT littermates. To ensure that
there was no gross motor impairments in the transgenic model. Rats were placed into a 45 x 45
cm box with 2 adjacent opaque walls and 2 adjacent translucent walls. This occluded the rat’s
ability to observe other animals during testing. The animals were able to freely explore the box
for 20 min while they were tracked using a webcam and ANYmaze software (Version 4.99,
Stoelting, Wood Dale, IL, USA). Distance travelled and time spent in the center (6x6 cm centered
square) and surrounding perimeter was recorded. The distance each rat travelled and time spent
in the center and perimeter of the box were totalled across the 20 min of testing. Additionally,
the data for each animal was averaged in to 5 min blocks (total of 4 blocks) in order to assess the
changes in locomotor behaviour across time.
To assess short-term habituation of locomotor behaviour a three-way repeated measures
ANOVA (genotype × sex × time) was performed. The total distance travelled was analysed using
a two-way ANOVA (genotype × sex) and the time spent in the center or perimeter was analysed
separately from distance using a repeated measures three-way ANOVA (genotype × sex × area).

4.2.3 Inhibition of Cholinergic PPT Neurons
To inhibit cholinergic neurons of the PPT we induced expression of the designer receptor
exclusively activated by designer drugs (DREADD) protein hM4Di, a modified muscarinic receptor,
using Cre-dependant viruses in our transgenic (Cre-ChAT) rat model. This receptor is activated
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by the biologically inert ligand clozapine N-oxide (CNO). Activation of the hM4Di protein
hyperpolarizes neurons through G-protein activation of inward rectifying potassium channels
(Armbruster et al., 2007) as well as by inhibiting presynaptic neurotransmitter release (Stachniak
et al., 2014)
We performed sensory filtering and sensorimotor gating assessment of the ASR (hM4Di
n=12/group, 7 male, 5 female) or exploratory behaviour (n=6/group, males only) following PPT
cholinergic inhibition. As a positive behavioural control paradigm, we added assessment of
morphine-induced conditioned place preference (CPP; n=6/group, males only). To verify
inhibition of cholinergic PPT neurons we completed immunohistochemisty in addition to in vitro
patch clamp (single neuron analysis) and in vivo (multi-unit analysis) electrophysiology.
4.2.3.1 Surgical Procedure
For viral injections into the PPT, animals (aged 10-14 weeks) were induced with a 5%
isoflurane and 95% oxygen for induction, and maintained with a 2% isoflurane and 98% oxygen
combination. A subcutaneous injection of meloxicam (1 mg/kg) and intramuscular injection of
Baytril (10 mg/kg) were administered before surgery and as needed 7 days post-surgery for pain
management. Blunt-ended ear bars and a snout mask were used to secure the head in the
stereotaxic frame. A midline incision was made in the skin on top of the head, and bilateral bore
holes were drilled at the following co-ordinates from bregma: ± 2.0mm medial/laterally, -7.2mm
ventrally and either -7.6 (weight 300g) or 7.8mm (weight <400g) caudally. (Paxinos and Watson,
2005). We injected 1 µl/side of virus solution (rAAV8-hSyn-DIO-hDM4(Gi)-mCherry, 5.3*10e12
vg/ml, Lot: AV4680b. UNC Vector Core, Chapel Hill, NC, USA; or its control rAAV8-hSyn-DIO117

mcherry, 3.8*10e12 vg/ml, Lot: AV4680b. UNC Vector Core, Chapel Hill, NC, USA) at a rate of
0.1µl/min using a blunt end 1.0 µl Hamilton syringe (Model 7001 KH SYR, Knurled Hub NDL, 25
gauge, 2.75 in, point style 3; Hamilton, Reno, NV, USA). The syringe rested for 1 min prior to
injection and 7 minutes post before retraction. Silk suture was used to close the wound and rats
were given a 21 day recovery period to promote maximal expression of the DREADD (or control)
protein before testing began.
4.2.3.2 Behavioural Testing With DREADDs
After a 21 day recovery period animals started acclimatization to the startle boxes,
underwent I/O testing, and behavioural testing began. Animals were administered an
intraperitoneal (IP) injection of the DREADD ligand CNO (10 mg/kg in 18% Dimethyl Sulfoxide
(DMSO), Toronto Research Chemicals, Toronto, ON, CAN) or vehicle (18% DMSO, in saline) 20
min prior to testing. Each animal underwent at least 4 days of testing (2 CNO, 2 vehicle). Order
of drug administration was randomized and counterbalanced across groups.
Experimental parameters of startle testing were identical to that depicted in figure 4.1,
with the exception of a variable ITI (15-25ms) in the habituation block. For a schematic
representation of the timeline and testing see figure 4.2. With respect to %PPI, STH ratios and
startle reactivity, data was analyzed identically to that described above. Statistical analysis was
also similar to that described previously however it now replaced genotype with virus type and
included the variable of drug type (CNO vs. vehicle) in ANOVAs (e.g. virus type × drug × sex ×
prepulse dB SPL × ISI).
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Once animals completed startle testing a subset of males (n=6/group), were given a 5
minute rest period in their home-cages before being placed in locomotor boxes (refer to figure
4.2). Administration of CNO was given prior to startle testing which lasted an estimated 30
minutes. In mice, the half-life of CNO is an estimated 1.5 hours (Guettier et al., 2009) but
behavioural effects in rats have been shown to persist much longer (Mahler et al., 2014;
Wirtshafter and Stratford, 2016), therefore cholinergic PPT inhibition was still in effect during
locomotor testing. Experimental parameters were identical to those discussed previously, see
section 4.2.2.3. Data analysis was similar to that described above, however,

genotype was

replaced with virus type and included the variable of drug type (CNO vs. Vehicle) in ANOVAs (e.g.
virus type × drug × time).

119

Figure 4.2 Behavioural Testing During DREADD Inhibition of Cholinergic PPT Neurons
Prior to testing, animals received bilateral infusions of a Cre-dependent virus (hM4Di or mCherry
control) into the PPT. 21 days later, behavioural assessment began. Animals were first acclimated
to the startle chamber three times (5 min, grey box). Their startle reactivity was then assessed
using an input/output function. After this, habituation and PPI of the ASR was tested. This testing
was roughly the same as described in figure 4.1, except there was a variable ITI of 15-25 s during
ASR testing. Additionally, testing was preceded with either a systemic injection of CNO (10 mg/kg
in 18% DMSO) or vehicle (18% DMSO) 20 min prior to testing. Following ASR testing there was a
5 min rest in their home cages before animals completed locomotor testing.
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4.2.3.3 Conditioned Place Preference (Positive Behaviour Control)
A subset of males (n=6/group) underwent an unbiased, counterbalanced, conditioned
place preference (CPP) procedure, as described previously (Ahmad et al., 2013). Briefly, saline
vehicle or morphine injections (5 mg/kg IP, administered immediately prior to placement in the
chamber) were paired with one of two environments that differed in color (black or white),
texture (smooth floor or textured with woodchip bedding), and smell (2% acetic acid or no added
scent). As reported previously, rats display no baseline preference for either of these two
environments (Laviolette and van der Kooy, 2003). Animals received alternating exposure to the
morphine-paired and saline-paired environment for a total of 3 exposures per environment (1
session/day). Drug assignment to environment type was counterbalanced. Thirty minutes prior
to the morphine or saline injection, all animals were administered CNO (10 mg/kg in 18% DMSO,
IP).
Three days after the conditioning phase ended, animals were tested for a place
preference (with no injections prior to testing). They were able to freely explore a test chamber
for 10 min. The test chamber consisted of two compartments with environments identical to
those used in conditioning on either end with a small neutral gray zone separating them. Testing
began when the animal was placed in this neutral zone and the distance travelled and time spent
in each compartment was recorded and tracked using a webcam and ANYmaze software (Version
4.99, Stoelting, Wood Dale, IL, USA). For each animal, CPP behavior was expressed by plotting
the time spent in each compartment and using an individually calculated place preference score
(time in morphine paired environment/time in saline).
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Time spent in each chamber during the test day was analyzed using a repeated measures
ANOVA (environment × virus). The preference score was analysed using a one-sample t-test. As
no preference would have a score of 1, we used a one-tailed t-test for each group to determine
if this score significantly differed from no preference.
4.2.3.4 Immunohistochemistry
Animals were euthanized by IP injections of an overdose of sodium pentobarbital
(Euthanyl: Bimeda-MTC Animal Health Inc. Cambridge, ON, CAN) and transcardially perfused with
saline followed by 4% paraformaldehyde. The brains were harvested and stored in 30% sucrose
until sliced into 40 µm slices using a freezing microtome (KS34S, Thermo Fischer Scientific,
Waltham, MA, USA). Slices were divided into 4 parallel series and stored at -20˚C in cryoprotectant solution (30% sucrose, 30% ethylene glycol, and 5% of 0.01% sodium azide in 0.1M
phosphate buffer (PB)).
Prior to free-floating immunohistochemistry being performed, as well as in between all
incubations with antibodies, all slices were thoroughly rinsed in 0.1M PB. Antibodies were
delivered in a 0.1M PB and 0.1% bovine serum albumin (BSA) solution. Slices were pre-treated
with a 1% H2O2 in 0.1M PB (Caledon Laboratories Ltd., Georgetown, ON, CAN) for 10 min then
blocked for 1 hour in a 0.1M PB plus 0.4% Triton X-100 and 0.1% BSA (Fisher Scientific, Hampton,
NH, USA) solution before incubation with primary antibodies. Next, tissue was incubated
overnight with an anti-mCherry antibody (1:25000, rabbit, polyclonal; ab167453 Abcam, Toronto,
ON, CAN). The mCherry antibody was amplified, first by incubating tissue with a goat anti-mouse
biotinylated secondary antibody (1 h, 1:500; Vector Laboratories, CA, USA), followed by avidin122

biotin complex solution (1h, 1:500; Vectastain Elite ABC Kit, Vector Laboratories, Burlington, CA,
USA). Finally, slices were treated with 3,3′-diaminobenzidine tetrahydrochloride (DAB) solution
(0.04% H2O2, 0.2mg/ml DAB; Sigma-Aldrich, Oakville, ON, CAN).
To label cholinergic neurons, slices were then incubated in β nicotinamide adenine
dinucleotide phosphate (NADPh) solution (0.3% Triton-X, 0.1 mg/ml nitroblue tetrazolium, 1
mg/ml β NADPh, Sigma-Aldrich, ON, Canada) and rinsed. Tissue was then mounted onto
positively-charged glass slides and cover-slipped.
The tissue was imaged using a bright field Nikon DS-Qi2 microscope (Nikon, NY, USA) and
associated NIS-Elements AR software. Images were taken at 2 and 20x objectives.
4.2.3.4.1 Co-expression of mCherry and the Cholinergic Marker NADPh
Images were taken for each animal between post-surgery days 26-35. For each animal, a
representative image was taken at the injection site as well as one posterior and anterior to the
site at 20x magnification. The number of blue (NADPh), brown (mCherry), and blue and brown
(co-expressed) cells were counted manually by two individuals. Cell counts were tracked using
ImageJ software using the Fiji cell counter plugin (Schindelin et al., 2012; Schneider et al., 2012).
The inter-rater reliability was calculated using a two-way mixed effects model intra-class
correlation (ICC) and was revealed to be strong (ICC: 0.93). Once counted, an average of the two
cell counts was used for reporting and analysis. This method has been adapted from Pitchers et
al., (2010).
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4.2.3.5 In Vitro Patch Clamp Electrophysiology
In a separate group of animals, 0.3 µl of AAV virus containing mCherry (n=2) or hM4Di
(n=4) were injected bilaterally into PPT of 5 week old transgenic Cre-ChAT rats. Rats were
anesthetized with isoflurane 21-26 days after surgery and their brains were extracted. Brains
were cut into 300 µm coronal slices using a vibrating-blade microtome (HM 650V, Thermo
Fischer Scientific, Waltham, MA, USA) in ice-cold carbogen-equilibrated solution containing (in
mM): 2.5 KCl, 10 MgS04, 1.25 NaH2PO4, 24 NaHCO3, 0.5 CaCl2-2H2O, 11 Glucose, and 234
Sucrose. Slices containing the PPT (Bregma -7.20 mm to -8.10 mm) were then incubated at 32°C
for 1 hour in artificial cerebrospinal fluid (ASCF) containing (in mM): 124 NaCl, 3 KCl, 3 MgS04,
1.25 NaH2PO4, 26 NaHCO3, 1 CaCl2-2H2O and 10 Glucose.
4.2.3.5.1 Patch Clamp Recordings
Electrophysiological experiments were performed at room temperature and the protocol
was similar to that of previous studies (Zaman et al., 2011; Zaman et al., 2014). In K+-based wholecell current clamp mode, the spontaneous firing properties of PPT mCherry-positive neurons
were recorded in ASCF bubbled with carbogen.
Cholinergic neurons expressing the Cre-dependent viral marker, mCherry, were visualized
using an upright microscope (Zeiss Axioskop, Germany), equipped with an EMCCD camera (Evolve
512, Photometric, Tuscon, AZ). Recording electrodes were pulled on a P-97 Puller (Sutter
Instrument, Novato, CA, USA) from fabricated borosilicate glass capillaries (1B150F-4, OD;1.50
mm, ID;0.84 mm, World Precision Instruments, Sarasota, FL, USA) and had 4–6 MΩ tip resistance
when filled with an intracellular solution containing (in mM): 140 K-gluconate, 10 KCl, 1 MgCl2,
10 HEPES, 0.02 EGTA, 3 Mg-ATP, and 0.5 Na-GTP, pH adjusted to 7.35, 290–300 mosm/l.
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Slices were treated with 5 µM CNO (in 0.1% DMSO) for 10 minutes in recording chamber.
The spontaneous activity before and after the CNO treatment was recorded in PPT neurons at 50 mV holding potential. Signals were sampled at 10 kHz, amplified with Axopatch 200B, digitized
with Digidata-1550 and analyzed using pClamp10.4 (all Axon Instruments, Molecular Devices,
Sunnyvale, CA, USA).
To analyse the spontaneous firing frequency of mCherry-positive PPT neurons pre- and
post-CNO treatment, we performed a two way repeated measures ANOVA (virus type × drug).
4.2.3.6 In Vivo Electrophysiology
A total of 9 animals were used to assess the efficacy of hM4Di-induced inhibition in vivo
(hM4Di n=4, 2F, 2M mCherry n=5, 3F 2M). Animals were anesthetized using an initial dose of
ketamine (80 mg/kg IP) and xylazine (5 mg/kg), and supplemental doses were given
intramuscularly as needed. The rat’s head was fixed in a stereotaxic frame using blunt ear bars
and a headpost was attached to the skull with acrylic dental cement. A stainless steel screw was
inserted into the right frontal skull bone to serve as an anchor for the headpost and electrical
ground. A craniotomy (2 x 2 mm; 5-8 mm posterior to bregma) was performed in the left frontal
skull bone to expose the brain. At the end of the surgical procedure, the right ear bar was
removed to allow free-field auditory stimulation during the electrophysiological recordings in the
contralateral PPT.
4.2.3.6.1 In vivo Recordings
Extracellular electrophysiological signals were collected using a 32-channel electrode
array which consisted of a single shank with 32 equally-spaced recording sites, spanning 0.25 mm
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in length (A1x32-Poly3-10mm-25s-177-A32; NeuroNexus Technologies, Ann Arbor, MI). The
electrode array was connected to a high-impedance headstage (NN32AC, Tucker Davis
Technologies (TDT), FL, USA), and the neuronal activity was pre-amplified and digitized (two
RA16SD Medusa preamps, TDT). It was then sent to a RZ5 processing module. For each of the 32
channels, the neuronal activity was digitally sampled at 25 kHz and bandpass filtered online at
300 – 3000 Hz using a voltage threshold for spike detection of three standard deviations above
the noise floor.
To record, the electrode was inserted in the brain 7.6-7.8 mm posterior from bregma and
2.0 mm medially from bregma. Using a hydraulic microdrive (FHC, ME, USA), the electrode array
was lowered until all 32 recording sites were within the PPT (estimated depth of 7.2-7.7 mm from
the skull). The depth of penetration was determined by probing the auditory responsiveness of
brain regions and mapping their progressive changes with increasing depth. Once the electrode
was determined to be in the PPT, it settled for 1 hour before conducting recordings. The electrode
was coated with DiI to verify placement.
In each subject, an audio stimulation paradigm was performed before and 20 min post an
administration of CNO (10 mg/kg in 18% DMSO, IP via a butterfly catheter inserted prior to the
rat being placed in the stereotactic frame). To assess auditory-evoked responses in the PPT,
computer-triggered auditory stimuli were presented using a RZ6 processing module (TDT, 100
kHz sampling rate) and custom Matlab software. Auditory stimuli consisted of noise bursts (1-32
kHz; 50 ms duration) from a speaker (MF1; TDT) positioned 10 cm above the surface of the
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stereotaxic frame and 10 cm from the base of the right pinna on a 30 degree angle from midline
in the contralateral space. Auditory stimuli were 85 dB SPL (4 ms, white noise bursts).
4.2.3.6.2 Offline Sorting and Statistical Analysis
To analyse multi-unit data, custom scripts in Matlab were used to generate rasters and
Peri-Stimulus Time Histograms (PSTH). The average spontaneous activity of a multi-unit cluster
was determined using the average firing rate within the final 100 ms of each trial. Auditory
responsiveness was determined as the average firing rate across trials within a 2-12 ms window
of time after the auditory stimulus onset. For representative rastor plots and PSTHs, see
supplemental figure A.2. We defined a multi-unit cluster to as responsive to an auditory stimulus
if it displayed a significantly increased firing rate during auditory stimulation compared to
spontaneous activity, as determined using paired t-test.
Multi-unit activity of spontaneous and auditory-evoked activity was compared prior to
CNO administration to 20 min post CNO administration. The average percent change in
spontaneous and auditory-evoked firing rate was calculated for each multi-unit cluster (e.g.
%Change= Activity pre-CNO/Activity post-CNO x 100%). This was then averaged for each animal
and within each virus type. For each animal, we also determined the proportion of multi-units
who’s activity decreased (%Change <0) and averaged this within groups. Both these measures
were compared between groups using an unpaired Student’s t-test.
4.2.3.6.3 Immunohistochemisty and Imaging
Immunohistochemistry was performed to verify electrode placement and virus
expression similarly to described in section 4.2.3.4, however because the electrode was coated
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with a fluorescent marker, DiI, we used a fluorescent secondary antibody for mCherry
fluorescently (Alexa-594, donkey anti-rabbit, 1:500 Thermo-Fischer Scientific Waltham, MA,
USA).
Images were acquired using a Leica LSM 800 (Zeiss, Germany) confocal microscope and
associated Zen software (Zeiss, Germany) using 10x magnification. Images were scanned using
the 546 nm laser line and collected wavelengths included 550-700 nm.

4.2.4 Optogenetic Activation of Cholinergic PPT Neurons
To activate cholinergic neurons of the PPT we induced expression of the optogenetic
protein, a modified Channel Rhodopsin 2 (ChR2(H134R)) using Cre-dependent viruses in our
transgenic (Chat-Cre) rat model. The light-gated ChR2(H134R) ion channel is activated maximally
by blue light (465 nm), and once opened cations freely enter the cell according to electrochemical
gradients. The ChR2(H134R) opsin has been modified to conduct a larger current compared to
ChR2 when activated, although it displays slightly slower protein kinetics (Fenno et al., 2011).
We completed sensorimotor gating assessment of the ASR paired with photostimulation
of the PPT (ChR2(H134R) n=7, 1M 6F YFP n=6, 1M 5F). The same animals also completed
optogenetically-induced CPP testing as a positive behavioural control. To further verify that our
photostimulation paradigm was effective in activating cholinergic neurons in the PPT, animals
received photostimulation 60-90 min prior to perfusion, and c-FOS expression was analysed.
4.2.4.1 Surgical Procedure
To induce expression of the light-sensitive channel ChR2(H134R) we bilaterally injected
the Cre dependant rAAV5-EF1α-DIO-hChR2(H134R)-eYFP (4.3*10e12 vg/ml, Lot:AV4313p. UNC
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Vector Core, Chapel Hill, NC, USA) or its control rAAV5-EF1α-DIO-eYFP (4.9*10e12 vg/ml,
Lot:AV4836c. UNC Vector Core, Chapel Hill, NC, USA). Viruses were aliquoted and stored at -80
°C. For more details regarding surgical procedure and coordinates see section 4.2.3.1.
We injected 1.0 µl of virus per side, at a rate of 0.1µl/min. The syringe rested for 7 min
before retracting. Bilateral fiber-optic cannulae (7.2 mm, 400/430 µm core, NA 0.48; Doric
Lenses, Franquet, QC, CAN) were then lowered into the same location where viral injections had
taken place. Once in place, they were secured using acrylic dental cement. Three jeweler’s screws
were placed in the skull to improve security of the implants (2 bilaterally over the parietal skull
bones and 1 on the left frontal skull bone). Silk suture was used to close the wound and rats were
given a 28 day recovery period to promote maximal expression of ChR2(H134R) before testing.
4.2.4.2 Optogenetic Stimulation During Sensorimotor Gating Assessment
28 days post-surgery animals began ASR testing (ChR2(H134R) n=7, 1M 6F; YFP n=6, 1M
5F). First, they were acclimated to a modified startle chamber: the startle platform and speakers
were identical to that explained in the previous section, however animals were tested in a clear,
rectangular holding chamber (w: 25 cm, h: 30 cm), placed in a partially enclosed box. This ensured
the rat was comfortably tethered to the Light Emitting Diode (LED; housed with a fiber-optic
rotary joint: FRJ 1x1, Doric Lenses, Franquet, QC, CAN), which was suspended on top of the box.
The LED was connected to the animal using a branching opto-patchcord (400/430 µm core, 0.48
NA, Doric Lenses, Franquet, QC, CAN).
Prior to testing, animals were acclimated to the tether procedure. Animals were tethered
two times (15 min) while freely exploring their home cages. During their first exposure to the
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startle chambers, animals were not tethered (15 min), however for the following 3 acclimation
procedures they were tethered to the LED but received no photostimulation. Since tethering
required the use of a larger holding chamber during startle testing, the acclimation procedure
was lengthened to 15 min to reduce movement artifacts during testing.
An I/O function identical to that described previously (section 4.2.2.1) was done to
determine startle reactivity. Once testing began, it was composed of three blocks of trials (figure
4.3). The first block consisted of 20 habituation trials (105 dB SPL white noise, 20 ms duration),
with a variable ITI of 20-60 s. This was to ensure startle magnitude was relatively stable before
optogenetic manipulations.
The second block was to determine the effects of PPT cholinergic optogenetic stimulation
on baseline startle. It consisted of 15 trials (105 dB SPL white noise, 20 ms duration) with a fixed
ITI of 60 s. The first 5 trials were startle-alone trials. The next 10 startle stimuli were presented
with concurrent optogenetic stimulation (photostimulation duration: 60 ms, see below section
4.2.4.2.1 for details, triggered 1 ms prior to startle pulse, duration: 20 ms). To determine the
impact of concurrent photostimulation on startle we normalized trials with photostimulation to
the average 3 trials that preceded photostimulation for each individual rat. Additionally, we
averaged trials with photostimulation and those without and divided these values to create an
individualized total ratio (Stim Ratio: avg with stim/avg without). This was compared between
groups using a one-way ANOVA.
Block III assessed auditory PPI and optogenetically-induced PPI. The first trial consisted of
an auditory prepulse (85 dB SPL, 4 ms) with an ISI of 15, 30, 100 or 200 ms. In the following trial
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blue light was delivered to the PPT (causing activation of these cells) instead of the auditory
prepulse. These trial types were termed Opto-induced PPI. Prepulse inhibition was analysed using
a three way ANOVA (virus type × prepulse type × ISI).
4.2.4.2.1 Photostimulation
Optogenetic stimulation was triggered by a 28V signal from the Med Associates boxes,
which was transformed using a converter (SG231, Med Associates Inc.) into a TTL-pulse. This TTLpulse triggered a waveform generator (DG1022, Rigol Technologies, OR, USA) which was used to
modulate light stimulation. The waveform generator triggered the LED driver (LED RV 1Ch 1000
Single LED, Doric Lenses, Franquet, QC, CAN), which controlled the LED light fiber.
Light stimulation was delivered using a blue LED (465 nm, FRJ 1x1, Doric Lenses, Franquet,
QC, CAN), CAN) at 50 Hz (3 pulses of 15 ms of light, 5 ms rest), 10 Hz (3 pulses of 15 ms, 85 ms
rest), or 1 Hz (15 ms pulse). Light illumination varied from 21-24.7 mW. Optical power was
measured using an energy meter console (PM100D paired with photodiode sensor S120C,
Thorlabs Inc., NJ, USA).
In a subset of experimental animals (n=3, 1 male, 2 female), testing was re-run with
unilateral stimulation of the anatomical left PPT, or low-light stimulation of 1-4 mW/side (data
reported in appendix A). There was a minimum of 2 days separating testing. Data analysis was
similar to that explained previously, but we introduced the photostimulation (frequency or
laterality) and into the ANOVA (virus type × stimulation × ISI).

131

4.2.4.2.2 Drugs
All animals were re-tested with the 50 Hz photostimulation as described above, but
received an IP injection of mecamylamine hydrochloride (3 mg/kg) or saline, 7 days apart, prior
to testing. During startle testing, the acclimation was shortened to 7 min to account for the halflife of mecamylamine (1.2 hours, Debruyne et al., 2003). Short-term habituation curves, ratios
and PPI were calculated as described above (section 4.2.2.2). To analyze PPI however, a separate
repeated measures ANOVA (virus × drug × ISI) was performed for photostimulation as a prepulse
and auditory PPI.
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Figure 4.3 Schematic of Sensorimotor Gating Testing Paired with Optogenetic Stimulation
Animals were acclimated to the startle chamber three times (indicated by the grey box).
Animals then completed an input/output function to assess startle reactivity (blue box) where
animals were presented with increasingly louder auditory stimuli (indicated by the black bars)
and the resulting startle magnitude was recorded. Animals began testing with a 5 min reacclimation to the box. Block I habituated the animal so that startle reached a stable level of
responding. Block II assessed the role of cholinergic release from the PPT on startle magnitude.
Photostimulation of the PPT coincided with the presentation of a startle pulse.
Photostimulation is represented by the blue bar. In the final block of testing (block III), some
prepulses were replaced by photostimulation to optogenetically-induce PPI. Prior to a startlepulse, animals were presented with an auditory prepulse OR photostimulation.
Pseudorandomly placed within this block were 10 startle alone trials to determine baseline
startle amplitudes.
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4.3.2.3 Opto-Induced CPP
The same rats were used as in startle experiments above (n=7, 1 male, 6 female ChR2;
YFP-control n=6, 1 male, 5 female). The general CPP procedure has been described above. Instead
of pairing a chamber type with morphine, here we paired it photostimulation of cholinergic PPT
neurons (50 Hz, 25 x 15 ms light pulse; 19.8-22.3 mW). Animals were placed in either chamber
type for 30 minutes for a total of 3 exposures to each environment type. Photostimulation-paired
and unpaired chamber environments were counterbalanced. Animals were tested the next day.
Testing parameters and data analysis occurred in the same manner described previously (section
4.2.3.3). During testing animal were tethered, but did not receive light stimulation.
4.3.2.4 Immunohistochemistry and Imaging
Prior to perfusion, animals received bilateral 50 Hz light stimulation (25 pulses of 15 ms
duration/min) for 30 min. Animals were perfused 60-90 min after, as previously described.
Immunohistochemistry was performed using an antibody for c-FOS (1:1000; polyclonal rabbit,
Sc-52, Santa Cruz Biotechnology, Dallas, TX, USA) and a secondary antibody Alexaflour594
(donkey anti-rabbit, ThermoFischer Scientific, Waltham, MA, USA), in order to ensure stimulation
parameters activated target neurons. This validation of photostimulation has been used in the
past (see Liu et al., 2012; Yamamoto et al., 2015). In order to verify virus expression in cholinergic
cells we used an antibody for choline transporter (ChT; 1:500, monoclonal mouse, EMD Millipore,
Etobicoke, ONT, CAN) and amplified this using the ABC method described previously and tagged
this using Streptavidin Alexaflour594 conjugate (1:1000, ThermoFischer Scientific, Waltham, MA,
USA). Staining was identical to that described previously. Co-expression with the fluorescent tag
EYFP, labelling neurons expressing the ChR2(H134R) protein, was analyzed. Images were
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acquired using a Leica LSM 800 (Zeiss, Germany) confocal microscope using 20 & 40x
magnification. Images were scanned using the 488 and 546 nm laser lines individually, and we
collected wavelengths 490-550 and 560-700 nm, respectively. Images were merged using Zen
software (Zeiss, Germany). Analysis of images was described previously (section 4.2.3.5). To
estimate cellular activation with photostimulation, two individuals counted the number of yellow
fluorescent protein (YFP)-expressing neurons, and c-FOS positive cells, as well as the number of
YFP neurons that co-expressed c-FOS for both experimental (ChR2(H134R)-YFP) animals and
controls (YFP only). Cell counts were tracked using ImageJ software using the Fiji cell counter
plug-in (Schindelin et al., 2012; Schneider et al., 2012). The inter-rater reliability between
counters was calculated using a two-way mixed effects model ICC which revealed an acceptable
correlation (0.90). Once counted, an average of the two cell counts was used for reporting.

4.3 Results
The results of this chapter are broken into three sections. The first examines if the CreChAT transgenic ratline is a valid model to use for sensory filtering and sensorimotor gating
testing. The second examines the effects of inhibition of cholinergic PPT neurons on these
processes, whereas the final section examines the effect of activation of these neurons. For all
these experiments, both male and female rodents were used; while this factor was always
included in our statistical analysis (except for optogenetic experiments), we only graphed groups
according to sex when it was determined to significantly influence our results.
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4.3.1 Validation of Cre-ChAT Transgenic Rats as an Appropriate Model
In order to achieve cell-type specificity we used a transgenic rodent model (Long EvansTg(Chat-Cre)5.1Deis). This animal model was generated using a BAC containing the genomic
sequence for the Cre protein right after the ChAT promoter (Witten et al., 2011). Using this model
allowed us to use Cre dependent viruses to target solely cholinergic cells. Transgenic mice
previously created with this BAC have a greatly enhanced cholinergic tone which has been shown
to alter cognitive function (Kolisnyk et al., 2013). This was due to the BAC which contained the
open reading frame for the vesicular acetylcholine transporter (VAChT) protein between the first
and second exon of the ChAT gene. VAChT is the rate limiting factor for ACh release, so overexpression of VAChT may increase ACh release. Therefore, it was important to investigate if
sensory filtering and sensorimotor gating processes were normal in transgenic rats.
4.3.1.1 Startle Reactivity in the Cre-ChAT Transgenic Rat Model
Prior to habituation and PPI testing, transgenic rats (Cre-ChAT n=16, 7 male, 9 females)
and WT littermates (n=16, 8 males, 8 females) had their startle reactivity assessed using an I/O
function. This function documented the changes (if any) in startle magnitude with increased
auditory stimulus intensity (65-120 dB SPL).
A three way ANOVA (sex × genotype × sound level) revealed that both genotypes showed
increasing startle magnitudes in response to increasing sound intensities (Greenhouse-Geisser
corrections applied; F(3.6,97.2)=29.6, p<0.001). Most importantly, both genotypes began to startle
at the same stimulus level (85 dB SPL, see figure 4.4A), however transgenic animals reached a
maximum startle magnitude that was lower than that of WT littermates. While there was no
significant effect of sex (F(1,27)=2.2, p=0.15) or genotype (F(1,27)=2.2, p=0.15), and no significant
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interaction between genotype, sex, and sound intensity (F(3.6,97.2)=2.4, p=0.23), there was a
significant sex by genotype interaction (F(1,27)=5.6, p=0.03). As shown in figure 4.4B, WT males
showed a greater maximal startle magnitude compared to female counterparts (F (1,14)=6.4,
p=0.02). This sex difference was absent in Cre-ChAT animals (F(1,13)=0.5, p=0.49). Differences in
weight, which could influence the range of signal detection of our startle measurements, did not
contribute to this finding, as both sexes’ weights were similar across genotypes (WT female: 280g
±5, Cre female: 275g ±6g, WT male: 455g ±14, Cre male: 453g ±8).
However, as Cre-ChAT rats of both sexes showed increased startle magnitudes with
increasing stimulus intensity, had a similar startle threshold at around 80-85 dB SPL, and reached
a maximal startle amplitude that was both robust and at similar sound levels to that of WT
females, we believed their startle reactivity was still appropriate for sensory filtering testing.

Figure 4.4 Startle Reactivity of Transgenic Cre-ChAT Rats Compared to Wild-type Littermates
As shown in A), both genotypes increased their startle amplitude with increasing sound intensity.
Additionally, both genotypes began to display a robust startle response at the same stimulus level
(~80-85 dB SPL), however the transgenic animals reached a maximum startle magnitude that was
lower than that of wild-type. Further analysis determined that this was due to sex differences. As

137

shown in B) WT males and females show a difference in maximal startle amplitude, which is
absent in Cre-ChAT rats (Cre-ChAT n=16, 7 males 9 females, WT n=16, 8 males, 8 females).

4.3.1.2 Short-Term Habituation of the ASR in the Cre-ChAT Transgenic Rat Model
Startle amplitude was plotted across trials in order to examine short-term habituation of
the ASR (figure 4.5A). This was analyzed using a three way repeated measures ANOVA (genotype
× sex × trial) which revealed that both genotypes showed progressively decreased startle
magnitudes as there was a significant effect of trial (F(29,754)=6.11, p<0.001). There was no impact
of genotype (F(1,26)=0.2, p=0.66) or sex (F(1,26)=1.18, p=0.29), and no interaction between trial,
genotype, and sex (F(29,754)=1.03, p=0.43) which indicated that the rate of habituation in
transgenic rats was not different from WT.
We quantified the total reduction in startle magnitude using a short-term habituation
(STH) Ratio. This reflected the final startle amplitude relative to the initial startle. As shown in
figure 4.5B, both genotypes displayed equal ratios (F(1,26)=2.34, p=0.13), with WT showing
reduced responses to 0.65 (±0.08) of initial magnitude and Cre-ChAT rats to 0.55 (±0.05). In
contrast to the analysis above, which examined the progression of habituation, we found a
significant effect of sex (F(1,26)=0.22, p=0.64) when we compared the habituation score. This effect
was equal in both genotypes as there was no sex by genotype interaction (F(1,26)=0.41, p=0.53) or
effect of genotype (F(1,26)=2.3, p=0.14). In both cases, males showed significantly more short-term
habituation, as shown in figure 4.5C.
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Figure 4.5 Short-Term Habituation of the ASR is Unaltered in Cre-ChAT Rats
A) The progressive decrease in startle amplitude across trials in both genotypes was not different.
The total reduction in startle amplitude for each animal was normalized using an STH Ratio (B
&C). Both genotypes showed decreased startle to ~0.55-0.65 of initial response magnitude
(shown in B), however, in both genotypes, the different sexes displayed significantly different
amounts of habituation (shown in C). In general, males tended to show stronger reduction of
startle (Cre-ChAT n=16, 7 males, 9 females, WT n=16, 8 males, 8 females).
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4.3.1.3 Short-Term Habituation of Locomotor Behaviour in the Cre-ChAT Transgenic Rat Model
We found no difference in the short-term habituation of locomotion or locomotor
behaviour of transgenic Cre-ChAT rats (figure 4.6). The distance travelled during 5 minute blocks
of open field testing was analysed using a three way repeated measures ANOVA (genotype × sex
× time). Both groups showed decreased activity during the 20 min exploration as we observed a
significant effect of time (F(3,81)=224.8, p<0.001), indicative of short-term habituation. Both
genotypes travelled to a similar degree as we saw no effect of genotype (F(1,27)= 0.1, p=0.75). We
did uncover a significant effect of sex (F(1,27)=5.3, p=0.03) but no interaction between sex,
genotype, and time (F(1,27)=3.8, p=0.07), which indicates that the influence of sex was equal across
genotypes.
To further uncover the effect of sex, we calculated the cumulative distance travelled by
each genotype and sex throughout the duration of the test and examined this using a two-way
ANOVA (sex × genotype). As shown in figure 4.6B females travelled to a greater degree than their
male counterparts in both genotypes (F(1,27)=10.4, p<0.01).
To further ensure transgenic rats displayed normal open field behaviour, we calculated
the total time spent in the perimeter versus the center of the open field (figure 4.6C). This ratio
is also indicative of anxiety-like behaviour, since anxious animals tend to stay closer to the walls.
Consistent with previous studies (Lamprea et al., 2008), we documented that both genotypes
displayed a strong preference for the perimeter of the open-field (three way repeated measures
ANOVA sex × genotype × area: F(1,27)=522, p<0.001). This was equal across genotypes (F(1,27)=0.1,
p=0.75) and sexes (F(1,27)=0.14, p=0.71), and there was no interaction between any of these
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factors (F(1,27)=1.3, p=0.26). Overall this revealed that locomotor activity of the transgenic rats
was not different from WT animals.

Figure 4.6 Short-Term Habituation of Locomotor Behaviour in Cre-ChAT Rats
A) Short-term habituation of exploratory behaviour was not different between WT and
transgenic rats. B) Overall, female rats were significantly more active than males (B), but that this
was equal across genotypes. C) Transgenic rats displayed the same strong preference for the
perimeter as WT littermates, indicative of normal thigmotactic behaviour (Cre-ChAT n=16, 7
males, 9 females, WT n=16, 8 males, 8 females).
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4.3.1.4 Prepulse Inhibition of the ASR in the Cre-ChAT Transgenic Rat Model
As our hypothesis was mainly centered upon sensorimotor gating of the ASR, it was
critical to ensure that PPI was normal in Cre-Chat transgenic rats. Displayed in figure 4.7 is the
percent of inhibition induced by a prepulse (%PPI) across genotypes. A four way ANOVA
(genotype × sex × prepulse dB SPL × ISI) showed that both genotypes showed similar startle
inhibition by a prepulse as we detected no main effect of genotype (F(1,27)=0.03, p=0.86) or sex
(F(1,27)=0.12, p=0.73), or interaction between genotype and sex (F(1,27)=0.91, p=0.34).
In general, we saw PPI of 65-79% in both genotypes (depending on ISI). Using a 75 or 85
dB SPL prepulse resulted in similar PPI (F(1,27)=0.6, p=0.44), however at both prepulse levels, we
saw a significant difference according to ISI (F(2,54)=6.3, p<0.01). We tended to observe maximal
PPI using the 30 ms ISI (see figure 4.7A).
Baseline startle during the PPI block of testing was not different between genotypes (two
way ANOVA genotype × sex: F(1,27)=0.72, p=0.40), or sex (F(1,27)=0.28, p=0.60). There was also no
interaction between group and sex on baseline startle amplitude (F(1,27)=0.47, p=0.5). Baseline
startle was measured using individually calibrated movement-sensitive platform (gain values; see
section 4.2.2.1). Together, this data implies that PPI was not different between transgenic and
WT animals (figure 4.7B).
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Figure 4.7 Prepulse Inhibition is Normal in Cre-ChAT Transgenic Rats
A) The amount of PPI in transgenic and WT rats. The data is plotted as %PPI, which reflects the
amount of inhibition relative to baseline startle amplitude. Both genotypes showed similar startle
inhibition by a prepulse. B) Baseline startle magnitude (calculated from startle pulse alone trials
during PPI measurements) of WT and transgenic animals showed no difference between
genotypes (Cre-ChAT n=16, 7males, 9 females, WT n=16, 8 males, 8 females).
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4.3.1.5 Summary of Behavioural Validation of the Cre-ChAT Transgenic Rat Model
Overall, we observed that transgenic rats had similar startle reactivity, short-term
habituation and PPI of the ASR as their WT littermates. Additionally, locomotor activity and shortterm habituation of non-reflexive behaviours were not significantly altered in this rat model.
Therefore, I concluded that these rodents were an appropriate model to use for the remainder
of our studies.

4.3.2 DREADD-Induced Inhibition of Cholinergic PPT Neurons
For chemogenetic inhibition of cholinergic PPT neurons we injected a Cre-dependent
DREADD virus (rAAV8-hSyn-DIO-hM4Di-mCherry; n=12, 7 males, 5 females) or control virus
(rAAV8-hSyn-DIO-mCherry; n=12, 7 males, 5 females) into the PPT of Cre-ChAT rats. Animals were
tested using a 10 mg/kg dose of CNO (IP, 18% DMSO) or vehicle. This dose of CNO was chosen
based on pilot data (Appendix A).
4.3.2.1 Startle Reactivity of hM4Di Expressing Rats Compared to mCherry Controls
Prior to conducting startle testing, all animals completed an I/O function. There was no
administration of CNO or vehicle prior to this, so we included data from our pilot group
(n=16/group, 7 females, 9 males). We used a 3-way repeated measures ANOVA (virus × sex × dB
SPL) to analyze unamplified startle amplitudes.
Both groups showed an increase in startle magnitude as sound level increased
(F(6.6,178)=26.5, p<0.001). Surprisingly, we observed a significant effect of virus (F(1,27)=8.0, p=0.01),
but no effect of sex (F(1,27)=1.4, p=0.31). As clearly shown in figure 4.8, startle magnitude of the
hM4Di expressing animals was consistently greater than mCherry expressing control animals. As
144

we found no interaction between virus type, sex, and sound intensity (F(6.6,178)=0.6, p=0.73),
which suggested that there was greater startle responses in hM4Di animals, but that the relative
increase in this response with sound intensity was equal to that of controls. In other words, the
startle-reactivity curve between each virus group progressed similarly, but the hM4Di curve
reached a higher maximum level.

Figure 4.8 Startle Reactivity in hM4Di Expressing Animals is Altered
Both groups of transgenic animals showed increased startle magnitudes with increasing sound
intensity; however the hM4Di expressing animals, on average, displayed significantly higher
startle amplitudes, while startle threshold and sound level for maximum startle amplitude
remained the same. It is important to note that this test was run without CNO administration
(n=16/group, 7 females, 9 males).
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4.3.2.2 Short-term Habituation of the ASR Following Inhibition of Cholinergic Neurons of the
PPT
In order to quantify habituation, startle amplitudes were normalized to the average of
the first two trials for each animal. This helped to remove the differences in absolute startle
reactivity observed between individual animals and virus types (see figure 4.8), while also
reducing the impact of any long-term habituation that may occur across testing sessions. One
female rat from each group (mCherry and hM4Di) was removed from this analysis as they were
outliers (STH ratio: ±3 standard deviations). Animals received CNO (10 mg/kg IP) or vehicle (18%
DMSO) prior to testing. As revealed by the repeated measures ANOVA (virus × sex × drug x trial),
both hM4Di and mCherry control animals showed progressively decreased startle across trials,
indicative of short-term habituation (F(29,522)=4.4, p<0.001). There was no main effect of sex
(F(1,18)=0.9, p=0.35), or drug (F(1,18)=0.74, p=0.78); however there was a significant effect of virus
(F(1,18)=4.90, p=0.04), as well as a significant interaction between virus, drug and trial (F(29,522)=1.8,
p<0.01). A follow up repeated measures ANOVA (trial × sex × drug) within each group revealed
that CNO administration significantly impacted the short-term habituation in hM4Di expressing
animals (F(1,9)=5.90, p=0.04), but not in mCherry controls (F(1,9)=1.33, p=0.27).
As shown in figure 4.9A, it appeared that CNO administration improved short-term
habituation in the hM4Di expressing animals. This was further quantified using STH Ratios, as
shown in figure 4.9B. In control animals startle responses were reduced to about half of their
initial magnitude when given vehicle or CNO (0.53 ± 0.06, 0.52 ± 0.08, respectively). With vehicle
administration, hM4Di expressing animals showed decreased responding by the same amount
(0.53 ± 0.09), however, when given CNO, this ratio decreased to 0.37 (±0.05) which indicated
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improved habituation. A repeated measures ANOVA (sex × virus × drug) on STH ratios revealed
that this trend failed to reach statistical significance, as we saw no effect of drug (F (1,18)=1.90
p=0.19), virus (F(1,18)=1.05, p=0.32), or sex (F(1,18)=1.77, p=0.2), and no interaction these factors
on STH ratios (F(1,18)=0.78, p=0.39).
Overall, this suggests that inhibition of cholinergic PPT neurons altered short-term
habituation as our ANOVAs revealed that the habituation curve of hM4Di animals was
significantly changed when given CNO. During cholinergic PPT inhibition, hM4Di animals showed
a greater and more prolonged gradual decrement in startle before reaching a stable level of
responding (by around trial 20) compared to control groups (figure 4.9A). This also resulted in a
slightly lower STH ratio in the hM4Di animals when given CNO (figure 4.9B), however, the latter
failed to reach statistical significance. Thus, it appeared that the greatest effect of DREADDinhibition was detected in the slope of the STH curve, which reflects a faster rate of habituation.
4.3.2.3 Short-term Habituation of Locomotion Following Inhibition of Cholinergic Neurons of
the PPT
For analysis of locomotion only male rats were used (n=6/group). We saw normal shortterm habituation in exploratory behaviour in both mCherry and hM4Di expressing rats.
Ambulatory distance decreased greatly across time, as revealed by a three way repeated
measures ANOVA (time × drug × virus). There was a significant effect of time (GreenhouseGeisser corrections applied: F(2.3,20)=67.8, p<0.001), and at each time point, both groups travelled
to a similar degree as there was no effect of virus type (F(1,9)=0.2, p=0.67), or CNO administration
(F(1,9)=0.9, p=0.37), and no interaction between these factors (F(5,45)=0.6, p=0.7). Overall, this
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suggests that inhibition of the cholinergic PPT neurons do not influence the short-term
habituation of non-reflexive behaviours, as displayed in figure 4.9C.
As an important control we calculated the cumulative distance travelled, shown in figure
4.9D, and analysed this using a two way ANOVA (virus × drug). We found that total distance
travelled did not differ between virus groups (F(1,9)=0.1, p=0.76). We observed no main effect of
drug (F(1,9)=0.4, p=0.54), or interaction between these factors (F(1,9)=4.0, p=0.08), which denoted
normal activity levels after cholinergic PPT inhibition.
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Figure 4.9 Cholinergic Inhibition of the PPT Improves Short-Term Habituation of the ASR but
not Locomotion
A) All groups showed short-term habituation of startle as there was a progressive decrease in
normalized startle magnitude (data normalized to the first 2 trials within each animal). However,
there was a significant increase in habituation in hM4Di expressing animals when administered
CNO. B) In hM4Di expressing animals there was a trend toward further decreased STH ratios,
which failed to reach statistical significance (n=11/group, 7 males, 4 females). C) Both virus
groups showed reduced exploration of the open field across time, indicative of normal
habituation. This decrease was unaffected by CNO administration. D) Displays total distance
travelled, which did not differ between virus groups or with CNO treatment (n=6 males/group).
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4.3.2.4 Prepulse Inhibition of the ASR Following Inhibition of Cholinergic Neurons of the PPT
Overall, we did not find an influence on PPI during inhibition of the cholinergic cells of the
PPT, in contrast to our initial hypothesis. A repeated measures ANOVA (virus × sex × drug × ISI ×
dB SPL) on %PPI values revealed no effect of drug (F(1,20)=1.1, p=0.3), virus type (F(1,20)=0.7, p=0.49)
or sex (F(1,20)=0.8, p=0.48). Silencing cholinergic PPT neurons did not influence PPI across ISIs or
prepulse intensity as we found no interaction between virus, drug, sex, prepulse intensity, and
ISI (F(2,40)=0.2, p=0.82).
Consistent with past PPI studies, we observed a significant effect of prepulse intensity
(F(1,20)=11.42, p<0.005), as shown in figure 4.10A, with greater PPI following the more intense
prepulse (85 dB SPL). We also observed a significant effect of ISI (F(1,40)=9.48, p=0.001), and
maximum PPI occurred using a 30 ms ISI. At this ISI (and a 85 dB SPL prepulse), control animals
displayed 83% (±4%) inhibition with vehicle administration and 79% (±4%) with CNO; similarly
hM4Di expressing animals showed 84% (±2%) inhibition with vehicle and 85% (±2%) with CNO.
As shown in figure 4.10B, we observed that inhibition of cholinergic PPT neurons
impacted baseline startle magnitude. Although our three-way repeated measures ANOVA (virus
× sex × drug) revealed a trend towards an effect of drug (F(1,20)=4.3, p=0.05), we saw no effect of
virus, (F(1,20)=0.5, p=0.47), sex (F(1,20)=0.1, p=0.86), or interaction between drug, sex and virus
(F(1,20)=1.0, p=0.31). However, we did observe a significant interaction between drug and virus
(F(1,20)=4.7, p=0.04). Post-hoc t-tests revealed that CNO selectively decreased baseline startle in
the hM4Di expressing group (t11=2.6, p=0.02) but not in mCherry controls (t11=0.36, p=0.72).
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Figure 4.10 Inhibition of Cholinergic PPT Neurons did not Impair Prepulse Inhibition, but did
Alter Startle Magnitude
Contrary to the major predictions of the field, inhibiting the cholinergic cells of the PPT did not
disrupt PPI, as shown in A). Prepulse inhibition is plotted as % PPI, which reflects the amount of
inhibition induced by a prepulse. We saw no difference in %PPI between control expressing
mCherry animals and hM4Di infected animals, and no effect of systemic CNO administration
across all testing conditions. During PPI testing, we did observe a decrease in baseline startle
magnitude selectively in the hM4Di expressing group when given CNO, shown in B). This suggests
that cholinergic inhibition of PPT cells may influence startle reactivity (n=12/group, 5 female, 7
male).
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4.3.2.5 In vitro Patch Clamp Recordings of hM4Di Expressing Neurons
In order to determine the efficacy of our DREADD-induced inhibition on a cellular level, in
vitro patch clamp recordings of PPT neurons expressing the viral tag mCherry were performed in
the current clamp mode (mCherry n=2, hM4Di n=4). Cells were held at a resting membrane
potential of -50 mV by a constant current. Prior to CNO administration, firing frequency was 1.96
Hz (±0.11) in mCherry expressing control cells and 1.95 Hz (±0.11) in hM4Di expressing cells. After
being bathed in CNO (5 µM in 1% DMSO) the firing frequency of mCherry cells was unchanged
(1.96 Hz (±0.21), whereas the firing of hM4Di expressing cells was greatly reduced (0.19 Hz ± 0.06;
figure 4.11). This reduction was statistically significant as a two way repeated measures ANOVA
(virus × drug) revealed a significant effect of drug (F(1,4)=37.04, p=0.004), and interaction between
drug and virus (F(1,4)=37.56, p=0.004). Overall this shows on the cellular level that CNO effectively
inhibits hM4Di expressing neurons.
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Figure 4.11 hM4Di Expressing Neurons are Strongly Inhibited by CNO In Vitro
A) A representative trace of electrophysiological in vitro patch clamp recordings of mCherry
positive neurons in the PPT in control mCherry and hM4Di-mCherry neurons before and after
CNO treatment. B) Both types of neurons showed similar spontaneous firing rates when the
membrane potential was held at -50 mV. When treated with CNO, hM4Di neurons showed a
drastic decrease in firing frequency, whereas mCherry control neurons were unaffected
(mCherry n=2, hm4Di n=4 slices).
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4.3.2.6 In vivo Electrophysiological Recordings of the PPT Following hM4Di-Induced Inhibition of
the Cholinergic PPT Neurons
In order to observe the effects of DREADD-induced inhibition of the cholinergic PPT
neurons at the population level, and to determine if this inhibition impacts auditory processing,
we performed in vivo electrophysiological recordings (mCherry n=5, hM4Di n=4 animals). For
each animal, we normalized individual multi-unit cluster activity to pre-CNO levels
(%Change=activity with CNO/activity pre-CNO, 100%=no change). As shown in figure 4.12C, we
saw that spontaneous activity was slightly, but significantly, decreased after systemic CNO
administration in hM4Di animals as their spontaneous firing frequency was 93% (±4) of pre-CNO
levels, whereas the mCherry controls firing frequency was 106% (±3; t6=3.6, p=0.01). Moreover,
the proportion of multi-units within each animal that displayed a decrease in activity post-CNO
(%Change<0) was also significantly greater in hM4Di animals (70% ±8) compared to mCherry
controls (41% ±4; t6=3.63, p=0.01). This is displayed in figure 4.12D. As we expected to inhibit
only a subset of neurons within the PPT, i.e. cholinergic, but not glutamatergic or GABAergic cells,
our slight but significant inhibition of multi-unit spontaneous activity confirms our DREADD
system is functional at a population level in vivo.
Interestingly, the auditory-evoked multi-unit activity to an 85 dB SPL noise burst was
unchanged after cholinergic inhibition by CNO administration (t6=1.7, p=0.14). Control animals’
auditory-evoked activity was 103% (±3) of pre-CNO levels, whereas hM4Di animals displayed 95%
(±8) of pre-CNO activity. The proportion of auditory-evoked multi-unit responses within each
animal that showed a decrease (%Change >0) was not different between groups either (t6=1.5,
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p=0.18), with 40% ± 9.5 in mCherry animals and 57% ±14 in hM4Di animals (figure 4.12E & F).
Overall this suggests that auditory responsive cells in the PPT are mainly non-cholinergic.

Figure 4.12 The Spontaneous Activity of Multi-Unit Clusters is Reduced in hM4Di Animals via
CNO
A) Depicts the target area of recording within the PPT. Image was adapted from Paxinos and
Watson (2005). B) The orange trace shows where the recording electrode, coated with DiI, was
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placed, red cells are mCherry positive cells. Included in this analysis are animals with recording
sites verified within the PPT and close to mCherry positive cells. Scale bar is 200 µm. C) The
activity of each multi-unit was normalized to pre-CNO levels (100%, as indicated by the dotted
line) and averaged within each animal to create an overall average for each group. The
spontaneous activity of multi-units in hM4Di expressing animal’s post-CNO was significantly
lower than controls (mCherry: 109%, hM4Di: 93%). D) Additionally, the average proportion of
multi-units that decreased their activity (%Change <0) was significantly greater in hM4Di animals.
E) Relative activity of multi-units to auditory stimulation (85 dB SPL, 4 ms white noise) post CNO
(pre-CNO = 100%, as indicated by the dotted line). Auditory responsiveness was not different
between groups post CNO. F) The proportion of multi-units that displayed decreased activity
(%Change <0) post CNO was also not different between groups. This suggests that auditory
responsiveness was intact in hM4Di animals, despite inhibition of cholinergic neurons (hM4Di
n=4, mCherry n=5).

4.3.2.7 Conditioned Place Preference Following Cholinergic Inhibition of the PPT (Positive
Behavioural Control)
Although the experiments above provide strong evidence that our DREADD system
inhibited cholinergic PPT neurons at the cellular and population level, it was important to prove
that our inhibition was also able to alter behaviour. Therefore, as a positive behavioural control,
we performed morphine-induced CPP. A subset of male rats used in ASR testing were used for
CPP testing (n=6/group). Pre-treatment with CNO was given 30 min prior to all conditioning
sessions (morphine and saline-paired environments). On the test day the time spent in each
chamber was analysed using a three way repeated measures ANOVA (virus × drug × environment
type).
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We observed that DREADD-induced inhibition of cholinergic neurons disrupted the
development of CPP. We found a significant effect of drug (F(1,10)=5.9 , p=0.03) and interaction
between drug and virus type (F(1,10)=5.3, p=0.04). Post hoc t-tests revealed that on average,
control animals spent more time exploring a morphine-paired environment compared to the
saline-paired (t5=3.6, p=0.02). There was no place preference in the hM4Di animals (t5=0.06,
p=0.94), as shown in figure 4.13A. We further quantified this using a preference score (time in
morphine-paired environment/time in saline; 1=no preference). As shown in figure 4.13B,
mCherry expressing control animals displayed a preference score of 3.96 (±0.7) which was
significantly greater than one (one sample t-test; t5=2.9, p=0.02), indicating a strong preference
for morphine. Again, this was absent in hM4Di animals who had a score of 1.20 (±0.34; one
sample t-test t5=0.8, p=0.23). Overall this suggests that our DREADD-induced inhibition of
cholinergic PPT neurons was effective at preventing the development of CPP.
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Figure 4.13 Morphine-Induced Conditioned Place Preference is Blocked by Inhibition of
Cholinergic PPT Neurons
A) During the conditioning phase, both groups were pre-treated with CNO 20 min prior to
exposure to saline- or morphine-paired environments. We observed that inhibition of cholinergic
neurons disrupted the development of CPP. On test day hM4Di animals spent equal time in both
environments, whereas mCherry controls spent more time in the morphine-paired environment,
exhibiting CPP. B) CPP within each animal was quantified using a preference score (time spent in
Morphine-paired environment/time in Saline, 1=no preference as indicated by the dotted line).
Animals expressing mCherry displayed a preference score significantly greater than 1, but hM4Di
animals did not (n=6 males/group).
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4.3.2.8 Verification of DREADD Virus Expression
Bilateral expression of the viral-tag mCherry in the PPT was verified for all animals
included in this study. Figure 4.14 displays a representative image of virus expression throughout
the PPT. We examined mCherry expression within the PPT for five representative slices (see
figure 4.14). Then, the proportion of animals expressing mCherry at that representative slice was
calculated (n=12 animals total; # of animals expressing mCherry/12). In general, most injections
(90%+) targeted the mid to caudal aspect of the PPT, however good expression occurred through
the majority of the PPT. In some animals, uni-or-bilateral expression was also observed in the LDT
(mCherry n=2, hM4Di n=1) and PGB (mCherry n=4, hM4Di n=5). Overall, expression patterns did
not differ substantially between mCherry control animals (data not shown) and hM4Di expressing
animals.
To determine the proportion of cholinergic cells targeted by the virus, we performed
immunohistochemistry for the viral-tag mCherry and examined the co-expression with the
cholinergic midbrain marker, NADPH. The hM4Di protein (or mCherry control) seemed to be
trafficked well throughout the cell as clear labelling of the fibers could be seen. We counted the
number of cells labelled with mCherry (DAB-brown), NADPH (blue) and cells labelled with both.
Overall, we estimated that the hM4Di-mCherry protein was expressed in 89% of PPT cholinergic
neurons (mCherry control=87%). Representative images are shown in figure 4.15C and D. Of note
there was a small percentage of neurons that were only mCherry positive (%mCherry cells that
were cholinergic: hM4Di=88%, mCherry=90%), roughly half of these mCherry only cells were very
small with a diameter of less than 10 µm.
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All our behavioural and electrophysiological data was collected during the 21-35 day timepoint and so we included only animals sacrificed at these time points for co-expression analysis
as this more accurately represented viral expression during our experiments (mCherry n=4,
hM4Di n=5). Animals sacrificed past this date had very strong expression of mCherry, with very
heavy expression in areas the cholinergic PPT neurons project to (supplemental figure A.3). Using
a fluorescent mCherry antibody, it was clear that this was due mCherry being expressed heavily
by the axons and terminals of infected neurons. This occurred with both virus types. It may also
be due to accumulated fluorescent toxicity, as has been suggested previously (Liu et al., 1999; for
review see Allen et al., 2015).
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Figure 4.14 Expression of the hM4Di-mCherry Protein Throughout the PPT
To determine the efficacy of our viral injection we examined the expression of the viral tag
mCherry in hM4Di expressing animals and plotted this across representative images of the PPT.
We determined if mCherry expression within the PPT for each representative slice was present
for each animal. Then the proportion of animals expressing mCherry at that representative slice
was calculated (n=12). The highest proportion of animals (90%+) expressed mCherry in the
caudal aspect of the PPT, and the lowest in the anterior (>20%). Some animals displayed
mCherry expression in non-targeted regions, including the LDT (caudal aspect, shown in slice 8.16) and PGB (anterior aspect, -7.4-6.84 mm). The expression of control animals did not differ
substantially (data not shown). Images were adapted from (Paxinos and Watson, 2005).
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Figure 4.15 The hM4Di-tag mCherry is Co-expressed with the Cholinergic Marker, NADPH
In both images mCherry was labelled in brown (DAB), whereas NADPH (blue) marked midbrain
cholinergic neurons. A) Representative image of mCherry and NADPH expression in the PPT (2x
magnification). The scale bar represents 500 µm. B) Representative image of co-expression of
NADPH and hM4Di-mCherry in the PPT at 20x magnification. Dually-labelled neurons appeared
very dark blue, almost black, compared to cholinergic neurons not expressing mCherry (indicated
by the red arrow). Overall, we determined that hM4Di-mCherry was expressed in 89% of
cholinergic neurons. Here, the scale bar represents 25 µm.
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4.3.2.9 Summary of Inhibition of the Cholinergic Neurons of the PPT
Overall, we saw that DREADD-induced inhibition of cholinergic cells using CNO improved
short-term habituation of the ASR, and reduced baseline startle magnitude. We did not observe
an impact on PPI or habituation of non-reflexive behaviours. Our control experiments show that
DREADD-induced inhibition was effective at a cellular and population level as demonstrated by
in vitro patch clamp recordings and in vivo electrophysiology. Furthermore we observed that
multi-unit auditory responsiveness in the PPT was unaltered by DREADD-induced inhibition,
complementing our finding of no impairment of auditory PPI. Finally, we confirmed that our
DREADD-induced inhibition was able to alter behaviour as inhibiting cholinergic neurons of the
PPT blocked morphine-induced CPP.

4.3.3 Activation of Cholinergic PPT Neurons Using Optogenetics
For this experiment we injected a Cre-dependant optogenetic virus (rAAV5-EF1α-DIOChR2(H134R)-EYFP, n=7, 1 male, 6 female), or the respective control virus (rAAV5-EF1α-DIOEYFP, n=6, 1 male, 5 female) into the PPT and implanted a light fiber. Cells expressing
ChR2(H134R) were activated by blue light. In this section, sex was not included as a factor in our
statistical analysis because of the low number of males (n=1/group).
4.3.3.1 Startle Reactivity of ChR2 Expressing Animals
Prior to sensorimotor gating testing, all animals completed an I/O function, which
assessed startle reactivity with increasingly intense auditory stimuli. During testing animals were
tethered to the LED commutator, but received no light stimulation. As revealed by a two way
repeated measures ANOVA (virus type × sound intensity) on unamplified startle amplitudes, both
YFP only expressing controls and ChR2 animals show increasing startle magnitudes concordantly
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with increasing sound intensity. We found a significant effect of sound level (F(9,90)=9.2, p<0.001),
but no effect of virus type (F(1,10)=0.9, p=0.37) or interaction between virus and sound level
(F(9,90)=0.4, p=0.91). This indicates normal startle reactivity in both groups, without optogenetic
stimulation, as shown in figure 4.16.

Figure 4.16 Startle Reactivity is Normal in ChR2 Expressing Animals
Both YFP controls and ChR2 expressing animals showed increasing startle responses with
increasing sound intensity. This suggests that the expression of ChR2 - in contrast to DREADD
expression - does not alter startle reactivity (YFP n=6, ChR2 n=7).
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4.3.3.2 Activation of Cholinergic PPT Neurons and its Effects on Startle Magnitude
To see the effect of cholinergic PPT neuron activation on startle magnitude, we
photostimulated these neurons simultaneously with the presentation of an auditory startle
pulse. We individually normalized startle amplitudes by calculating a startle magnitude ratio
(ratio: average startle magnitude with photostimulation/average startle magnitude without
photostimulation). Differences from 1 indicated that photostimulation altered startle magnitude.
As displayed in figure 4.17A, the control animals showed no change in startle magnitude with
photostimulation as they had a ratio of 1.05 (±0.5), whereas ChR2 expressing animals had a ratio
of 1.82 (±0.32), indicative of an increased startle magnitude with photostimulation. This
difference in ratio was statistically significant (independent samples t-test: t11=2.23, p=0.04).
Interestingly this effect became greater as the number of consecutive trials with
photostimulation progressed. This is shown in figure 4.17B. One animal was removed from ChR2
group as it was an outlier.
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Figure 4.17 Photostimulation of Cholinergic PPT Neurons Increased Startle Magnitude
A) For each animal, we normalized startle amplitudes after photostimulation (Ratio: average
startle amplitude with photostimulation/average without, 1=no change as indicated by the
dotted line). ChR2 animals showed significantly increased startle magnitudes during stimulation
compared to YFP controls. As shown in B) this increase appeared to be progressive. Startle
magnitude was normalized to the first three trials prior to photostimulation for each animal.
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4.3.3.3 Optogenetically-Induced PPI
If PPI is mediated by the activation of cholinergic PPT neurons inhibiting the startle
pathway, we predicted we could induce PPI by activating these neurons prior to a startling sound.
In order to investigate this, we administered several photostimulation frequencies and
intensities, in both unilateral or bilateral stimulation paradigms, prior to the startle pulse (see
appendix A for more detail). Within each testing session, we also presented trials with an auditory
prepulse as a control condition (see figure 4.3).
Bilateral photostimulation of cholinergic PPT neurons at 50 Hz did not induce any
inhibition of startle. In fact, similar to concurrent photostimulation, prior activation of cholinergic
neurons facilitated startle and caused negative %PPI values, as shown in figure 4.18. We analysed
this using a three way repeated measures ANOVA (type of prepulse × ISI × virus) and found a
significant difference in %PPI depending on whether a optogenetic or auditory prepulse was
administered (F(1,11)=1106, p<0.001). Most importantly, we found a significant interaction
between virus and prepulse type (F(1,11)=97, p<0.001), which suggested that photostimulation
influenced ChR2 animals and controls differently.
A follow-up ANOVA (virus × ISI) on %PPI using photostimulation prepulse conditions only,
revealed that stimulation produced significantly different effects on ChR2 compared to YFP
control animals across all ISIs (F(1,5)=17, p<0.01). This effect was greatest at 15 ms, which induced
an increase of startle magnitude by 86% (±13%) of baseline startle magnitude. Unilateral
stimulation produced an increase in startle roughly half to bilateral stimulation (supplemental
figure A.4), indicating that there is a dose effect depending on the amount of photostimulation
administered before the startle stimulus.
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As a control, within each testing session, auditory PPI was also assessed. Auditory
prepulses (85 dB SPL) induced normal PPI in both ChR2 and control animals. We analyzed this
using a follow up two way repeated measures ANOVA (virus × ISI) which showed no effect of virus
type on PPI (F(1,11)=0.4, p=0.54). In control animals PPI ranged from 67-85% depending on the ISI;
similarly in ChR2 animals it ranged from 69-87% (figure 4.18), indicating that the lack of
optogenetically-induced PPI was not due to a general PPI deficit in these animals.
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Figure 4.18 Activation of Cholinergic PPT Neurons as a Prepulse Induces Startle Facilitation
Bilateral activation of cholinergic PPT neurons induced a facilitation of startle magnitude in ChR2
expressing animals, which resulted in negative %PPI values (denoted startle amplitude with a
prepulse relative to startle amplitude without). This effect was not present in YFP expressing
control animals. The greatest facilitation of startle was observed at the 15 ms ISI (as denoted by
a, which references that %PPI was statistically different at 200 vs 15 ms). Auditory prepulses (85
dB SPL) produced normal %PPI values in both ChR2 and YFP expressing animals, this suggests that
our failure to optogenetically-induce PPI was not due to a general PPI impairment in these
animals (ChR2 n=7, YFP n=6).
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4.3.3.4 Optogenetically-Induced Startle Facilitation was Blocked by Systemic Nicotinic
Antagonism
In order to gain some insight into what kind of ACh receptor subtype mediates the
increase in startle by photostimulation, we examined if blockade of nicotinic receptors could
prevent this increase across both photostimulation paradigms (photostimulation as a prepulse
OR simultaneous photostimulation during a startling sound). Animals were injected with saline
or the nAChR antagonist mecamylamine (3 mg/kg IP) one week apart, before they were re-tested
with 50 Hz photostimulation.
We analyzed startle magnitude following photostimulation of the PPT as a prepulse using
a three way repeated measures ANOVA (drug × virus × ISI). We reconfirmed that ChR2 expressing
animals showed significantly increased startle during photostimulation as there was a main
effect of virus type (F(1,11)=13.5, p<0.01). We also found a significant difference between
mecamylamine treatment and saline (F(1,11)=15.6, p<0.01), and a significant interaction between
drug and virus type (F(1,11)=13.8, p<0.01). Post hoc t-tests revealed that, in ChR2 expressing
animals, startle magnitude (measured by -%PPI values) significantly differed when give
mecamylamine compared to saline (t6=4.4, p<0.01); whereas in YFP controls this was not the case
(t5=1.0, p=0.18). Again, this effect was most prominent at the 15 ms ISI, where startle magnitude
was facilitated by 37% by photostimulation under saline treatment (%PPI: -37 ±7%), but
photostimulation had negligible effects under mecamylamine treatment as startle was
magnitude was similar to baseline values without a prepulse (%PPI: 6 ±10%). Overall, in ChR2
animals, mecamylamine blocked the increase in startle magnitude by photostimulation across
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ISIs as there was no interaction between drug and interstimulus interval (F(3,33)=0.8, p=0.5; figure
4.19A).
As a control, we examined if baseline startle magnitude or auditory PPI was impacted by
mecamylamine treatment. Basal startle amplitude (prior to photostimulation) was not different
in ChR2 expressing animals when given saline or mecamylamine (t6=1.7, p=0.14). With saline, raw
startle values were 1335 mV (±240) and with nicotinic antagonism it was 1626 mV (±265).
Additionally, auditory PPI was also unaffected by mecamylamine treatment (figure 4.19B). In a
separate three way ANOVA (virus × drug × ISI) that examined auditory PPI, we found no effect of
drug (F(1,11)=1.0, p=0.34), or virus type (F(1,11)=1.5, p=0.25) or interaction between these variables
(F(3,33)=0.1, p=0.96). This demonstrated that mecamylamine’s actions were specific to blocking
the startle facilitating effect via photostimulation of cholinergic PPT neurons.
Similar results were obtained using concurrent photostimulation of cholinergic PPT
neurons with an acoustic startle sound (figure 4.19C). We analyzed individually normalized startle
amplitudes (Ratio: photostimulation startle amplitude/startle without) using a two way repeated
measures ANOVA (virus × drug). Again, we re-confirmed that 50 Hz stimulation caused a
significant enhancement of startle magnitude in ChR2 animals, but not controls, as there was a
significant effect of virus (F(1,11)=6.9, p=0.02). The amount of enhancement with saline treatment,
1.70 (±0.31), was almost identical to that previously observed with our 50 Hz testing, 1.80
(±0.32), which demonstrated the stability of this effect (compare see figure 4.19C with 4.18A).
Most importantly however, we found that there was a significant interaction between drug and
virus type (F(1,11)=6.2, p=0.03). Post-hoc tests revealed that mecamylamine treatment completely
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blocked the optogenetically induced increase in startle in the ChR2 animals (t 6=2.5, p=0.04),
whereas there was no effect of drug in YFP controls (t6=1.0, p=0.36).

Figure 4.19 Nicotinic Antagonism Blocked Optogenetically-Induced Startle Facilitation
A) ChR2 and YFP control animals received an IP injection of saline (SAL) or mecamylamine (MEC),
before undergoing photostimulation of cholinergic PPT neurons prior to a startling sound.
Positive %PPI indicates startle inhibition, whereas negative values indicate startle facilitation.
Photostimulation enhanced startle magnitude relative to when no prepulse was present in ChR2
animals. This was blocked by administration of mecamylamine. B) Presentation of an auditory
prepulse prior to a startling pulse induced robust PPI in all animals, which was unaffected by
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mecamylamine treatment in all groups. C) Mecamylamine was also able to prevent startle
facilitation by concurrent photostimulation of cholinergic PPT neurons in ChR2 animals (YFP n=6,
ChR2 n=7).

4.3.3.5 Optogenetically-Induced Conditioned Place Preference (Positive Behavioural Control)
It has been demonstrated previously that pairing optogenetic PPT stimulation with a
context induces conditioned place preference (Xiao et al., 2016). To ensure that our
photostimulation paradigm was effective at activating cholinergic PPT neurons we
optogenetically induced CPP in ChR2 expressing animals as a positive behavioural control.
Animals were repeatedly exposed to two different environments; one was paired with bilateral
photostimulation of the PPT and the other was not. One animal from the ChR2 group was
eliminated from analysis as it was unable to complete testing.
On test day, animals freely roamed the test chamber and the time spent in each
environment type was recorded. We analysed this using a two way repeated measures ANOVA
(environment × virus). Animals expressing ChR2 tended to spend more time in the
photostimulation-paired environment (287 ± 26 s) compared to no stimulation-paired (215 ± 20s,
see figure 4.20A). Control YFP animals spent a similar amount of time in the stimulation-paired
environment as the unpaired (198 ± 24s and 238 ± 24s, respectively). However this trend just
failed to reach statistical significance as we saw no effect of virus (F(1,10)=4.3, p=0.06),
environment (F(1,10)=0.14, p=0.71) or interaction between these factors (F(1,10)=2.3, p=0.16).
An individual preference score was calculated for each animal (time spent in paired/time
spent in unpaired, 1=no preference). On average ChR2 animals had a preference score of 1.42
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(±0.2), which was significantly different from 1 (one-tailed, one sample t-test: t5=2.3, p=0.03).
Control YFP animals had a preference score of 0.94 (±0.2), which was not significantly different
from 1 (t5=0.2, p=0.42; figure 4.20B). This suggests that photostimulation-induced a mild
conditioned place preference in ChR2 animals but not controls.
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Figure 4.20 Activation of Cholinergic PPT Cells is Sufficient to Induce Mild CPP
Animals were exposed to two different environments, one paired with photostimulation of the
PPT and one without. A) On test day, ChR2 animals tended to spend more time in the side paired
with activation of cholinergic PPT neurons, however, this just failed to reach statistical
significance (p=0.06). B) A preference score was calculated for each individual animal (time spent
in stimulation-paired environment/time in non-stimulated environment, 1=no preference as
indicated by the dotted line). ChR2 displayed a significant preference for the paired side, whereas
YFP controls did not (n=6/group).
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4.3.3.6 Verification of ChR2 Expression and Photostimulation Efficacy using c-FOS
All of the animals included in this analysis had bilateral expression of the either the virus
containing the ChR2(H134R) opsin or YFP control. Placements of the light fiber implants were
also verified to be within (or just above) the PPT (see figure 4.21). Although there was some
spread in terms of the location of the light fiber, in general, most targeted the mid PPT.
We examined the expression of the viral-tag YFP and the co-expression with the
cholinergic marker ChT or the cellular activation marker, c-FOS. The ChR2(H134R) protein (or YFP
control) seemed to be trafficked through the cell well as clear labelling of many fibers could be
seen. We counted the number of cells labelled with YFP, ChT (red) and cells labelled with both.
Overall we estimated that the ChR2(H134R)-YFP protein was expressed in 70% of PPT cholinergic
neurons (YFP control=73%). Inversely, 95% of YFP expressing neurons were cholinergic
(ChR2(H134R), YFP controls: 89%). An example image is shown in figure 4.22A. This confirmed
that ChR2 was expressed in the majority of PPT cholinergic neurons, but not in non-cholinergic
neurons.
We then analysed the co-expression of YPF with the cellular activation marker, c-FOS. We
found that our stimulation parameters induced c-FOS expression in 71% of ChR2(H134R)-YFP
expressing neurons, whereas in YFP controls only 8% of YFP expressing cells also expressed cFOS. An example image is shown in figure 4.22B. In both YFP control and ChR2(H134R) animals
non-YFP labelled cells were also expressing c-FOS. This could be due to basal levels of expression,
as animals were awake and mobile in their home-cages during photostimulation. We cannot rule
out however, that the heat or light activated off-target cells. Overall however, our staining
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indicated a good expression level of the optogenetic virus specifically in cholinergic cells, and that
our photostimulation paradigm was sufficiently activating these cells.

Figure 4.21 Placement of Bilaterally Implanted Light Fibers
A) This image displays the sagittal view of the PPT (medial/lateral plane: ±2.1). Shown in blue are
the placements of the light fiber tips in ChR2(H134R) expressing animals, and black represents
YFP controls. Triangles denote placement on the right side and dots on the left. It appeared that
in both groups, the hits varied throughout the PPT, denoting good placement and stimulation.
Images were adapted from (Paxinos and Watson, 2005). B) Is a representative image of the tracts
of implanted light fibers. Scale bar is 500 µm.
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Figure 4.22 ChR2(H134R) is Expressed in Cholinergic Neurons and Photostimulation is Effective
A) Expression of ChR2(H134R and its co-expression with a cholinergic marker, ChT. Overall we
estimated that the virus was expressed in 70% of cholinergic neurons within the PPT (YFP
controls: 73%). Furthermore, we verified our photostimulation was effective using the cellular
activation marker, c-FOS, shown in panel shown in panel B). Expression of c-FOS and
ChR2(H134R)-YFP neurons: 71% of ChR2(H134R)-YFP neurons expressed c-FOS, (YFP control
animals: 8%)
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4.3.3.7 Summary of Cholinergic PPT Activation
Overall, we observed that activation of cholinergic PPT neurons facilitated startle. This
was reliably observed if activation was during a startling sound or if activation was used as a
prepulse. This enhancement was blocked by the nicotinic antagonist mecamylamine. We
validated our optogenetic manipulations by recapitulating the previously reported induction of
CPP through PPT cholinergic activation, as well as increased c-FOS activation in infected
cholinergic neurons.

4.4 Discussion
The goal of these studies was to decipher the role of PPT cholinergic neurons in startle
and startle modulation. The anatomical and cell-type specificity necessary for these experiments
required the use of a transgenic rat model. As previously discussed, it is important to ensure that
the transgene expression does not alter basal sensory filtering or sensorimotor gating abilities.
As a first step, we therefore tested transgenic animals in comparison with WT littermates. We
found that transgenic males had slightly lower maximal startle amplitude than their WT
counterparts (figure 4.4B). The transgenic male’s startle magnitude was still very robust,
detectable, and identical to that of WT females. Additionally, all transgenic animals had the same
startle threshold as WT (~85-90 dB SPL, figure 4.4A). This difference in maximum startle
amplitude was not due to an effect of weight on signal detection as males from both genotypes
weighed approximately the same. Regardless of this difference in startle reactivity, I found no
differences in habituation (figure 4.6) or PPI (figure 4.7) of the ASR in transgenic rats. Moreover,
we found no differences in the habituation of motivated behaviours or general locomotor
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behaviour (figure 4.6). Therefore, I concluded that these animals were an appropriate model to
study sensory filtering and sensorimotor gating mechanisms using optogenetics and DREADDS.
This study used two complimentary approaches to investigate cholinergic PPT
contributions to startle, PPI and locomotor behaviour: neuronal silencing by DREADDS and
optogenetic activation. We validated that methods were functional using electrophysiological
recordings (figure 4.11 & 4.13) or c-FOS labelling (figure 4.22). Functionality at a cellular level,
however, does not necessarily equate that a system will be sufficient to impact behaviour.
Therefore, we included CPP a positive behavioural control. Inhibition of these neurons disrupted
morphine-induced CPP (figure 4.13), whereas activation of these neurons were sufficient to
induce CPP (Xiao et al., 2016, also see Gut & Winn, 2016 for discussion). We confirmed these
findings (figures 4.13 and 4.20); as these served as a positive control measure, they will not be
discussed further. Together, the control experiments across different levels of analysis suggest
that both the DREADD inhibition and optogenetic activation were functional.

4.4.1 Prepulse Inhibition
According to the current hypothesis of the majority of sensorimotor gating literature, the
major mechanism of PPI is an inhibition provided by cholinergic neurons of the PPT to startlemediating areas of the brainstem, the PnC. To test this directly, we inhibited these neurons during
sensorimotor gating testing using DREADDs. We found no impairment of PPI (figure 4.10A).
Instead, we found that in hM4Di-expressing animals, CNO induced a general decrease in startle
magnitude (figure 4.10B). The lack of PPI impairment following cholinergic PPT inhibition was not
due to a dysfunctional DREADD system. We confirmed our cholinergic PPT inhibition was
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functional through in vitro recordings at the neuronal level and observed robust inhibition (figure
4.11). Additionally when we performed in vivo electrophysiological recordings we saw a slight
reduction in the spontaneous activity of multi-unit clusters following CNO administration (figure
4.12C & D). This was fitting with select inhibition of a subset of neurons within the PPT. We also
examined auditory-evoked activity and found that cholinergic inhibition did not significantly alter
auditory responsiveness within the PPT (figure 4.12E & F). If these neurons were critical for
auditory PPI, we should have observed a decrease in auditory responsiveness.
Intact auditory processing and PPI post CNO administration provided a cohesive rationale
for our findings and past studies (e.g. MacLaren et al., 2014), however it must be acknowledged
that we inhibited these neurons, not irreversibly silenced them. Activation of the hM4Di protein
hyperpolarizes neurons via activation of potassium channels (Armbruster et al., 2007) and
inhibits presynaptic neurotransmitter release (Stachniak et al., 2014). It cannot be ruled out that
suprathreshold stimuli may have overpowered this inhibition. However, our complimentary
optogenetic data suggests this was not a large factor. In general, our findings mirror the effects
of a cholinergic lesion by a diphtheria toxin-fusion protein as reported by MacLaren et al. (2014),
however, their reduction in startle magnitude was much more profound. Our hM4Di tag,
mCherry, was highly expressed by cholinergic neurons and expression spread throughout the
majority of the PPT (figures 4.15 and 4.16), much like the spread and efficacy of the previously
reported lesions. Therefore, differences in the magnitude of startle reduction between these two
studies may highlight the difference between temporary inhibition compared to total removal of
these neurons.
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To further address the role of cholinergic PPT neurons in PPI, we also attempted to induce
PPI by optogenetically activating these neurons prior to a startling sound – basically to see if
photostimulation could replace the acoustic prepulse. Instead of inhibiting startle, we found
activation of these neurons enhanced startle, resulting in negative PPI values, or startle
facilitation. The lack of optogenetically-induced PPI was not due to an impairment of PPI in
general as auditory prepulses reliably induced PPI (figure 4.18). Moreover, when we
photostimulated these neurons during a startle response, this also increased startle magnitude
(figure 4.17A). This nicely compliments our hM4Di-induced reduction in startle, indicating that
cholinergic neurons in the PPT can indeed modulate startle responses, but they seem to facilitate
startle rather than inhibit it, ruling out any major role in the mediation of PPI.
Our findings add to the growing body of more recent literature that has started to suggest
that PPT cholinergic neurons are not the primary mechanism underlying PPI. While this
contradicts the majority of the traditional predictions within the field, there is now converging
evidence using both acute (current study) and chronic manipulations (Machold, 2013; MacLaren
et al., 2014) of spatially restricted cholinergic function. Therefore, we suggest that ACh modulates
PPI, presumably at the level of the PPT, but it does not mediate PPI. It is likely that other cells,
within the PPT and/or even outside of it, play a more important role than previously assumed.
Future studies should seek to re-examine the neural circuitry of PPI and test if GABAergic and/or
glutamatergic PPT neurons are responsible for PPI.
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4.4.2 Modulation of Startle Magnitude
Both of our complimentary methods found that cholinergic PPT neurons modulated
startle reactivity: inhibition reduced startle magnitude whereas activation increased it. Thus, the
role of cholinergic midbrain neurons seems to be to maintain or enhance startle reactivity. This
is fitting with the cholinergic PPT neuron’s role in arousal. These neurons have been
demonstrated to be critical in sleep-wake transitions (Van Dort et al., 2015), and are part of the
Ascending Reticular Activating System. Increased startle reactivity may be a reflection of
increased arousal. Overall, based on our findings, we predict that the PPT acts as an integration
point to modulate startle magnitude.
Stimulation of cholinergic PPT neurons enhanced startle magnitude (figure 4.17B & figure
4.18A), fitting with sensitization and/or PPF. Our observed improvement of short-term
habituation of the ASR was surprising when examined in within the scope of previous literature
as ACh has not been linked short-term habituation of the ASR. However, our results would be
very logical if these neurons are involved in sensitization of startle. According to the dual process
theory, behavioural output is the sum of the opposing forces: habituation and sensitization
(Groves and Thompson, 1970). Inhibition of these neurons could have inhibited sensitization,
resulting in improved short-term habituation. Indeed, our observed enhancement of short-term
habituation had the greatest influence on the rate of habituation, i.e. at early trials, which are
supposedly influenced by sensitization to a greater degree than later trials, where sensitization
subsides (Pilz and Schnitzler, 1996). Additionally, cholinergic drugs have been known to generally
enhance startle magnitude (see Chapter 3 or Acri et al., 1995; Philippens et al., 1997), but little
research has investigated if these types of effects contribute to the mechanism of startle
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sensitization. Furthermore, as these studies have used systemic manipulations it is unclear to
what extent cholinergic effects on startle magnitude are due to modulatory brain regions, or due
to side effects on motor systems. Our evidence highlights a potential central mechanism of
sensitization that involves the cholinergic cells of the PPT.
It has been well documented that substance P is involved in the sensitization of the ASR.
Local infusions of substance P into the PnC increased startle magnitude; furthermore,
antagonism of this neuropeptide prevented sensitization of startle via foot shocks (Krase et al.,
1993). Interestingly, Kungel et al. (1994) found that the substance P innervation of the PnC mainly
came from the PPT and LDT. They also observed that substance P’s ability to increase excitability
of PnC neurons was increased with the co-administration of a cholinergic agonist. An estimated
30% of cholinergic neurons in the PPT co-express substance P markers (Standaert et al., 1986).
At this point, it is unclear if these neurons modulate startle in the same manner as solely
cholinergic neurons or not. It could be that cholinergic neurons that co-express substance P have
a role in sensitization and enhance startle magnitude, whereas those that only release ACh are
important for PPI and inhibit startle magnitude. Both our DREADD and optogenetic methods
would have infected both types of cholinergic neurons. If this was the case, it appears that
cholinergic substance P expressing neurons have a dominant effect on startle magnitude that
overshadowed any inhibition of startle. This would be fitting with the well-documented inhibition
of giant PnC neurons that occurs in vitro (Bosch and Schmid, 2006, 2008; Pinnock et al., 2015).
However, there is evidence to suggest that this dual role of cholinergic neurons is not
feasible. Our findings of unimpaired auditory processing within the PPT following inhibition of
cholinergic neurons indicate that non-cholinergic neurons are better suited to provide the
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inhibition necessary for PPI. Additionally, in vitro recordings of unidentified PnC neurons in the
cat following electrical stimulation of the PPT caused prolonged excitatory responses which was
blocked by administration of scopolamine, a muscarinic antagonist, and could be induced using
an ACh agonist (Homma et al., 2002). Therefore, we propose that ACh may have differential
effects depending on cell types within the PnC, and/or depending on whether it is synaptically
released or tonically present. However, it remains undetermined how cells within the PnC
incorporate various inputs to determine behavioural output, or how other cell types modulate
giant-neuron activity. Regardless, the dominant effect of midbrain cholinergic regulation
appeared to be an increase in PnC excitability, which resulted in higher startle amplitudes.

4.4.3 Nicotinic Receptors and Startle Magnitude
Our optogenetically-induced enhancement of startle magnitude was blocked by systemic
administration of the nicotinic antagonist, mecamylamine (figure 4.19A). Although it robustly
reduced the enhancement of startle, mecamylamine treatment did not alter auditory PPI (figure
4.19B) consistent with previous studies (Curzon et al., 1994; Higashino et al., 2016). Although
here we have shown that nicotinic receptors are critical for optogenetically-induced
enhancement, it is not clear which nAChR subtype is responsible. In general, systemic nicotine
and nicotinic receptor agonism have been well documented to increase startle magnitude and
improve PPI (Acri et al., 1994; Acri et al., 1995). In Chapter 3 we suggested that the α7-nAChR is
critical for the systemic nicotine effect. However, local infusions of nicotine directly into the PnC
have been shown to disrupt PPI, which appeared to be mediated by α4-β2 nAChRs and not α7nAChRs. Therefore, both α4-β2 nAChRs as well as α7-nAChRs seem to modulate startle, although
apparently at different brain regions. Whereas there is evidence that α4-β2 nAChRs are
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expressed in the PnC, startle modulation by α7-nAChRs seems to be mediated by higher brain
structures (Pinnock et al., 2015). Both could be involved in our observed nicotinic-mediated
modulation of startle reactivity. Moreover, it is important to note that chronic activation of
nicotine receptors by agonists might lead to receptor internalization, thereby rendering them
antagonists, hence any study involving the application of nicotine or other agonists must be
interpreted very carefully.
Local circuitry within the PnC and PPT is poorly understood. It is important to keep in mind
that the optogenetic and chemogenetic manipulations of PPT cholinergic neurons could have
impacted either inhibitory glycinergic or GABAergic interneurons or other excitatory cell types
within the PPT or PnC, which ultimately promoted excitability of the giant-neurons and enhanced
startle. Additionally, cholinergic PPT neurons also project to several other areas known to be
critical for startle, including the inferior colliculus (Semba and Fibiger, 1992) and cochlear nucleus
(Mellott et al., 2011). For example, it has been shown that cholinergic agonism within the
cochlear nucleus increased neuronal activity (Chen et al., 1998), which could fit with our observed
results. As we have stated before, studies have also shown that within the PnC substance P
induces excitatory responses of unidentified neuron types, and that was enhanced by cholinergic
agonism (Kungel et al., 1994). Therefore, it could be that some of our findings are also due to the
actions of substance P.
Overall, we conclude that there is no simplistic circuit that could reconcile all observations
with regards to cholinergic modulation of startle. But regardless of where the mechanism of
action occurs, it is clear from our data that cholinergic projections from the PPT serve to modulate
startle, more specifically enhance it, and that this is at least partially mediated though nicotinic
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receptor activation. Future experiments need to address the details of neural circuitry and
synaptic mechanisms.

4.4.4 Habituation of the ASR and Locomotor Behaviour
In contrast to effect on short-term habituation of the ASR, we did not observe any
influence on the short-term habituation of the motivated behaviour, i.e. locomotion (figure 4.9C
& D). Habituation of the ASR and locomotor behaviour have been long known to be differentially
regulated (Hughes, 1984). Here we provide evidence that sensitization of these behaviours are
also differentially regulated. Our evidence suggests that sensitization (or enhanced arousal,
future studies will need to pinpoint the mechanism underlying our observed startle modulation)
mechanisms do not reflect a global heightening of excitability that robustly enhances all
behavioural responding. Instead, sensitization of different behaviours appeared to be
differentially mediated.
ACh has been previously documented to be important for both the short- and long-term
habituation of locomotor behaviour (Schildein et al., 2002; Lamprea et al., 2003; Dere et al.,
2008). In particular, cholinergic activity within the nucleus accumbens, an area the PPT projects
to (Dautan et al., 2014), has been particularly implicated (Schildein et al., 2002). However, our
data indicates that the midbrain cholinergic neurons are not providing the input necessary for
this behaviour. Other cholinergic centers may relay this information to the nucleus accumbens.
Indeed, it has been shown that habituation of locomotor behaviour was more strongly correlated
with cholinergic activity in the hippocampus (Thiel et al., 1998; Giovannini et al., 2001).
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Finally, the PPT has been traditionally thought of as a nucleus that is highly important for
motor control, specifically locomotion. In a recent review it was suggested that the PPT does not
directly mediate locomotion, but can modulate it through its participation in part of a lower-level
action selection process (Gut and Winn, 2016). We observed no impairment in locomotion
following cholinergic inhibition of the PPT (figure 4.9D) and no impact of cholinergic activation
on locomotor behaviour (data not shown). This is fitting with the newly conceptualized role of
the PPT as part of a low level action selection circuit, as proposed by Gut and Winn (2016).

4.4.5 Caveats
Like any study, our observations should be considered with a few caveats in mind. Firstly,
although we found no alterations in the sensory filtering or sensorimotor gating capabilities of
within the transgenic Cre-ChAT rat line, transgenic animal models may not always best reflect
normal physiological functioning. Transgenic animals can have off-target effects that alter
behaviour, cognitive, or muscular function (e.g. see Kolisnyk et al., 2013). Although we found no
major indication that this was the case, and others have published behavioural studies using this
identical line (Pienaar et al., 2015; Xiao et al., 2016), there could be off-target effects that we are
not currently aware of.
With regards to our DREADD-induced inhibition of the cholinergic PPT, we found some
unexpected data that should be noted. Firstly, we saw that startle magnitude and reactivity was
different between hM4Di-expressing animals and mCherry controls (figure 4.8). This was of
special concern because this testing was conducted without administration of CNO. Cre-ChAT
rats (with no virus injection) show a very similar curve to that of mCherry control Cre-ChAT rats
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(compare with figure 4.4) indicating that the surgical procedure itself did not impact this.
Therefore, this implies that the hM4Di receptor potentially had constitutive or basal activity that
did not require ligand binding. A recent paper by Roth (2016) has reviewed how high expression
levels of DREADD proteins may be particularly susceptible to this. As we observed very robust
inhibition at the neuronal level (figure 4.11) and mCherry labelling was very dark and trafficked
well throughout the entire neuronal body and processes (figure 4.15), it is likely that this
accounted for our observed increase in startle reactivity. Furthermore, during our in vivo
electrophysiological recordings it is possible that we again detected this constitutive activity: the
signal to noise ratio we observed specifically in hM4Di infected PPT neuronal recordings
prevented us from being able to isolate single-unit data. This was not a technical issue because
we were able to decipher single-unit activity in mCherry controls. Why constitutive activity of an
inhibitory receptor would increase startle reactivity or alter the noise-floor of
electrophysiological recordings is unknown, but it might be through non-specific effects on any
signalling pathway within the cell.
Lastly, it should be noted that although optogenetic stimulation is a powerful tool, the
stimulation frequency and intensity used in this study likely does not accurately reflect
endogenous physiological activity of cholinergic PPT neurons. This is a frequent critique of
optogenetics as it is still a new technology (Boyden, 2015; Deisseroth, 2015). Our stimulation
paradigm was 50 Hz, but the maximum frequency the ChR2(H134R) opsin can entrain to is likely
around 40 Hz (Fenno et al., 2011). It is unknown which stimulation frequency would be best
suited to capture the natural activity of PPT cholinergic neurons, if it is possible at all. Instead, we
decided to use a stimulation paradigm that presumably induced maximum cholinergic-PPT
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activation. Therefore, our high photostimulation frequency should induce robust, but not timelocked, neuronal activity. Future studies should attempt to modulate neuronal activity in a more
physiologically relevant manner when possible.

4.4.6 Conclusions
This study has uncovered an exciting role for midbrain cholinergic neurons in the
modulation of startle. Fitting with more recent studies by others, we were unable to find any
alteration of PPI with cholinergic PPT manipulation. Our DREADD and optogenetic systems were
validated at the neuronal and behavioural level which indicated that the lack of on impact on PPI
was not due to methodological issues. This adds to the growing evidence suggesting that
activation of these neurons are not the primary mechanism underlying PPI (see also Machold,
2013; MacLaren et al., 2014). Instead, we found that midbrain cholinergic function serves to
generally modulate startle reactivity. Inhibition of these neurons decreases startle, whereas
activation reliably enhances it, in accordance to the role of cholinergic PPT neurons in arousal
and hinting on a potential role in startle sensitization. There is no impact of these neurons on
locomotor behaviour. Although we have implicated nicotinic receptors in mediating this
enhancement of startle magnitude, future studies will have to determine if other receptors play
a role, and at what part in the startle circuitry this effect occurs. Although we did not discuss the
role of the cholinergic midbrain in CPP here this is an exciting development. Future studies may
also want to better examine the impact on VTA and nucleus accumbens dopaminergic signalling,
and what receptors are responsible for this as well. Again, this may lead to a better understanding
about how the cholinergic cells serve to encode context, and if this is related to their function in
arousal.
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5. Chapter 5: General Discussion
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5.1 A Summary of Cholinergic Modulations of the Acoustic Startle Response
Appropriate filtering of unnecessary sensory information is critical for normal cognitive
functioning. To study sensory filtering, I used prepulse inhibition and habituation of the ASR. I
manipulated cholinergic activity using a variety of methods including transgenic and KO mice
models, DREADDs and optogenetics. The results are summarized in Table 1.
In Chapter 2, I reported that reduced cholinergic tone did not impact PPI or short-term
habituation, but impaired long-term habituation. I was able to rescue this deficit by enhancing
remaining cholinergic activity via galantamine. This is the first evidence that ACh is involved in
long-term habituation of the ASR, as ACh was previously assumed to have no role in habituation
of reflexive behaviours.
Next, narrowing my research focus, I investigated which specific cholinergic receptors might
mediate cholinergic modulation of the ASR. To do so I examined habituation and PPI in an α7nAChR KO mouse line (Chapter 3). Disruptions in this receptor have been documented in
schizophrenic populations and have been correlated with other measures of auditory gating
(Freedman et al., 1997; Freedman et al., 2000; Leonard et al., 2002). I found normal long- and
short-term habituation, but mildly impaired PPI in these mice. This suggests that the α7-nAChR
is not critically involved in mediating PPI. Despite impairments in PPI, I found no correlation with
higher cognitive spatial abilities in the Barnes maze task. Future studies may want to investigate
if sensory filtering and sensorimotor gating disruptions correlate better with differential aspects
of cognition (e.g. sustained attention) to provide an overview of how these processes relate to
the broad spectrum of cognition (Cyr et al., 2015).
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I also found exciting evidence that nicotine-induced enhancement of startle magnitude and
PPI were absent in α7-nAChR KO mice. This is the first evidence that narrows the mechanism of
this PPI enhancement by nicotine to a single receptor. It also adds another layer to the well
documented pro-cognitive effects α7-nAChR agonism, further supporting the targeting of these
receptors as treatment options for individuals with PPI impairments, namely schizophrenia
(Martin et al., 2004; Olincy et al., 2006).
Lastly, my goal was to pinpoint to what extent midbrain cholinergic neurons in the PPT are
responsible for startle modulations using the newly available tools of optogenetics and DREADDs.
For the first time, this allowed for the transient and specific activation/inactivation of these
neurons during sensory filtering and sensorimotor gating tasks. The PPT has largely been
hypothesized to provide inhibitory cholinergic input that mediates PPI (Koch et al., 1993;
Swerdlow and Geyer, 1993; Fendt et al., 2001). In contrast to this long-standing concept, I found
that inactivation of these neurons reduces startle magnitude and enhances short-term
habituation, whereas activation of PPT cholinergic neurons increases startle magnitude. I
interpreted these results to suggest that cholinergic PPT neurons modulate startle reactivity, but
not in the way the field traditionally thought. It appears that the dominant effect of cholinergic
neurons is to enhance, not inhibit, startle. I suggest that this modulation fits well with the general
role of these neurons in arousal and discuss that this may also be a mechanism of startle
sensitization. In fact, one possibility is that the PPT may serve as a locus of plasticity and
integration for long-term modulation of startle (i.e. long-term habituation or sensitization).
Fitting with its role in arousal and association of environments and rewards (Olmstead and
Franklin, 1993; Kobayashi et al., 2002; Petzold et al., 2015; Xiao et al., 2016), these cells could
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serve to tonically regulate startle-mediating PnC excitability. I found no role of these neurons in
regulating locomotor activity, adding to the growing body of literature that suggests that PPT
neurons are a center for early action selection rather than a locomotor area (Gut & Winn, 2016).

5.1.1 Future Directions
Overall, my studies did not reveal a substantial role for Ach signaling in PPI, contrary to
the predominant theories in the field. This may suggest that ACh only modulates, but not
mediates, PPI. This is clearly illustrated in Table 1: we used several different manipulations of
cholinergic activity, none of which profoundly impacted PPI. In fact, the only impairment of PPI
we found was a mild deficit in α7-nAChR KO mice; additionally optogenetic stimulation of
cholinergic neurons facilitated, not inhibited, startle response magnitude. Therefore, it is likely
that other neurotransmitters play a more important role than traditionally thought.
Overall, my evidence suggests that the neural circuitry of PPI may need a new framework
that remedies its current emphasis on the cholinergic midbrain. Firstly, better understanding the
independent roles of GABAergic or glutamatergic cells within the PPT is critical as it is probable
that one, or both, of these cell types are very important for PPI, since general lesions to the PPT
reliably induced PPI deficits (Koch et al 1993; Swerdlow and Geyer, 1993; MacLaren et al., 2014).
Additionally, it would be interesting to investigate other potential sources of cholinergic
input to the PnC or other areas within the startle circuitry that may impact PPI. Better
understanding of cholinergic inputs to the PnC and other brain regions involved in PPI is the key
to determining the site of cholinergic modulation of PPI as pharmacological studies have reliably
documented this effect (Fendt and Koch, 1999; Jones and Shannon, 2000a, b; Yeomans et al.,
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2010; Pinnock et al., 2015). As our evidence suggests that cholinergic PPT neurons may not be as
critical as traditionally thought, these types of future studies will help us more accurately reframe
the PPI network (figure 1.3). Future studies should consider examining a recently suggested
circuit for PPI that entails cholinergic neurons of the ventral nucleus of the trapezoid body
modulating the activity of cochlear root neurons, a critical junction within the primary startle
pathway (Gomez-Nieto et al., 2008; Gomez-Nieto et al., 2014, see figure 1.3).
Furthermore, as my results also suggest a new role for the PPT in startle modulation, i.e.
maintaining and potentially sensitizing general startle reactivity, this role will need to be further
studied (see Table 1). Firstly, I hypothesize that the observed results are mediated mainly by the
subset of cholinergic neurons that co-express Substance P. Differentially examining the role of
cholinergic neurons that co-express substance P versus those that do not, could uncover a subtle
network that may exist within the PPT. Secondly, our observed midbrain cholinergic modulation
of startle magnitude may suggest that this center may be the locus of plasticity necessary for
long-term habituation. This locus was previously proposed (see Jordan and Leaton, 1983; Leaton
et al., 1985), however the field has not yet determined the site for this integration. We believe
the cholinergic midbrain is of particular interest because in Chapter 2 we highlighted that ACh
was important for long-term habituation. Due to methodological considerations, I was unable to
include an investigation of long-term habituation in Chapter 4, so ongoing studies are currently
addressing this.
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5.2 Differential Cholinergic Modulation of Reflexive vs. Non-Reflexive Behaviours
It has been well documented that ACh differentially modulates habituation of reflexive
and non-reflexive behaviours (Hughes, 1984). To examine this issue, I compared the habituation
of the ASR compared to locomotor behaviour in α7-nAChR KO mice, as well as during inhibition
of cholinergic PPT neurons. In both cases I did not find an impact on habituation of locomotor
behaviour. This highlights the potential importance of other cholinergic brain regions, e.g. the
hippocampus, in this type of behaviour.
I reported that inhibition of cholinergic PPT neurons improved startle habituation, likely
via a reduction in sensitization, without impacting locomotor habituation. This suggests that both
habituation and sensitization of reflexive vs. non-reflexive behaviours is differentially mediated.
Again, this highlights the complexity of related, but distinct, cognitive processes and shows that
there is no ubiquitous sensory filtering mechanism. It is important to identify these subtle
distinctions underlying these processes so that we can identify common treatment targets for
the shared hallmarks of cognitive dysfunction across diseases.

5.3 The Role of Nicotinic Receptors in Startle Modulation
I have reported that nicotinic receptors, particularly the α7-nAChR modulate PPI (Chapter
3). I have also demonstrated that nicotinic receptors play a key role in the modulation of startle
magnitude. Nicotine-induced enhancement of startle magnitude was absent in α7-nAChR mice,
and global nicotinic blockade was able to prevent optogenetically-induced enhancement of
startle. Future studies should seek to determine at what points within the startle circuitry this
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modulation is occurring, and what the physiological or behavioural relevance of startle
magnitude may indicate.
Many disorders have been documented to have an increase in startle magnitude including
Post-Traumatic Stress Disorder (Grillon et al., 1996; however, see Morgan et al., 1996) or
Generalized Anxiety Disorder (Ray et al., 2009). We need to better understand the mechanisms
underlying enhancement of startle magnitude, including PPF or sensitization, in order to help find
treatment options for populations like this. However, it should be noted that ACh has not been
strongly linked to either of these disorders.
Manipulation
of Cholinergic
Activity
Global
Reduction of
Cholinergic
Tone (via
VAChT KD)
Global KO of
the α7-nAChR

Impact on PPI

None

Mild
impairment,
nicotineinduced
enhancement
of PPI is absent
None

Chemogenetic
Inhibition of
Cholinergic PPT
Neurons
Optogenetic
Facilitates
Activation of
startle
Cholinergic PPT response:
Neurons
(-%PPI)
Table 5.1: A Summary of Results

Impact on
Baseline Startle
Magnitude
None

Impact on STH

Impact on
LTH

None

Grossly
impaired,
rescued by
ACh agonism

None, nicotineinduced
enhancement of
startle is absent

None

No Impact

Reduced

Slight
enhancement

N/A

Enhanced,
blocked by
nicotinic
antagonism

May induce
sensitization

N/A

Overall, manipulations of cholinergic activity did not impact PPI. While we were able to see a mild
contribution of nicotinic receptors to PPI, a global knock-down of ACh did not impact PPI.
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Furthermore, manipulation of cholinergic neurons in the midbrain nucleus, the PPT, impacted
startle response magnitude in the opposite manner traditionally supposed by the field. Our
results suggest that ACh plays a minor role in PPI but that future studies should re-examine the
role of other neurotransmitters in this process.
5.4 Conclusions
This thesis highlights the modulatory role of cholinergic activity during the processing of
the acoustic startle response. My results indicated that cholinergic signaling is not critical for
mediating PPI, as traditionally hypothesized. Instead, my studies demonstrate that the most
robust effect of cholinergic modulation is to maintain startle reactivity and potentially regulate
sensitization of the startle response, which seems to be at least partially mediated through
nicotinic receptors. This is summarized in Table 1. Future studies should seek to further
understand if this midbrain cholinergic modulation of the ASR is critical for sensitization and its
potential role in long-term habituation phenomena. In addition, my findings would suggest that
the functional neuronal circuitry underlying PPI needs to be re-evaluated, starting with
distinguishing GABAergic vs glutamatergic modulations of PPI within the PPT.
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A. Appendix A

Contained in this Appendix are the supplementary figures for Chapter 4
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Figure A.1 Pilot Data Determining Effective CNO Dosage
Pilot testing demonstrated that only at a 10 mg/kg dose of CNO we were able to see a differential
effect in hM4Di animals compared to mCherry controls. At this dose, hM4Di animals show
significantly decreased startle amplitudes (raw data plotted, t7=3.6, p=0.004). This was not
apparent in control animals, or at any other dose tested (3 mg/kg in saline or 3 mg/kg in DMSO).
Therefore, this dose was selected for future experiments (n=4/group). Animals also completed
habituation and PPI testing. No effect of CNO was observed (data not shown).
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Figure A.2 Representative In Vivo Electrophysiological Spiking Activity in hM4Di and Control
Animals
A) Representative rastor plots (top row) and PSTH (bottom row) of evoked activity to an 85 dB
SPL noise burst in the PPT of an example mCherry control animal or B) hM4Di expressing animal
before and after systemic CNO administration. The average firing rate for each trial was
calculated using the spiking activity during 2-12 ms from stimulus onset. This is plotted in the
right bar graphs for both example animals. Stimulus onset and duration is noted by the red line
on rastor and PSTHs. The average spontaneous activity rate was defined by using the last 100 ms
of each trial. This is shown by the line on the bar graphs labelled SpontR. Most notably, these
examples recapitulate that in hM4Di animals spontaneous activity was reduced by CNO but
auditory evoked activity was not. No changes were seen in control mCherry animals.
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Figure A.3 mCherry Expression Changes with Time
As time progressed, mCherry expression changed. Shown in brown is mCherry staining (DAB) and
NADPH staining of cholinergic neurons (blue). The brown appeared to intensify with time
progression beyond 40 days after surgery. Please note that this was not due to an increase the
number of labelled neurons, but rather diffuse staining of the neuropil. This could be due to
improved mCherry trafficking to neuronal processes, or an indicator of fluorescent protein
accumulative toxicity. All behavioural and electrophysiological experiments were performed
between days 21-35. Images were taken at 2x magnification, scale bar is 500 µM.
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Startle Facilitation is Frequency Dependent
In order to determine the most effective photostimulation paradigm, we ran a subset of
animals with 10 and 1 Hz stimulation (YFP n=3, ChR2 n=4) in addition to the previously discussed
50 Hz (YFP n=6, ChR2 n=7). We analysed this using a three-way repeated measures ANOVA (virus
× frequency × ISI). Again, we confirmed that only ChR2 expressing animals showed a facilitation
of startle as there was a main effect of virus type(F(1,20)=14, p<0.001). While we observed a main
effect of stimulation frequency (F(1,20)=8.8, p<0.01), most importantly we also found a significant
interaction between virus type and frequency (F(1,20)=8.7, p<0.01). This denotes that some
photostimulation frequencies were more effective than others in the ChR2 expressing animals.
Post-hoc t-tests with Bonferroni corrections revealed that in ChR2 animals, the 50 Hz stimulation
was significantly different than the 10 and 1 Hz paradigms (independent samples t-test: t45=5.0,
p>0.001, t45=3.5, p>0.005 respectively). This highlights 50 Hz photostimulation as the most
effective, as shown in figure A.4A
Startle Facilitation is Maximal with Bilateral (vs. Unilateral) Photostimulation
In a subset of ChR2 expressing animals (n=3), we stimulated at 50 Hz unilaterally in order
to see whether there are any lateralization affects. A two way repeated measures ANOVA
(stimulation laterality × ISI) found no statistical difference between unilateral and bilateral
stimulation on PPI (F(1,2)=3.2, p>0.05) or interaction between interstimulus interval and
stimulation (F(3,6)=1.7, p>0.05). However, it appeared that within animals unilateral stimulation
produced roughly half the increase of bilateral stimulation (figure A.4B).
Startle Facilitation is Light-Intensity Dependant

211

We documented that the facilitation of startle was also dependant on the intensity of LED
photostimulation. We ran a subset of ChR2 expressing animals (n=3) with high (19.6-22.1 mW)
or low intensity (1-4 mW) photostimulation. We analysed this using a two-way repeated
measures ANOVA (photostimulation intensity × ISI). Low intensity photostimulation did not
enhance startle as effectively as we found a main effect of intensity (F(1,2)=24.8, p<0.05). In this
group, startle magnitude was always greater in the high intensity stimulation condition as there
was no interaction between intensity and interstimulus interval (F (3,6)=1.6, p>0.05). Overall this
indicated that sufficient light intensity, not just presentation of light alone, was necessary to
facilitate startle, as demonstrated in figure A.4C.
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Figure A.4 Facilitation of Startle is Dependant on Frequency, Laterality and Light Intensity
As shown in A) we reconfirmed that photostimulation was only effective in ChR2 expressing
animals, as denoted by the asterisk. Furthermore, we observed that stimulation frequency
differentially altered startle magnitude. We found that 50 Hz stimulation produces significantly
more enhancement of startle compared to 10 (denoted by a) or 1 Hz (denoted by b), across all
ISIs (50 Hz YFP n=6, ChR2=7, 10 and 1 Hz YFP n=3, ChR2=4). B) In a subset of animals (n=3),
unilateral (compared to bilateral) stimulation of the PPT produced a similar, but not quite as
large, enhancement of startle. However, this trend failed to reach statistical significance. Lastly,
as shown in C) this enhancement of startle was dependant on the intensity of stimulation. Low
intensity photostimulation (1-4 MW) failed to increase startle across all ISIs intervals, unlike high
intensity stimulation (n=3).
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